Home The Word Brain My Amedeo FAQ Privacy About


Amedeo Chinese

For Medical Students & Physicians

A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever.

Download the free PDF: Amedeo Chinese PDF

  Breast Cancer

  Free Subscription


Articles published in Ann Surg Oncol

Retrieve available abstracts of 824 articles:
HTML format



Single Articles


    September 2026
  1. NUNEZ O, Govind V, Wolde T, Heath R, et al
    ASO Visual Abstract: Variant of Uncertain Significance is Associated with Increased Bilateral Mastectomy in Lumpectomy-Eligible Breast Cancer Patients.
    Ann Surg Oncol. 2026 Sep 8. doi: 10.1245/s10434-026-20518.
    PubMed    


  2. AMBURN T, Joseph KA
    ASO Author Reflections: Preferred Language as a Social Determinant of Health in Breast Cancer Care.
    Ann Surg Oncol. 2026 Sep 8. doi: 10.1245/s10434-026-20540.
    PubMed    


  3. TSENG J, Dimitroff K, Sauder CAM, Chien AJ, et al
    Correction: ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.
    Ann Surg Oncol. 2026 Sep 5. doi: 10.1245/s10434-026-20527.
    PubMed    


  4. TSENG J, Dimitroff K, Sauder CAM, Chien AJ, et al
    Correction: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.
    Ann Surg Oncol. 2026 Sep 3. doi: 10.1245/s10434-026-20526.
    PubMed    


  5. LEGALL C, Darrigues L, Sabah J, Hamy AS, et al
    ASO Visual Abstract: Impact of Tumor Size on Neoadjuvant Chemotherapy Outcomes in Breast Cancer.
    Ann Surg Oncol. 2026 Sep 2. doi: 10.1245/s10434-026-20454.
    PubMed    


  6. GALLOWAY OW, Wilbers A, Sogade OO, Naaseh A, et al
    A Single-Institution Comparative Analysis of Bracketed Localization for Partial Mastectomy Using Traditional Wire and Wireless Methods.
    Ann Surg Oncol. 2026;33:8216-8224.
    PubMed     Abstract available


  7. LORENTZEN EH, Reich AJ, Nguyen K, Minami CA, et al
    Evaluation of Surgeon Attitudes Toward Frailty Screening in Breast Oncology Patients.
    Ann Surg Oncol. 2026;33:8195-8205.
    PubMed     Abstract available


  8. PARK KU, Delisle M, Hassett MJ, Minami CA, et al
    From Clinical Trial Awareness to Practice: Factors Associated with Intent to Omit Axillary Surgery Based on the SOUND Clinical Trial.
    Ann Surg Oncol. 2026;33:8165-8174.
    PubMed     Abstract available


  9. BAILEY V, Juckett L, Pessin S, Ghahrai N, et al
    Assessing Recent Trends in Lumpectomy and Concomitant Oncoplastic Procedures: A National Insurance Database Analysis.
    Ann Surg Oncol. 2026;33:8156-8164.
    PubMed     Abstract available


    August 2026
  10. CLARKE P, Pessoa EC, Coelho BA, de Araujo Brito Buttros D, et al
    Cavity Margins Sample Shaving as Part of Extended Vacuum-Assisted Breast Biopsy: A Potential Approach to Predict Percutaneous Breast Cancer Excision.
    Ann Surg Oncol. 2026 Aug 28. doi: 10.1245/s10434-026-20464.
    PubMed     Abstract available


  11. BECK AC, Carroll EF, Mukhtar RA, Cassidy MR, et al
    ASO Visual Abstract: Multidisciplinary Management Considerations in Invasive Lobular Breast Cancer: It Isn't Just Ductal.
    Ann Surg Oncol. 2026 Aug 28. doi: 10.1245/s10434-026-20455.
    PubMed    


  12. STRAUSS E, Hyman J, Paluch-Shimon S, Breuer S, et al
    Fertility Preservation Pathways in Young Women With Breast Cancer: A Single-Center Analysis in a Publicly Funded System.
    Ann Surg Oncol. 2026 Aug 26. doi: 10.1245/s10434-026-20414.
    PubMed     Abstract available


  13. AMBURN T, Louie D, Schwartz S, McFarlane A, et al
    Increased Axillary Nodal Metastasis in Patients with Breast Cancer and Limited English Proficiency.
    Ann Surg Oncol. 2026 Aug 24. doi: 10.1245/s10434-026-20422.
    PubMed     Abstract available


  14. CONROY MM, Gaur KS, Rein LE, Szabo A, et al
    A Population Based Analysis of Breast Cancer Outcomes Among Disaggregated Asian American and Pacific Islander Women.
    Ann Surg Oncol. 2026 Aug 22. doi: 10.1245/s10434-026-20451.
    PubMed     Abstract available


  15. LEGALL C, Darrigues L, Sabah J, Hamy AS, et al
    Impact of Tumor Size on Neoadjuvant Chemotherapy Outcomes in Breast Cancer.
    Ann Surg Oncol. 2026 Aug 21. doi: 10.1245/s10434-026-20307.
    PubMed     Abstract available


  16. SETO A, Port E, Bernik S, Sheng T, et al
    ASO Author Reflections: Radiologic Assessment of Residual Axillary Lymphadenopathy in Locally Advanced Breast Cancer After Neoadjuvant Therapy.
    Ann Surg Oncol. 2026 Aug 21. doi: 10.1245/s10434-026-20439.
    PubMed    


  17. XIA LY, Cao XC, Hu QL
    Discordance between Breast and Axillary Responses After Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer: Implications for Surgical De-Escalation.
    Ann Surg Oncol. 2026 Aug 20. doi: 10.1245/s10434-026-20437.
    PubMed     Abstract available


  18. PITSINIS V, Khitab N, Jordan L, Vinci A, et al
    ASO Author Reflections: From Feasibility to Implementation: Establishing Indocyanine Green as a Single-Tracer Strategy for Sentinel Lymph Node Biopsy in Breast Cancer.
    Ann Surg Oncol. 2026 Aug 19. doi: 10.1245/s10434-026-20444.
    PubMed    


  19. BECK AC, Carroll EF, Mukhtar RA, Cassidy MR, et al
    Multidisciplinary Management Considerations in Invasive Lobular Breast Cancer: It Isn't Just Ductal.
    Ann Surg Oncol. 2026 Aug 17. doi: 10.1245/s10434-026-20368.
    PubMed     Abstract available


  20. WAGNER BD, Chen J, Boe LA, Graziano FD, et al
    ASO Visual Abstract: Using Machine Learning to Predict Breast-Cancer-Related Lymphedema following Axillary Lymph Node Dissection.
    Ann Surg Oncol. 2026 Aug 11. doi: 10.1245/s10434-026-20391.
    PubMed    


  21. TAYLOR N, Chew YL, Ng TS, Palesty JA, et al
    ASO Visual Abstract: Recurrence in Real Time: Rethinking Breast Cancer Follow-Up with Circulating Tumor DNA.
    Ann Surg Oncol. 2026 Aug 11. doi: 10.1245/s10434-026-20371.
    PubMed    


  22. KAWASHIMA K, Chida K, Oshi M, Yamada A, et al
    ASO Author Reflections: Neuron Projection Guidance-A transcriptomic perspective on tumor-induced neural recruitment in breast cancer.
    Ann Surg Oncol. 2026 Aug 10. doi: 10.1245/s10434-026-20049.
    PubMed    


  23. KAWASHIMA K, Chida K, Oshi M, Yamada A, et al
    ASO Visual Abstract: A Neuron Projection Guidance Signature Associates With Immune-Cold Tumor Microenvironment and Poor Outcomes in Breast Cancer.
    Ann Surg Oncol. 2026 Aug 6. doi: 10.1245/s10434-026-20348.
    PubMed    


  24. BLACK DM, Glasgow AE, Degnim AC, Hieken TJ, et al
    ASO Visual Abstract: Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer by Age, Race, and Tumor Subtype.
    Ann Surg Oncol. 2026 Aug 5. doi: 10.1245/s10434-026-20346.
    PubMed    


  25. EUM JL, Smilen SH, Barmettler G, Boolbol SK, et al
    HER2 Copy Number Predicts Treatment Response in Patients with Breast Cancer: A NCDB Study.
    Ann Surg Oncol. 2026 Aug 4. doi: 10.1245/s10434-026-20367.
    PubMed    


  26. CHEN JH, Peregrin-Alvarez I, Warneke CL, McKenzie LJ, et al
    ASO Author Reflections: Can We Preserve Fertility without Compromising Oncologic Outcomes?: Preoperative Oncofertility for ER-Positive Breast Cancer.
    Ann Surg Oncol. 2026 Aug 4. doi: 10.1245/s10434-026-20373.
    PubMed    


  27. ZAVERI S, Whitham Z, Nguyen A, Nadar A, et al
    ASO Visual Abstract: Variation in Surgical Management of Stage IV Breast Cancer-Local/Institutional and Regional Geographic Considerations.
    Ann Surg Oncol. 2026 Aug 3. doi: 10.1245/s10434-026-20244.
    PubMed    


  28. TAYLOR N, Chew YL, Ng TS, Palesty JA, et al
    Recurrence in Real Time: Rethinking Breast Cancer Follow-Up Evaluation with Circulating Tumor DNA.
    Ann Surg Oncol. 2026 Aug 3. doi: 10.1245/s10434-026-20252.
    PubMed     Abstract available


  29. TSENG J, Dimitroff K, Sauder CAM, Chien AJ, et al
    Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy on the I-SPY2 Trial.
    Ann Surg Oncol. 2026 Aug 3. doi: 10.1245/s10434-026-20153.
    PubMed     Abstract available


  30. MYERS SP, Gokun Y, Slover B, Davenport SP, et al
    Receipt of Combined Axillary Dissection and Nodal Irradiation Varies by Age.
    Ann Surg Oncol. 2026;33:7216-7228.
    PubMed     Abstract available


  31. JAEN DM, Adwer LM, Lanoux-Nguyen AS, Hon HH, et al
    How to Find the Nerve: Nipple Nerve Allograft Reconstruction for Sensory Restoration in Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2026;33:7247-7248.
    PubMed     Abstract available


  32. PAWLOSKI KR, Nelson JA, Sevilimedu V, Le T, et al
    Predictors of Satisfaction with Breasts and Psychosocial Well-Being After Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2026;33:7193-7205.
    PubMed     Abstract available


  33. SARS C, Chen EY, Johansson ALV, Dickman PW, et al
    Socioeconomic Status and Survival in Sarcomas of the Breast: Nationwide Cohort Study.
    Ann Surg Oncol. 2026;33:7181-7192.
    PubMed     Abstract available


    July 2026
  34. BAE SJ, Lee J, Do SI, Kim EY, et al
    ASO Visual Abstract: Risk of pN2/3 Understaging in Sentinel Node-Positive ER+/HER2- Breast Cancer: A Composite Clinicopathologic Score for Safe RxPONDER and MonarchE Application.
    Ann Surg Oncol. 2026 Jul 31. doi: 10.1245/s10434-026-20321.
    PubMed    


  35. TSENG J, Dimitroff K, Sauder CAM, Chien AJ, et al
    ASO Visual Abstract: Surgical Management of Young Women with High-Risk Breast Cancer Receiving Neoadjuvant Systemic Therapy in the I-SPY2 Trial.
    Ann Surg Oncol. 2026 Jul 31. doi: 10.1245/s10434-026-20217.
    PubMed    


  36. KOPKASH K, Hwang R
    ASO Author Reflections: The Role of the Robot for Early-Stage Breast Cancer Patients Undergoing Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2026 Jul 30. doi: 10.1245/s10434-026-20343.
    PubMed    


  37. PITSINIS V, Khitab N, Jordan L, Vinci A, et al
    ICG-only Sentinel Lymph Node Biopsy in Breast Cancer: A Prospective UK Cohort Demonstrating Consistent Detection Across Patient and Tumour Characteristics-A Follow-on to the INFLUENCE Trial.
    Ann Surg Oncol. 2026 Jul 29. doi: 10.1245/s10434-026-20316.
    PubMed     Abstract available


  38. WAGNER BD, Chen J, Boe LA, Graziano FD, et al
    Using Machine Learning to Predict Breast Cancer-Related Lymphedema Following Axillary Lymph Node Dissection.
    Ann Surg Oncol. 2026 Jul 29. doi: 10.1245/s10434-026-20309.
    PubMed     Abstract available


  39. BLACK DM, Glasgow AE, Degnim AC, Hieken TJ, et al
    Contralateral Prophylactic Mastectomy in Women with Unilateral Breast Cancer by Age, Race, and Tumor Subtype.
    Ann Surg Oncol. 2026 Jul 29. doi: 10.1245/s10434-026-20306.
    PubMed     Abstract available


  40. LATTIMORE CM, Johnson HM
    ASO Author Reflections: Rethinking Local Therapy for Occult Breast Cancer with Advanced Nodal Disease.
    Ann Surg Oncol. 2026 Jul 29. doi: 10.1245/s10434-026-20299.
    PubMed    


  41. SETO A, Port E, Bernik S, Sheng T, et al
    ASO Visual Abstract: Preoperative Radiologic Assessment of the Axilla in Locally Advanced Breast Cancer After Neoadjuvant Systemic Therapy: A Contemporary comparison.
    Ann Surg Oncol. 2026 Jul 28. doi: 10.1245/s10434-026-20332.
    PubMed    


  42. LI K, Zhang Y, Liu Z, Wang S, et al
    Global Inequalities in Female Breast Cancer Burden by Decomposition and Age-Period-Cohort Analysis, 1990-2021.
    Ann Surg Oncol. 2026 Jul 28. doi: 10.1245/s10434-026-19798.
    PubMed     Abstract available


  43. KORSHOLM RHR, Kroman N, Tvedskov THF, Munck F, et al
    ASO Visual Abstract: Axillary Recurrence and Survival After Omission of Axillary Lymph Node Dissection in Patients with Breast Cancer and Micrometastases or Isolated Tumor Cells in the Sentinel Node: A Danish National Register Study.
    Ann Surg Oncol. 2026 Jul 27. doi: 10.1245/s10434-026-20234.
    PubMed    


  44. KAWASHIMA K, Chida K, Oshi M, Yamada A, et al
    A Neuron Projection Guidance Signature Associates with Immune-Cold Tumor Microenvironment and Poor Outcomes in Breast Cancer.
    Ann Surg Oncol. 2026 Jul 25. doi: 10.1245/s10434-026-19932.
    PubMed     Abstract available


  45. YOO JW, Byeon J, Park WK, Kim J, et al
    ASO Visual Abstract: Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20224.
    PubMed    


  46. KOPKASH K, Piltin M, Jakub J, Javid S, et al
    ASO Visual Abstract: A Prospective, Multi-Center Randomized Controlled Trial (RCT) of the da Vinci SP Surgical System Versus Open Surgery in Nipple Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20251.
    PubMed    


  47. HAGER MG, Day CN, Corbin KS, Boughey JC, et al
    Impact of Omission of Sentinel Lymph Node Surgery on Radiation Treatment in Patients Age 50 and Older with Breast Cancer Treated with Lumpectomy: A Single-Institution Retrospective Review.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20148.
    PubMed     Abstract available


  48. ZHANG L, Kinkade S, Margenthaler JA
    ASO Author Reflections: What Extent of Axillary Surgery Counts? Rethinking Total and Positive Lymph Node Counts After Neoadjuvant Chemotherapy in Young Women with Node-Positive Breast Cancer.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20298.
    PubMed    


  49. CASTRO HERNANDEZ L, Carpenter DJ, Julian TB, Coopey SB, et al
    ASO Author Reflections: Beyond Surgical Extent: Expanding Access to Resistance Training in Breast Cancer Survivorship.
    Ann Surg Oncol. 2026 Jul 23. doi: 10.1245/s10434-026-20262.
    PubMed    


  50. VARMAN PM
    ASO Author Reflections: Rethinking Clinical Nodal Staging in Breast Cancer.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20179.
    PubMed    


  51. JAEN DM, Millen JC
    ASO Author Reflections: Rethinking Axillary Management in cN2-cN3 Breast Cancer.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20249.
    PubMed    


  52. RADEMACHER N, Broman KK, Gutnik LA
    ASO Author Reflections: Navigating Axillary Management for Residual Nodal Disease after Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20194.
    PubMed    


  53. CASTRO HERNANDEZ L, Carpenter DJ, Julian TB, Coopey SB, et al
    ASO Visual Abstract: Functional Outcomes for Breast Cancer Survivors following an Intense Resistance Training Program based on Surgical Management of the Breast and Axilla.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20215.
    PubMed    


  54. SETO A, Port E, Bernik S, Sheng T, et al
    Preoperative Radiologic Assessment of the Axilla in Locally Advanced Breast Cancer After Neoadjuvant Systemic Therapy: A Contemporary Comparison.
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20257.
    PubMed     Abstract available


  55. SFARAD HK, Avisar E
    ASO Author Reflections: Imaging-Driven Breast Cancer Surgery-Are We Overlooking Specificity in Our Pursuit of Sensitivity?
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20287.
    PubMed    


  56. OMRANIPOUR R, Eslami B, Alipour S, Nazarian N, et al
    The Role of Locoregional Treatment in Non-Progressive De Novo Metastatic Breast Cancer under Systemic Treatment: A Randomized Controlled Trial (LTMBC).
    Ann Surg Oncol. 2026 Jul 20. doi: 10.1245/s10434-026-20187.
    PubMed     Abstract available


  57. SERRES S, Zaveri S
    ASO Author Reflections on "Variation in Surgical Management of Stage IV Breast Cancer: Local/Institutional and Regional Geographic Considerations.".
    Ann Surg Oncol. 2026 Jul 19. doi: 10.1245/s10434-026-20273.
    PubMed    


  58. MOKHBER A, Tang K, Situ O, O'Neill AC, et al
    ASO Visual Abstract: Association between Decision Regret and Psychosocial Outcomes Following Surgery Among Women with Unilateral Nonhereditary Breast Cancer.
    Ann Surg Oncol. 2026 Jul 19. doi: 10.1245/s10434-026-20246.
    PubMed    


  59. PRATHIBHA S, Day CN, Black DM, Boughey JC, et al
    ASO Visual Abstract: Evolution of Axillary Surgical Management of Patients with Occult Breast Cancer with Axillary Metastasis.
    Ann Surg Oncol. 2026 Jul 19. doi: 10.1245/s10434-026-20218.
    PubMed    


  60. MOKHBER A, Lim DW
    ASO Author Reflections: The Overlooked Burden of Decision Regret After Mastectomy for Breast Cancer.
    Ann Surg Oncol. 2026 Jul 18. doi: 10.1245/s10434-026-20274.
    PubMed    


  61. HAGER MG, Day CN, Corbin KS, Boughey JC, et al
    ASO Visual Abstract: Impact of Omission of Sentinel Lymph Node Surgery on Radiation Treatment in Patients Age 50 Years and Older with Breast Cancer Treated with Lumpectomy: A Single-Institution Retrospective Review.
    Ann Surg Oncol. 2026 Jul 18. doi: 10.1245/s10434-026-20214.
    PubMed    


  62. MOKHBER A, Tang K, Situ O, O'Neill AC, et al
    Association Between Decision Regret and Psychosocial Outcomes Following Surgery Among Women with Unilateral Nonhereditary Breast Cancer.
    Ann Surg Oncol. 2026 Jul 17. doi: 10.1245/s10434-026-20124.
    PubMed     Abstract available


  63. TSENG J, Boughey JC, Mukhtar RA
    ASO Author Reflections: Young Women with Breast Cancer may Safely Opt for Breast Conservation After Neoadjuvant Therapy.
    Ann Surg Oncol. 2026 Jul 17. doi: 10.1245/s10434-026-20250.
    PubMed    


  64. PRATHIBHA S, Day CN, Black DM, Boughey JC, et al
    Evolution of Axillary Surgical Management of Patients with Occult Breast Cancer with Axillary Metastasis.
    Ann Surg Oncol. 2026 Jul 17. doi: 10.1245/s10434-026-20155.
    PubMed     Abstract available


  65. KOPKASH K, Piltin M, Jakub J, Javid S, et al
    A Prospective, Multicenter Randomized Controlled Trial (RCT) of the da Vinci SP((R)) Surgical System versus Open Surgery in Nipple-Sparing Mastectomy (NSM) Procedures for Patients with Breast Cancer.
    Ann Surg Oncol. 2026 Jul 16. doi: 10.1245/s10434-026-20201.
    PubMed     Abstract available


  66. CHEN JH, Peregrin-Alvarez I, Warneke CL, McKenzie LJ, et al
    ASO Visual Abstract: Oncologic Safety of Preoperative Controlled Ovarian Stimulation for Fertility Preservation Among Women with Estrogen Receptor-Positive Breast Cancer.
    Ann Surg Oncol. 2026 Jul 16. doi: 10.1245/s10434-026-20221.
    PubMed    


  67. ZHANG L, Birla S, Tang SX, Galloway OW, et al
    ASO Visual Abstract: Impact of Total and Positive Lymph Node Count on Recurrence in Young Women with Node-Positive Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2026 Jul 16. doi: 10.1245/s10434-026-20222.
    PubMed    


  68. MEHTA D, Robinson D, Komenaka M, Welch J, et al
    Implementation of Green Changes Can Result in Shortened Turnover and Decreased Surgical Waste in Breast Cancer Operations.
    Ann Surg Oncol. 2026 Jul 16. doi: 10.1245/s10434-026-20140.
    PubMed     Abstract available


  69. VARMAN PM, Taft DA, Patel M, Rangan R, et al
    Is It Time to Redefine Clinical Nodal Staging for Breast Cancer?
    Ann Surg Oncol. 2026 Jul 16. doi: 10.1245/s10434-026-20128.
    PubMed     Abstract available


  70. VARMAN PM, Rangan R, Maggiotto A, Wu V, et al
    ASO Visual Abstract: Targeted Multidisciplinary Continuous Improvement Process Reduces Time to Breast Cancer Surgery with Immediate Reconstruction.
    Ann Surg Oncol. 2026 Jul 15. doi: 10.1245/s10434-026-20211.
    PubMed    


  71. JAEN DM, Dougherty CE, Helseth KA, Harwell PA, et al
    ASO Visual Abstract: Nodal Pathologic Response after Neoadjuvant Systemic Therapy in Clinically Advanced Node-Positive (cN2 and cN3) Breast Cancer.
    Ann Surg Oncol. 2026 Jul 14. doi: 10.1245/s10434-026-20204.
    PubMed    


  72. VARMAN PM, Rangan R, Maggiotto A, Wu V, et al
    Targeted Multidisciplinary Continuous Improvement Process Reduces Time to Breast Cancer Surgery with Immediate Reconstruction.
    Ann Surg Oncol. 2026 Jul 14. doi: 10.1245/s10434-026-20143.
    PubMed     Abstract available


  73. VARMAN PM, Taft DA, Patel M, Rangan R, et al
    ASO Visual Abstract: Is It Time to Redefine Clinical Nodal Staging for Breast Cancer?
    Ann Surg Oncol. 2026 Jul 14. doi: 10.1245/s10434-026-20174.
    PubMed    


  74. BOYLE MK, Giuliano AE
    ASO Author Reflections: Evolving Axillary Management in Young Women with Breast Cancer.
    Ann Surg Oncol. 2026 Jul 13. doi: 10.1245/s10434-026-20059.
    PubMed    


  75. ZAVERI S, Whitham ZA, Nguyen A, Nadar A, et al
    Variation in Surgical Management of Stage IV Breast Cancer: Local/Institutional and Regional Geographic Considerations.
    Ann Surg Oncol. 2026 Jul 11. doi: 10.1245/s10434-026-20123.
    PubMed     Abstract available


  76. MATHEWS AL, Fan B, Pesce C, Kopkash K, et al
    ASO Visual Abstract: Practice Patterns and Overall Survival for Octogenarians with Triple-Negative Breast Cancer Treated at Accredited Cancer Centers in the United States.
    Ann Surg Oncol. 2026 Jul 10. doi: 10.1245/s10434-026-20178.
    PubMed    


  77. GERVAIS C, Brouillette K, Benzouak T, Altuntur SK, et al
    ASO Author Reflections: Rethinking Surgical Timing Benchmarks in Upfront Breast Cancer Surgery.
    Ann Surg Oncol. 2026 Jul 10. doi: 10.1245/s10434-026-20166.
    PubMed    


  78. MATHEWS AL, Fan B, Pesce C, Kopkash K, et al
    Practice Patterns and Overall Survival for Octogenarians with Triple Negative Breast Cancer Treated at Accredited Cancer Centers in the USA.
    Ann Surg Oncol. 2026 Jul 10. doi: 10.1245/s10434-026-20133.
    PubMed     Abstract available


  79. JAEN DM, Dougherty CE, Helseth KA, Harwell PA, et al
    Nodal Pathologic Response After Neoadjuvant Systemic Therapy in Clinically Advanced Node-Positive (cN2 and cN3) Breast Cancer.
    Ann Surg Oncol. 2026 Jul 8. doi: 10.1245/s10434-026-20149.
    PubMed     Abstract available


  80. ZHANG L, Birla S, Tang SX, Galloway OW, et al
    Impact of Total and Positive Lymph Node Count on Recurrence in Young Women with Node-Positive Breast Cancer Undergoing Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2026 Jul 8. doi: 10.1245/s10434-026-20154.
    PubMed     Abstract available


  81. AMBURN T, Sporn M, Arthurs L, Marsh C, et al
    Lymphovascular Invasion in SOUND-Eligible Breast Cancer: Implications for Occult Axillary Nodal Metastasis.
    Ann Surg Oncol. 2026 Jul 8. doi: 10.1245/s10434-026-20135.
    PubMed     Abstract available


  82. AMBURN T, Gemignani ML
    ASO Author Reflections: The Role of Lymphovascular Invasion in Early-Stage Breast Cancer Identified After the Omission of Sentinel Lymph Node Biopsy.
    Ann Surg Oncol. 2026 Jul 7. doi: 10.1245/s10434-026-20177.
    PubMed    


  83. CASTRO HERNANDEZ L, Carpenter DJ, Julian TB, Coopey SB, et al
    Functional Outcomes for Breast Cancer Survivors Following an Intense Resistance Training Program Based on Surgical Management of the Breast and Axilla.
    Ann Surg Oncol. 2026 Jul 6. doi: 10.1245/s10434-026-20152.
    PubMed     Abstract available


  84. LATTIMORE CM, Wanis KN, Kuerer HM, Hunt KK, et al
    Is Mastectomy Necessary in Patients with Occult Breast Cancer and Advanced (N2/N3) Nodal Disease?
    Ann Surg Oncol. 2026 Jul 6. doi: 10.1245/s10434-026-20141.
    PubMed     Abstract available


  85. CAMPBELL EJ, Doughty L, Sakellariou S, Trafford P, et al
    Potential Impact of Sentinel Lymph Node Biopsy Omission on Adjuvant Treatment Decisions in Low-Risk Breast Cancer: A Regional Multicenter 775 Patient Review of Current Practice in the United Kingdom.
    Ann Surg Oncol. 2026 Jul 6. doi: 10.1245/s10434-026-20134.
    PubMed     Abstract available


  86. KORSHOLM RHR, Kroman N, Tvedskov TF, Munck F, et al
    Axillary Recurrence and Survival After Omission of Axillary Lymph Node Dissection in Patients with Breast Cancer and Micrometastases or Isolated Tumor Cells in the Sentinel Node: A Danish National Register Study.
    Ann Surg Oncol. 2026 Jul 6. doi: 10.1245/s10434-026-20072.
    PubMed     Abstract available


  87. CHEN JH, Peregrin-Alvarez I, Warneke CL, McKenzie LJ, et al
    Oncologic Safety of Preoperative Controlled Ovarian Stimulation for Fertility Preservation Among Women with Estrogen Receptor Positive Breast Cancer.
    Ann Surg Oncol. 2026 Jul 5. doi: 10.1245/s10434-026-20156.
    PubMed     Abstract available


  88. LATTIMORE CM, Wanis KN, Kuerer HM, Hunt KK, et al
    ASO Visual Abstract: Is Mastectomy Necessary in Patients with Occult Breast Cancer and Advanced (N2/N3) Nodal Disease?
    Ann Surg Oncol. 2026 Jul 5. doi: 10.1245/s10434-026-20181.
    PubMed    


  89. BOYLE MK, Attiyeh MA, Amersi F, Chung A, et al
    Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB): De-escalation of Axillary Surgery and Increased Use of Radiation.
    Ann Surg Oncol. 2026 Jul 2. doi: 10.1245/s10434-026-19993.
    PubMed     Abstract available


  90. BOYLE MK, Attiyeh MA, Amersi F, Chung A, et al
    ASO Visual Abstract: Trends in Breast and Axillary Operations in Young Patients with Operable Breast Cancer from the National Cancer Database (NCDB)-De-escalation of Axillary Surgery and Increased Use of Radiation.
    Ann Surg Oncol. 2026 Jul 2. doi: 10.1245/s10434-026-20043.
    PubMed    


  91. GERVAIS C, Brouillette K, Benzouak T, Altuntur SK, et al
    ASO Visual Abstract: Impact of Surgical Delay on Breast Cancer Prognosis: Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2026 Jul 2. doi: 10.1245/s10434-026-20098.
    PubMed    


  92. JEON JH, Higgins MG, Durden J, Adams M, et al
    Attitudes and Perspectives on Shared Decision Making Among Breast Surgical Oncologists: A Qualitative Study.
    Ann Surg Oncol. 2026;33:6433-6443.
    PubMed     Abstract available


  93. CORSI F, Pelizzola M, Bossi D, Zanella V, et al
    A Prospective Randomized Trial Comparing Radioguided Occult Lesion Localization (ROLL) and Magnetic Seed Localization for the Localization of Nonpalpable Breast Lesions: Analysis of Surgical Outcomes, Patient's Perception, and Costs.
    Ann Surg Oncol. 2026;33:6403-6413.
    PubMed     Abstract available


  94. JENG A, Morgan M, Willey SC, Chawla A, et al
    Recent Trends in Whole-Breast Irradiation Versus Partial-Breast Irradiation in Ductal Carcinoma in situ with Breast-Conserving Surgery 2011-2021: A National Cancer Database Study.
    Ann Surg Oncol. 2026;33:6367-6374.
    PubMed     Abstract available


  95. LEE JK, Alohaideb N, Pyon JK, Mun GH, et al
    Comprehensive Analysis of Full Coverage Versus Anterior Tenting Techniques for ADM Application in Prepectoral DTI Breast Reconstruction.
    Ann Surg Oncol. 2026;33:6839-6849.
    PubMed     Abstract available


  96. VENKATESH H, Castro Gierach G, Kanzaki L, Ali A, et al
    Pregnancy-Associated Breast Cancer: A Trimester and Subtype Based Clinical Decision Framework for the Surgeon and Surgical Trainee.
    Ann Surg Oncol. 2026 Jul 1. doi: 10.1245/s10434-026-20101.
    PubMed     Abstract available


    June 2026
  97. FENNIG S, Kirshtein A, Landman Y, Weiner N, et al
    Intraoperative Radiotherapy for Breast Cancer: Long-Term Experience.
    Ann Surg Oncol. 2026 Jun 29. doi: 10.1245/s10434-026-20078.
    PubMed     Abstract available


  98. RADEMACHER N, Gutnik LA, Broman KK
    ASO Visual Abstract: Factors Associated with Omission of Axillary Lymph Node Dissection for Patients with Clinical Node-Positive Breast Cancer who have Residual Nodal Disease on Pathology After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2026 Jun 29. doi: 10.1245/s10434-026-20002.
    PubMed    


  99. LAUDE E, Guyon C, Diaz LM, Cabel L, et al
    ASO Visual Abstract: Association Between Axillary Surgical Management and Survival in Patients with de novo Metastatic Breast Cancer.
    Ann Surg Oncol. 2026 Jun 29. doi: 10.1245/s10434-026-20040.
    PubMed    


  100. UEKI Y, Horimoto Y, Yuan M, Wu R, et al
    Cyclin E1 Expression Predicts Poorer Outcome in HER2-positive Breast Cancer with Residual Disease after Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2026 Jun 27. doi: 10.1245/s10434-026-20021.
    PubMed     Abstract available


  101. RADEMACHER N, Gutnik LA, Broman KK
    Factors Associated with Omission of Axillary Lymph Node Dissection for Patients with Clinical Node-Positive Breast Cancer Who have Residual Nodal Disease on Pathology After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2026 Jun 26. doi: 10.1245/s10434-026-19968.
    PubMed     Abstract available


  102. LAUDE E, Guyon C, Diaz LM, Cabel L, et al
    Association Between Axillary Surgical Management and Survival for Patients With De Novo Metastatic Breast Cancer.
    Ann Surg Oncol. 2026 Jun 23. doi: 10.1245/s10434-026-19992.
    PubMed     Abstract available


  103. CHAN K, Cohen L, Cotler JH, Carthcart-Rake E, et al
    Breast Cancer Outcomes in Intersex Individuals in the National Cancer Database.
    Ann Surg Oncol. 2026 Jun 20. doi: 10.1245/s10434-026-20027.
    PubMed    


  104. GERVAIS C, Brouillette K, Benzouak T, Altuntur SK, et al
    Impact of Surgical Delay on Breast Cancer Prognosis: Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2026 Jun 18. doi: 10.1245/s10434-026-20013.
    PubMed     Abstract available


  105. BAE SJ, Lee J, Do SI, Kim EY, et al
    Risk of pN2/3 Understaging in Sentinel Node-Positive ER+/HER2- Breast Cancer: A Composite Clinicopathologic Score for Safe RxPONDER and MonarchE Application.
    Ann Surg Oncol. 2026 Jun 15. doi: 10.1245/s10434-026-19966.
    PubMed     Abstract available


  106. HAGER MG, Hoskin TL, Ruddy KJ, Boughey JC, et al
    ASO Visual Abstract: Utility of 21-Gene Recurrence Score in Male Breast Cancer.
    Ann Surg Oncol. 2026 Jun 4. doi: 10.1245/s10434-026-19868.
    PubMed    


  107. KALLES V, Mitrousias A, Vlachogiorgos A, Toesca A, et al
    ASO Author Reflections: Enhancing Technical Reproducibility and Ergonomics in Single-Port Endoscopic Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2026;33:5620-5621.
    PubMed     Abstract available


  108. KALLES V, Mitrousias A, Vlachogiorgos A, Tsoti SM, et al
    Single-Port Endoscopic Nipple-Sparing Mastectomy Using a Handheld Motorized Articulating System: Technical Description and Initial Outcomes.
    Ann Surg Oncol. 2026;33:5606-5607.
    PubMed     Abstract available


  109. SCARDINA L, D'Archi S, Accetta C, Carnassale B, et al
    Axillary Nodal Positivity in Early-Stage Invasive Lobular Carcinoma: Implications for Sentinel Lymph Node Biopsy Omission.
    Ann Surg Oncol. 2026;33:5598-5605.
    PubMed     Abstract available


  110. MASHAL S, Melanson A, Apostolova C, Ferroum A, et al
    Impact of Ethnicity on the Uptake of Risk Reducing Mastectomy in Unaffected BRCA1/2 and PALB2 Carriers in Canada.
    Ann Surg Oncol. 2026;33:5590-5597.
    PubMed     Abstract available


  111. YOON J, Lee SB, Kim J, Chung IY, et al
    Omitting Axillary Surgery in Patients with Ipsilateral Breast Tumor Recurrence After Breast-Conserving Surgery.
    Ann Surg Oncol. 2026;33:5574-5580.
    PubMed     Abstract available


  112. HOLT L, Chamberlain V, Shern T, Gadd MA, et al
    Risk Stratification of Fibroepithelial Breast Lesions: Clinical and Ultrasound Features Associated with Fibroadenoma and Phyllodes Tumors.
    Ann Surg Oncol. 2026;33:5567-5573.
    PubMed     Abstract available


  113. QU FL, Cheng JY, Jiang SH, Zhang Q, et al
    Omission of Axillary Surgery in Patients with Negative Axillary Evaluation Integrated with LymphPET: A Prospective Clinical Study.
    Ann Surg Oncol. 2026;33:5558-5566.
    PubMed     Abstract available


  114. CHOI JE, Lee YW, Gwark S, Paek SH, et al
    Single-Port Robot-Assisted Nipple-Sparing Mastectomy: Main Analysis of a Retrospective Multicenter Study (SPROUT, KoREa-BSG 09).
    Ann Surg Oncol. 2026;33:5533-5540.
    PubMed     Abstract available


  115. GIANMATTEO P, Andrea P, Erica AA, Antuono L, et al
    RADar Reflector LocalisatIOn-SCOUT((R)) for CarcinOma Mammae, a Prospective Observational Study Sharing Clinical Experience at the European Institute of Oncology in Milan: RADIOSO Milan Trial.
    Ann Surg Oncol. 2026;33:5513-5523.
    PubMed     Abstract available


    May 2026
  116. LI K, Zhang Y, Liu Z, Wang S, et al
    ASO Visual Abstract: Global Inequalities in Female Breast Cancer Burden by Decomposition and Age-Period-Cohort Analysis, 1990-2021.
    Ann Surg Oncol. 2026 May 30. doi: 10.1245/s10434-026-19883.
    PubMed    


  117. STANCZYK M, Cheung TC, Lang JE
    The Past, Present, and Future of Sentinel Lymph Node Biopsy in Breast Cancer.
    Ann Surg Oncol. 2026 May 29. doi: 10.1245/s10434-026-19672.
    PubMed     Abstract available


  118. WANIS KN, Krasniqi R, Sun SX, Resetkova E, et al
    ASO Visual Abstract: Sentinel Lymph Node Positivity and Utility of Frozen Section Diagnosis After Neoadjuvant Therapy for Patients with Clinically Node-Negative Hormone Receptor-Positive, HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2026 May 26. doi: 10.1245/s10434-026-19872.
    PubMed    


  119. PETRELLI F, Pavesi V, Mercurio P, Burgoa L, et al
    Leaving the Axilla Untouched: Toward Surgical De-escalation in Early Luminal A Breast Cancer.
    Ann Surg Oncol. 2026 May 20. doi: 10.1245/s10434-026-19836.
    PubMed    


  120. WANIS KN, Krasniqi R, Sun SX, Resetkova E, et al
    Sentinel Lymph Node Positivity and Utility of Frozen Section Diagnosis following Neoadjuvant Therapy in Patients with Clinically Node-Negative, Hormone Receptor-Positive, HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2026 May 14. doi: 10.1245/s10434-026-19783.
    PubMed     Abstract available


  121. RODRIGUEZ L, Wu R, Kassi A, Ishikawa T, et al
    ASO Visual Abstract: High PARP7 Expression is Associated with Higher Estrogen Response and Immune Suppression but Less Cell Proliferation and Better Survival in Breast Cancer.
    Ann Surg Oncol. 2026 May 11. doi: 10.1245/s10434-026-19789.
    PubMed    


  122. HAGER MG, Hoskin TL, Ruddy KJ, Boughey JC, et al
    Utility of 21-Gene Recurrence Score in Male Breast Cancer.
    Ann Surg Oncol. 2026 May 11. doi: 10.1245/s10434-026-19779.
    PubMed     Abstract available


  123. GRAHAM-STEPHENSON A, Fanning CE, Geven EL, Migyanka F, et al
    ASO Visual Abstract: Geographic Differences in Patient Experience after a Diagnosis of Lobular Breast Cancer.
    Ann Surg Oncol. 2026 May 7. doi: 10.1245/s10434-026-19635.
    PubMed    


  124. MULLER M, Heil J, Pfob A, Cai L, et al
    Predictive Value of Routine Imaging for the Diagnosis of Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2026 May 4. doi: 10.1245/s10434-026-19670.
    PubMed     Abstract available


  125. SIDIROPOULOU Z
    The Superficial (Anterior) Plane in Mastectomy: An Under-Measured Margin Variable with Implications for Local Recurrence.
    Ann Surg Oncol. 2026;33:4648-4649.
    PubMed     Abstract available


  126. LLOYD K, Shern TP, Holt LR, Daly AE, et al
    Outpatient Mastectomy with Reconstruction at Ambulatory Surgery Centers.
    Ann Surg Oncol. 2026;33:4573-4583.
    PubMed     Abstract available


  127. CHANDRAN T, Wager JL, Obeid K, Baker J, et al
    Does Multidisciplinary Clinic Impact Rates of Breast Conserving Therapy?
    Ann Surg Oncol. 2026;33:4555-4562.
    PubMed     Abstract available


  128. CUILLERIER NJS, Almarzooqi H, Villareal-Corpuz V, Sabboobeh S, et al
    Adherence to Endocrine Prevention in Patients with Atypical Hyperplasia and Lobular Carcinoma In Situ: Promising Trends from Real-World Use of Low-Dose Tamoxifen.
    Ann Surg Oncol. 2026;33:4510-4517.
    PubMed     Abstract available


  129. HOLT L, Chamberlain V, Shern T, Abir FF, et al
    AI-FLEET: Phase I-Multimodal Deep Learning Model for Phyllodes Tumor Classification.
    Ann Surg Oncol. 2026;33:4503-4509.
    PubMed     Abstract available


  130. TAYLOR ND, Rezo A, Majeed U, He YM, et al
    Impact of Anterior Margin Status Following Skin- or Nipple-Sparing Mastectomy in Patients Undergoing Implant-Based Breast Reconstruction.
    Ann Surg Oncol. 2026;33:4494-4502.
    PubMed     Abstract available


  131. MASANAM MK, Kantor O, Pappas Brunco O, Faust AC, et al
    Evaluating the Impact of a Surgeon-Led Ductal Carcinoma in Situ Program on Endocrine Therapy Uptake.
    Ann Surg Oncol. 2026;33:4463-4471.
    PubMed     Abstract available


  132. GARCIA DI, Daly AE, Anderman KJ, Holt LR, et al
    Bracketed Lumpectomy: A Comparison of Radiofrequency Identification Tag Localization to Wire Localization.
    Ann Surg Oncol. 2026;33:4407-4416.
    PubMed     Abstract available


    April 2026
  133. CHIDA K, Wu R, Kawashima K, Grapes A, et al
    ASO Visual Abstract: Ki67 Gene Expression is Associated with Immune Cell Infiltration and Neoadjuvant Chemotherapy Response in ER+/HER2- Breast Cancer.
    Ann Surg Oncol. 2026 Apr 28. doi: 10.1245/s10434-026-19705.
    PubMed    


  134. MULLER M, Heil J, Pfob A, Cai L, et al
    ASO Visual Abstract: Predictive Value of Routine Imaging for the Diagnosis of Pathological Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2026 Apr 28. doi: 10.1245/s10434-026-19723.
    PubMed    


  135. CHIDA K, Wu R, Kawashima K, Grapes A, et al
    ASO Author Reflections: Does Ki67 Gene Expression Capture Immune Infiltration and Predict Chemotherapy Response in ER+/HER2- Breast Cancer?
    Ann Surg Oncol. 2026 Apr 27. doi: 10.1245/s10434-026-19720.
    PubMed    


  136. CHEN JH, Wanis KN, Rahman M, Gianchandani A, et al
    ASO Visual Abstract: Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.
    Ann Surg Oncol. 2026 Apr 22. doi: 10.1245/s10434-026-19661.
    PubMed    


  137. SARIDEMIR S, Guler OC, Dincer B, Karayigit A, et al
    Axillary Pathologic Complete Response as a Stronger Prognostic Marker than Breast pCR in Clinically Node-Positive Stage II-III Breast Cancer.
    Ann Surg Oncol. 2026 Apr 19. doi: 10.1245/s10434-026-19630.
    PubMed     Abstract available


  138. LEE YR, Giannakeas V, Narod SA, Lim DW, et al
    Association Between Tumor Size and Nodal Positivity for HER2+ and Triple-Negative Early-Stage Breast Cancer: A Population-Based Study.
    Ann Surg Oncol. 2026 Apr 19. doi: 10.1245/s10434-026-19581.
    PubMed     Abstract available


  139. LEE YR, Giannakeas V, Narod SA, Lim DW, et al
    ASO Visual Abstract: Association Between Tumor Size and Nodal Positivity for HER2+ and Triple-Negative Early-Stage Breast Cancer: A Population-Based Study.
    Ann Surg Oncol. 2026 Apr 17. doi: 10.1245/s10434-026-19659.
    PubMed    


  140. WANG J, Chen J, Amburn T, Wagner BD, et al
    ASO Visual Abstract: Axillary Lymph Node Dissection Through a Separate Incision Does Not Increase Rates of Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2026 Apr 17. doi: 10.1245/s10434-026-19367.
    PubMed    


  141. SHERN TP, Holt LR, Lloyd K, Daly AE, et al
    ASO Visual Abstract: Economic and Health System Impact of Implementing the SOUND Trial Approach in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2026 Apr 16. doi: 10.1245/s10434-026-19657.
    PubMed    


  142. SHAH A, Love JA, Butler M, Butler LN, et al
    ASO Visual Abstract: Integrating Generative AI into Nomograms for Breast Cancer Nodal Risk Predictions.
    Ann Surg Oncol. 2026 Apr 15. doi: 10.1245/s10434-026-19605.
    PubMed    


  143. CHIDA K, Wu R, Kawashima K, Grapes A, et al
    Ki67 Gene Expression is Associated with Immune Cell Infiltration and Neoadjuvant Chemotherapy Response in ER+/HER2- Breast Cancer.
    Ann Surg Oncol. 2026 Apr 10. doi: 10.1245/s10434-026-19620.
    PubMed     Abstract available


  144. HANNOUN-LEVI JM, Kirova Y
    Re-irradiation for Second Ipsilateral Breast Cancer Event: Is There Any Debate?
    Ann Surg Oncol. 2026 Apr 10. doi: 10.1245/s10434-026-19584.
    PubMed    


  145. CHEN JH, Wanis KN, Rahman M, Gianchandani A, et al
    Implications for Sentinel Lymph Node Biopsy Omission in Patients with Early-Stage Node-Negative HR+/HER2- Breast Cancer Undergoing Mastectomy.
    Ann Surg Oncol. 2026 Apr 8. doi: 10.1245/s10434-026-19588.
    PubMed     Abstract available


  146. MONTAGNA G, Weber WP, Morrow M, Sevilimedu V, et al
    Letter to the Editor Regarding Abdulla, H.A., et al. "Oncologic Outcomes of Sentinel Lymph Node Biopsy Versus Targeted Axillary Dissection for Node-Positive Breast Cancer Patients After Neoadjuvant Chemotherapy: A Systematic Review and Meta-analysis".
    Ann Surg Oncol. 2026 Apr 5. doi: 10.1245/s10434-026-19602.
    PubMed    


  147. BOCCARDO F
    ASO Author Reflections: LYMPHA for Prevention of Breast Cancer-Related Lymphedema: Long-Term Evidence from a 15-Year Follow-Up.
    Ann Surg Oncol. 2026 Apr 5. doi: 10.1245/s10434-026-19596.
    PubMed    


  148. ABDULLA HA, McGarry J, Prichard RS, Boland MR, et al
    Reply to: "Letter to the Editor Regarding Abdulla HA, McGarry J, Kaczorowska R, et al. Oncologic Outcomes of Sentinel Lymph Node Biopsy Versus Targeted Axillary Dissection for Node-Positive Breast Cancer Patients After Neoadjuvant Chemotherapy: A Syst
    Ann Surg Oncol. 2026 Apr 3. doi: 10.1245/s10434-026-19615.
    PubMed    


  149. STONEBANKS CUILLERIER NJ, Wong SM
    Reply to "Beyond Uptake Aligning Low-Dose Tamoxifen Adherence with Absolute Breast Cancer Risk," by Hu, Zhiping et al.
    Ann Surg Oncol. 2026 Apr 2. doi: 10.1245/s10434-026-19525.
    PubMed    


  150. JUNG JJ, Kim HK, Kang E, Park EK, et al
    ASO Visual Abstract: Enhancing Early Detection of Contralateral Breast Cancer in Breast Cancer Survivors Using AI-Assisted Mammography.
    Ann Surg Oncol. 2026 Apr 2. doi: 10.1245/s10434-026-19535.
    PubMed    


  151. VETTER CD, Boughey JC, Johnson JE
    Cost-Effectiveness Analysis of Axillary Management Options at the Time of Contralateral Prophylactic Mastectomy.
    Ann Surg Oncol. 2026;33:3273-3282.
    PubMed     Abstract available


  152. MORTON CR, Chen YJ, Williams K, Bloch RA, et al
    Efficiency of Sorting Site of Care for Frail Patients Undergoing Mastectomy.
    Ann Surg Oncol. 2026;33:3319-3326.
    PubMed     Abstract available


  153. MRDUTT MM, Day CN, Madrigrano A, Boughey JC, et al
    ALND Experience During Breast Surgical Oncology Fellowship over the Years: An SSO/ASBrS Collaborative Analysis.
    Ann Surg Oncol. 2026;33:3414-3420.
    PubMed     Abstract available


  154. GAILLARD T, Beddok A, Baadj Y, Feron JG, et al
    Outcomes of Second Breast-Conserving Surgery Without Reirradiation for Breast Tumor Recurrence.
    Ann Surg Oncol. 2026;33:3364-3373.
    PubMed     Abstract available


  155. SHAO Y, Wang X, Yang J, Huang Y, et al
    From Proteomics to Pathology: S100A8's Impact on Breast Phyllodes Tumors Grading.
    Ann Surg Oncol. 2026;33:3651-3665.
    PubMed     Abstract available


  156. LEONARD L, Yi M, Wingate E, Singh P, et al
    Axillary Management after Neoadjuvant Endocrine Therapy (NET).
    Ann Surg Oncol. 2026;33:3327-3337.
    PubMed     Abstract available


  157. NAKADAIRA U, Sakai T, Ogiya A, Inoue Y, et al
    Feasibility of Omitting Axillary Dissection after Repeat Sentinel Lymph Node Biopsy for Ipsilateral Breast Tumor Recurrence: A Single-Center Retrospective Study.
    Ann Surg Oncol. 2026;33:3338-3344.
    PubMed     Abstract available


  158. DONICA WRF, Shartzer DS, Ramakrishnan VG, Kuhl E, et al
    External Validation of a Pragmatic Scoring System for Predicting Upgrade of Atypical Ductal Hyperplasia at the Time of Surgery.
    Ann Surg Oncol. 2026;33:3283-3292.
    PubMed     Abstract available


  159. KIM J, Park C, Jeon BJ, Pyon JK, et al
    Complication Profiles of Immediate Implant-Based versus Deep Inferior Epigastric Perforator Flap Breast Reconstruction following Nipple/Skin-Sparing Mastectomy in Patients with Prior Breast-Conserving Surgery and Radiotherapy.
    Ann Surg Oncol. 2026;33:3056-3065.
    PubMed     Abstract available


  160. TOUADI M, Ross S, Sucandy I
    Robotic Partial Central Hepatectomy for Juxtahilar Tumor: Technique of Middle Hepatic Vein Tangential Reconstruction.
    Ann Surg Oncol. 2026;33:2926-2927.
    PubMed     Abstract available


  161. KAUR S, Gastman B, Broderick KP, Momoh AO, et al
    Antibiotics and Surgical Site Infection in Expander-Based Breast Reconstruction Trial (ASSERT).
    Ann Surg Oncol. 2026;33:3033-3044.
    PubMed     Abstract available


    March 2026
  162. GRAHAM-STEPHENSON A, Fanning CE, Geven EL, Migyanka F, et al
    Geographic Differences in Patient Experience After a Diagnosis of Lobular Breast Cancer.
    Ann Surg Oncol. 2026 Mar 31. doi: 10.1245/s10434-026-19523.
    PubMed     Abstract available


  163. GALLAGHER K, Feldman S, Barone J, Mammen J, et al
    ASO Visual Abstract: Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer.
    Ann Surg Oncol. 2026 Mar 30. doi: 10.1245/s10434-026-19402.
    PubMed    


  164. SHERN TP, Holt LR, Lloyd K, Daly AE, et al
    Economic and Health System Impact of Implementing the SOUND Trial Approach in Early-Stage Breast Cancer.
    Ann Surg Oncol. 2026 Mar 30. doi: 10.1245/s10434-026-19564.
    PubMed     Abstract available


  165. HU Z, Gu X, Fu H
    Beyond Uptake: Aligning Low-Dose Tamoxifen Adherence with Absolute Breast Cancer Risk.
    Ann Surg Oncol. 2026 Mar 30. doi: 10.1245/s10434-026-19521.
    PubMed    


  166. BOCCARDO F, Santori G, Fedre B, Fregatti P, et al
    LYMPHA Technique to Prevent Arm Lymphedema After Breast Cancer Treatment: A Single-Center Study Based on a 15-Year Follow-Up Period.
    Ann Surg Oncol. 2026 Mar 26. doi: 10.1245/s10434-026-19526.
    PubMed     Abstract available


  167. WRIGHT GP, Thompson JL
    ASO Author Reflections: Reexamining Physical Examination in Modern Breast Cancer Survivorship.
    Ann Surg Oncol. 2026 Mar 23. doi: 10.1245/s10434-026-19399.
    PubMed    


  168. MENEVEAU MO, Sevilimedu V, Le T, Eskreis-Winkler S, et al
    I?s Neoadjuvant Chemotherapy Justified When Triple-Negative Breast Cancer or HER2-Positive Breast Cancer Presents as >/=1 cm of Only Calcifications or as a Subcentimeter Mass with Surrounding Calcification?s?
    Ann Surg Oncol. 2026 Mar 22. doi: 10.1245/s10434-026-19475.
    PubMed     Abstract available


  169. DIMAANO K, Castillo O Jr, Moazzez A, Ozao-Choy J, et al
    ASO Visual Abstract: Examining the Representation of Minority Race and Ethnicity Groups in Breast Cancer Clinical Trials in the United States Published 2012-2022.
    Ann Surg Oncol. 2026 Mar 17. doi: 10.1245/s10434-026-19368.
    PubMed    


  170. SCHRANK Z, Landrum K, Agala CB, Gallagher KK, et al
    Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2026 Mar 14. doi: 10.1245/s10434-026-19198.
    PubMed     Abstract available


  171. SHAH A, Love JA, Butler M, Butler LN, et al
    Integrating Generative AI into Nomograms for Breast Cancer Nodal Risk Predictions.
    Ann Surg Oncol. 2026 Mar 13. doi: 10.1245/s10434-026-19482.
    PubMed     Abstract available


  172. KUEMMEL S, Fasching PA, Schmid P, Harbeck N, et al
    ASO Visual Abstract: Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer-Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
    Ann Surg Oncol. 2026 Mar 12. doi: 10.1245/s10434-026-19310.
    PubMed    


  173. AYUB S, Liu Y, Postlewait LM, Arciero C, et al
    ASO Author Reflections: Where You Live and How Much You Make Matters in Breast Cancer Care.
    Ann Surg Oncol. 2026 Mar 12. doi: 10.1245/s10434-026-19436.
    PubMed    


  174. MASANAM MK, Kantor O
    Reply to: "Breast-Conserving Surgery After Neoadjuvant Therapy in Multiple Ipsilateral Breast Cancer: Points to Consider," by Sanli, Deniz et al.
    Ann Surg Oncol. 2026 Mar 11. doi: 10.1245/s10434-026-19358.
    PubMed    


  175. TEKCAN SANLI DE, Sanli AN
    Breast-Conserving Surgery After Neoadjuvant Therapy in Multiple Ipsilateral Breast Cancer: Points to Consider.
    Ann Surg Oncol. 2026 Mar 11. doi: 10.1245/s10434-026-19357.
    PubMed    


  176. RYU HH, Lee YJ, Yoo TK, Kim J, et al
    ASO Visual Abstract: Clinical Utility of Oncotype DX Testing in Synchronous Bilateral and Unilateral Multifocal Breast Cancer.
    Ann Surg Oncol. 2026 Mar 10. doi: 10.1245/s10434-026-19418.
    PubMed    


  177. LEVINE A, Terrian L, Bishay D, Lawrence K, et al
    ASO Visual Abstract: Reassessing the Role of Regular Physical Examination in Post-treatment Breast Cancer Surveillance.
    Ann Surg Oncol. 2026 Mar 9. doi: 10.1245/s10434-026-19391.
    PubMed    


  178. JIANG X, Huang Z, Wang X, Long J, et al
    ASO Visual Abstract: Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer-Development and Validation of a Clinical-Inflammatory Nomogram.
    Ann Surg Oncol. 2026 Mar 9. doi: 10.1245/s10434-026-19427.
    PubMed    


  179. QU FL, Cheng JY, Li JJ, Shao ZM, et al
    ASO Author Reflections: Visions in Axilla Management with Clinical Advances in LymphPET for Breast Cancer.
    Ann Surg Oncol. 2026 Mar 7. doi: 10.1245/s10434-026-19472.
    PubMed    


  180. AYUB S, Marra A, Liu Y, Postlewait LM, et al
    ASO Visual Abstract: Rurality and Income on Breast Cancer Outcomes: An Analysis of the SEER Database.
    Ann Surg Oncol. 2026 Mar 6. doi: 10.1245/s10434-026-19423.
    PubMed    


  181. JUNG JJ, Kim HK, Kang E, Park EK, et al
    Enhancing Early Detection of Contralateral Breast Cancer in Breast Cancer Survivors Using AI-Assisted Mammography.
    Ann Surg Oncol. 2026 Mar 6. doi: 10.1245/s10434-026-19348.
    PubMed     Abstract available


  182. KLIMBERG VS
    ASO Author Reflections: Intracavitary Radiofrequency Ablation as a Means to Deescalate Radiation in Patients with Breast Cancer.
    Ann Surg Oncol. 2026 Mar 4. doi: 10.1245/s10434-026-19437.
    PubMed    


  183. YEE GN, Hwang S, Wilke LG, Freedman LM, et al
    ASO Visual Abstract: Commission on Cancer Quality Measure for Omission of Sentinel Lymph Node Biopsy (SNB) in Women Aged 70 Years or Older with Hormone Receptor-Positive (HR(+)) Invasive Breast Cancer (IBC) Undergoing Breast-Conserving Surgery (BCS):
    Ann Surg Oncol. 2026 Mar 3. doi: 10.1245/s10434-026-19390.
    PubMed    


  184. KO G, Li Q, Liu N, Amir E, et al
    ASO Visual Abstract: Breast Cancer Surgery Wait Times and COVID-19-A Canadian Population-Based Analysis.
    Ann Surg Oncol. 2026 Mar 2. doi: 10.1245/s10434-026-19185.
    PubMed    


  185. SHERN TP, Holt LR, Chamberlain V, Gadd MA, et al
    Sentinel Lymph Node Biopsy for Prophylactic Mastectomy: Necessary Precaution or Unnecessary Procedure?
    Ann Surg Oncol. 2026;33:2316-2323.
    PubMed     Abstract available


  186. WEISS A, Jin Q, Tayob N, Wrabel E, et al
    Axillary Management and Outcomes After Neoadjuvant Endocrine Therapy in the Randomized PELOPS Trial.
    Ann Surg Oncol. 2026;33:2275-2283.
    PubMed     Abstract available


  187. WEISS A, Revette A, Nava-Coulter B, Mittendorf EA, et al
    Surgeon Perspectives on Axillary Management Following Neoadjuvant Endocrine Therapy: Results from a Qualitative Substudy of the PELOPS Trial.
    Ann Surg Oncol. 2026;33:2267-2274.
    PubMed     Abstract available


  188. HARRIS N, Aiello P, Detz D, Hanssen D, et al
    Postoperative Impact of Closed Incision Negative Pressure Therapy Following Oncoplastic Breast Surgery.
    Ann Surg Oncol. 2026;33:2013-2018.
    PubMed     Abstract available


  189. KIM CW, Yoo TK, Kim J, Chung IY, et al
    Postoperative Outcomes of Single-Port Robot-Assisted Versus Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction.
    Ann Surg Oncol. 2026;33:2246-2254.
    PubMed     Abstract available


  190. SHAMMAS RL, Wang J, Boe LA, Levy J, et al
    Radiation and Reconstructive Failure: Long-Term Outcomes in Two-Stage Flap Versus Implant Breast Reconstruction.
    Ann Surg Oncol. 2026;33:1981-1989.
    PubMed     Abstract available


    February 2026
  191. SCHRANK Z, Landrum K, Agala CB, Gallagher K, et al
    ASO Visual Abstract: Impact of Age on Use of Neoadjuvant Chemoimmunotherapy and Outcomes for Patients with Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2026 Feb 28. doi: 10.1245/s10434-026-19334.
    PubMed    


  192. CHEN C, Ru L
    ASO Visual Abstract: Prognostic Associations between Adjuvant Chemotherapy and Survival in T1b-T2N0M0 Medullary Breast Cancer: A Population-Based Study of 2343 Patients.
    Ann Surg Oncol. 2026 Feb 28. doi: 10.1245/s10434-026-19271.
    PubMed    


  193. JIANG X, Huang Z, Cao Y, Ding J, et al
    ASO Author Reflections: Toward Personalized Neoadjuvant Therapy in HER2-Positive Breast Cancer-A Clinically Actionable Predictive Model.
    Ann Surg Oncol. 2026 Feb 27. doi: 10.1245/s10434-026-19295.
    PubMed    


  194. SIDHU AS, Chopra AA, Bisch EJ, Chopra A, et al
    Psychosocial Morbidity in Patients with Breast Cancer Related Lymphedema: An Evaluation of Mental Health Diagnoses in Breast Cancer Survivors.
    Ann Surg Oncol. 2026 Feb 25. doi: 10.1245/s10434-026-19345.
    PubMed    


  195. KUEMMEL S, Fasching PA, Schmid P, Harbeck N, et al
    Surgical Outcomes After Neoadjuvant Pembrolizumab Plus Chemotherapy for Triple-Negative Breast Cancer: Results from the Randomized, Placebo-Controlled Phase 3 KEYNOTE-522 Study.
    Ann Surg Oncol. 2026 Feb 25. doi: 10.1245/s10434-026-19121.
    PubMed     Abstract available


  196. PAN Y, Zhu L
    ASO Author Reflections: Large Language Models in Breast Cancer Decision-Making: Lessons from the St. Gallen International Breast Cancer Consensus.
    Ann Surg Oncol. 2026 Feb 24. doi: 10.1245/s10434-026-19330.
    PubMed    


  197. JACINTO AI, Keegan THM, Li Q, Maguire FB, et al
    ASO Visual Abstract: Differences in Treatment and Survival for Secondary Triple Negative Breast Cancer in Premenopausal Women.
    Ann Surg Oncol. 2026 Feb 24. doi: 10.1245/s10434-026-19126.
    PubMed    


  198. PAN Y, Duan C, Du J, Zhang J, et al
    ASO Visual Abstract: St. Gallen International Breast Cancer Consensus-Based Clinical Decision Validation: Concordance Assessment Between Deep Large Language Model Outputs and Global Expert Panel Recommendations.
    Ann Surg Oncol. 2026 Feb 24. doi: 10.1245/s10434-026-19319.
    PubMed    


  199. DIMAANO K, Castillo O Jr, Moazzez A, Ozao-Choy J, et al
    Examining the Representation of Minority Race and Ethnicity Groups in Breast Cancer Clinical Trials in the USA Published 2012-2022.
    Ann Surg Oncol. 2026 Feb 23. doi: 10.1245/s10434-026-19214.
    PubMed     Abstract available


  200. HANNOUN-LEVI JM
    ASO Author Reflections: Breast Cancer Local Recurrence: True Recurrence or New Primary?
    Ann Surg Oncol. 2026 Feb 22. doi: 10.1245/s10434-026-19297.
    PubMed    


  201. KASSI A, Rodriguez L, Wu R, Ishikawa T, et al
    ASO Author Reflections: PARP7 Association to Estrogen and Immunity in Clinical Breast Cancer.
    Ann Surg Oncol. 2026 Feb 21. doi: 10.1245/s10434-026-19296.
    PubMed    


  202. YEE GN, Hwang S, Wilke LG, Freedman LM, et al
    Commission on Cancer Quality Measure for Omission of Sentinel Lymph Node Biopsy (SNB) in Women Age 70 or Older with Hormone Receptor-Positive (HR+) Invasive Breast Cancer (IBC) Undergoing Breast-Conserving Surgery (BCS): Review of Historical Performan
    Ann Surg Oncol. 2026 Feb 21. doi: 10.1245/s10434-026-19222.
    PubMed     Abstract available


  203. AYUB S, Marra A, Liu Y, Postlewait LM, et al
    Rurality and Income on Breast Cancer Outcomes: An Analysis of the SEER Database.
    Ann Surg Oncol. 2026 Feb 19. doi: 10.1245/s10434-026-19254.
    PubMed     Abstract available


  204. RODRIGUEZ L, Wu R, Kassi A, Ishikawa T, et al
    High PARP7 Expression is Associated with Higher Estrogen Response and Immune Suppression but Less Cell Proliferation and Better Survival in Breast Cancer.
    Ann Surg Oncol. 2026 Feb 19. doi: 10.1245/s10434-026-19133.
    PubMed     Abstract available


  205. KINOSHITA T, Takayama S, Fujisawa T, Watanabe K, et al
    Radiofrequency Ablation for Early Stage Breast Cancer as a Potential Alternative to Partial Mastectomy: 5-Year Results from the Multiple-Center, Single-Arm, Phase 3 RAFAELO Study (NCCH1409).
    Ann Surg Oncol. 2026 Feb 18. doi: 10.1245/s10434-026-19220.
    PubMed     Abstract available


  206. PUJOL N, Gal J, Gautier M, Rizzi Y, et al
    Second Ipsilateral Breast Cancer Event: True Recurrence, New Primary, or True Recurrence Like? : Breast Cancer Local Recurrence.
    Ann Surg Oncol. 2026 Feb 18. doi: 10.1245/s10434-026-19131.
    PubMed     Abstract available


  207. SCHRANK Z, Selfridge JM
    ASO Author Reflections: Do Older Triple-Negative Breast Cancer Patients Respond Differently to Neoadjuvant Chemoimmunotherapy?
    Ann Surg Oncol. 2026 Feb 18. doi: 10.1245/s10434-026-19299.
    PubMed    


  208. ABDULLA HA, McGarry J, Kaczorowska R, Grealish A, et al
    ASO Visual Abstract: Oncological Outcomes of Sentinel Lymph Node Biopsy Versus Targeted Axillary Dissection in Node-Positive Breast Cancer Patients After Neoadjuvant Chemotherapy: A Systematic Review and Meta-analysis.
    Ann Surg Oncol. 2026 Feb 18. doi: 10.1245/s10434-026-19273.
    PubMed    


  209. JAYASWAL RP
    Letter Comments on: Differences in Breast Cancer Care Between Rural Women Undergoing Treatment at a Referral Center and Those Treated Locally.
    Ann Surg Oncol. 2026 Feb 17. doi: 10.1245/s10434-026-19258.
    PubMed    


  210. RYU HH, Lee YJ, Yoo TK, Kim J, et al
    Clinical Utility of Oncotype DX Testing in Synchronous Bilateral and Unilateral Multifocal Breast Cancer.
    Ann Surg Oncol. 2026 Feb 16. doi: 10.1245/s10434-026-19243.
    PubMed     Abstract available


  211. JIANG X, Huang Z, Wang X, Long J, et al
    Predictors of Pathological Complete Response to Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer: Development and Validation of a Clinical-Inflammatory Nomogram.
    Ann Surg Oncol. 2026 Feb 14. doi: 10.1245/s10434-026-19178.
    PubMed     Abstract available


  212. LEVINE A, Terrian L, Bishay D, Lawrence K, et al
    Reassessing the Role of Regular Physical Examination in Post-treatment Breast Cancer Surveillance.
    Ann Surg Oncol. 2026 Feb 12. doi: 10.1245/s10434-026-19227.
    PubMed     Abstract available


  213. KO G, Cil TD
    ASO Author Reflections: Patterns of Breast Cancer Management and Surgical Wait Times During the COVID-19 Pandemic.
    Ann Surg Oncol. 2026 Feb 12. doi: 10.1245/s10434-026-19206.
    PubMed    


  214. PAN Y, Duan C, Du J, Zhang J, et al
    St. Gallen International Breast Cancer Consensus-Based Clinical Decision Validation: Concordance Assessment Between Deep Large Language Model Outputs and Global Expert Panel Recommendations.
    Ann Surg Oncol. 2026 Feb 10. doi: 10.1245/s10434-026-19176.
    PubMed     Abstract available


  215. WANG J, Chen J, Amburn T, Wagner BD, et al
    Axillary Lymph Node Dissection Through a Separate Incision Does Not Increase Rates of Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2026 Feb 10. doi: 10.1245/s10434-026-19215.
    PubMed     Abstract available


  216. MASANAM MK, Bellon JR, Leone JP, Mittendorf EA, et al
    ASO Visual Abstract: Breast-Conserving Therapy for Multiple Ipsilateral Breast Cancer After Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2026 Feb 9. doi: 10.1245/s10434-026-19163.
    PubMed    


  217. HOLMES DR
    ASO Author Reflections: Breast Cancer Cryoablation-A Targeted, Patient-Centered Approach Surgeons Should Embrace.
    Ann Surg Oncol. 2026 Feb 9. doi: 10.1245/s10434-026-19144.
    PubMed    


  218. ELAM M, Hillas J, Moyal-Smith R, Padamsee TJ, et al
    ASO Visual Abstract: Bridging Operative Standards to Clinical Practice: A Case Comparison of Synoptic Operative Report Implementation in Breast Cancer Surgery.
    Ann Surg Oncol. 2026 Feb 7. doi: 10.1245/s10434-026-19190.
    PubMed    


  219. FENTENER VAN VLISSINGEN EMALC, Postma EL, Scholten AN, van der Leij F, et al
    ASO Visual Abstract: The Clinical Impact of the Surgical Removal of the Internal Mammary Chain Sentinel Node in Breast Cancer Patients: Do We Need to De-Escalate Our Former Strategy? Reevaluating the Role of Internal Mammary Sentinel Node Removal in B
    Ann Surg Oncol. 2026 Feb 5. doi: 10.1245/s10434-026-19159.
    PubMed    


  220. RAYMAKERS AM, King TA, Mittendorf EA, Dey T, et al
    ASO Visual Abstract: Impact of Breast-Cancer-Related Lymphedema on Cancer Care Costs: Longitudinal and Age-Based Analyses.
    Ann Surg Oncol. 2026 Feb 3. doi: 10.1245/s10434-026-19141.
    PubMed    


  221. TSUCHIDA J, Wu R, Nagahashi M, Ebos JML, et al
    ASO Visual Abstract: TRIM37 Expression is Associated with Immune Suppression, Poor Response to Neoadjuvant Chemotherapy, and Worse Survival in ER-Positive/HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2026 Feb 2. doi: 10.1245/s10434-026-19108.
    PubMed    


  222. LUDWIG KK, Kong A, Grossi S, Joseph KA, et al
    Implementation of Quality Improvement Projects: A Practical Guide From the American Society of Breast Surgeons Patient Safety and Quality Committee.
    Ann Surg Oncol. 2026;33:1221-1231.
    PubMed     Abstract available


  223. STURZ-ELLIS JL, Vetter CD, Day CN, Boughey JC, et al
    A Systematic Review of Occult Malignancy and Sentinel Lymph Node Metastasis at the Time of Contralateral Prophylactic Mastectomy.
    Ann Surg Oncol. 2026;33:1162-1170.
    PubMed     Abstract available


  224. FISH EM, Whittall I, Lyons W, Bleicher RJ, et al
    Axillary Management Trends and Survival in Men Undergoing Mastectomy with Positive Sentinel Nodes.
    Ann Surg Oncol. 2026;33:1150-1161.
    PubMed     Abstract available


    January 2026
  225. ELAM M, Hillas J, Moyal-Smith R, Padamsee TJ, et al
    Bridging Operative Standards to Clinical Practice: A Case Comparison of Synoptic Operative Report Implementation in Breast Cancer Surgery.
    Ann Surg Oncol. 2026 Jan 27. doi: 10.1245/s10434-025-19042.
    PubMed     Abstract available


  226. KO G, Li Q, Liu N, Amir E, et al
    Breast Cancer Surgery Wait Times and COVID-19: A Canadian Population-Based Analysis.
    Ann Surg Oncol. 2026 Jan 25. doi: 10.1245/s10434-025-19029.
    PubMed     Abstract available


  227. BEERTHUIZEN AWJ, Snellen TIM, Bartels SA, Kuijer A, et al
    ASO Visual Abstract: The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial.
    Ann Surg Oncol. 2026 Jan 24. doi: 10.1245/s10434-025-19063.
    PubMed    


  228. BARMETTLER G, Leonard S, Giannakou A, Park KU, et al
    ASO Visual Abstract: Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities.
    Ann Surg Oncol. 2026 Jan 22. doi: 10.1245/s10434-025-19077.
    PubMed    


  229. DAY CN, Habermann EB, Boughey JC
    Evolution of Breast Cancer Treatment 2010-2023.
    Ann Surg Oncol. 2026 Jan 20. doi: 10.1245/s10434-025-19065.
    PubMed     Abstract available


  230. GALLAGHER K, Feldman S, Barone J, Mammen J, et al
    Prospective Phase II Multicenter Trial of Ablation after Breast Lumpectomy Added To Extend (ABLATE) Intraoperative Margins for the Sole Local Treatment of Breast Cancer.
    Ann Surg Oncol. 2026 Jan 18. doi: 10.1245/s10434-025-19008.
    PubMed     Abstract available


  231. SHEN Y, Gadiraju GK, Gao R, Raymakers AM, et al
    ASO Visual Abstract: Breast Reconstruction for Inflammatory Breast Cancer: Improving Patient-Reported Outcomes in a High-Risk Population.
    Ann Surg Oncol. 2026 Jan 17. doi: 10.1245/s10434-025-18841.
    PubMed    


  232. ABDULLA HA, McGarry J, Kaczorowska R, Grealish A, et al
    Oncologic Outcomes of Sentinel Lymph Node Biopsy Versus Targeted Axillary Dissection for Node-Positive Breast Cancer Patients After Neoadjuvant Chemotherapy: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2026 Jan 16. doi: 10.1245/s10434-025-19070.
    PubMed     Abstract available


  233. HOLMES DR, Manoian S, Rahman RL, Ward RC, et al
    Cryoablation: A Minimally Invasive Alternative for Early-Stage Breast Cancer: 6-Year Outcomes of the FROST Clinical Trial.
    Ann Surg Oncol. 2026 Jan 15. doi: 10.1245/s10434-025-18991.
    PubMed     Abstract available


  234. DOUGLAS SR, Thomas SM, Chiba A, Botty van den Bruele A, et al
    ASO Author Reflections: Moving Toward Evidence-Based Guidelines for Axillary Surgery After Neoadjuvant Endocrine Therapy for Breast Cancer.
    Ann Surg Oncol. 2026 Jan 14. doi: 10.1245/s10434-025-18331.
    PubMed    


  235. CHEN C, Ru L
    Prognostic Associations Between Adjuvant Chemotherapy and Survival in T1b-T2N0M0 Medullary Breast Cancer: A Population-Based Study of 2343 Patients.
    Ann Surg Oncol. 2026 Jan 14. doi: 10.1245/s10434-025-19054.
    PubMed     Abstract available


  236. DZUBNAR JM, Habel LA, Jiang SF, Karlea A, et al
    Multigene Germline Testing in Patients with DCIS vs Invasive Breast Cancer in a Large, Integrated Health Care System.
    Ann Surg Oncol. 2026 Jan 13. doi: 10.1245/s10434-025-19053.
    PubMed     Abstract available


  237. ROSS VMS, Addie M, Pickard MR, Josey V, et al
    ASO Visual Abstract: Axillary Management in Patients with Breast Cancer with Positive Lymph Nodes Following Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2026 Jan 12. doi: 10.1245/s10434-025-19036.
    PubMed    


  238. GNANGNON FHR, Parente A, Allayambaye TE, Sacca HR, et al
    Epidemiology and Clinical Features of Breast Cancer in Cotonou (2014-2019): Insights from a Population-Based Registry Study.
    Ann Surg Oncol. 2026 Jan 11. doi: 10.1245/s10434-025-18976.
    PubMed     Abstract available


  239. JACINTO AI, Keegan THM, Li Q, Maguire FB, et al
    Differences in Treatment and Survival for Secondary Triple Negative Breast Cancer in Premenopausal Women.
    Ann Surg Oncol. 2026 Jan 9. doi: 10.1245/s10434-025-18892.
    PubMed     Abstract available


  240. JACINTO AI, Sauder C
    ASO Author Reflections: Treating Secondary Triple Negative Breast Cancer in Younger Women.
    Ann Surg Oncol. 2026 Jan 7. doi: 10.1245/s10434-025-19016.
    PubMed    


  241. WANG Z, Gu L, Yang M, Zhou Y, et al
    NUP62 Elevates USP10 Expression and Promotes Tamoxifen Resistance of Breast Cancer by Deubiquitinating ERalpha.
    Ann Surg Oncol. 2026 Jan 7. doi: 10.1245/s10434-025-18995.
    PubMed     Abstract available


  242. VAN GEMERT D, Beelen LM, Mos J, van Egdom L, et al
    ASO Author Reflections: Beyond Treatment Intensity: Understanding Individual Susceptibility in Breast Cancer-Related Lymphedema (BCRL).
    Ann Surg Oncol. 2026 Jan 7. doi: 10.1245/s10434-025-18851.
    PubMed    


  243. BEERTHUIZEN AWJ, van Duijnhoven FH
    ASO Author Reflections: The Added Value of Axillary Ultrasound in Early Breast Cancer: Insights from the AMAROS Trial.
    Ann Surg Oncol. 2026 Jan 6. doi: 10.1245/s10434-025-18998.
    PubMed    


  244. VAN VLISSINGEN EMALCF, Postma EL, Scholten AN, van der Leij F, et al
    The Clinical Impact of the Surgical Removal of the Internal Mammary Chain Sentinel Node in Breast Cancer Patients: Do We Need to De-Escalate our Former Strategy?
    Ann Surg Oncol. 2026 Jan 5. doi: 10.1245/s10434-025-18930.
    PubMed     Abstract available


  245. PARMAR P, Lin J, Bhimani F, Jao L, et al
    ASO Visual Abstract: Zip-Code-Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation.
    Ann Surg Oncol. 2026 Jan 5. doi: 10.1245/s10434-025-18860.
    PubMed    


  246. MASANAM MK, Bellon JR, Leone JP, Mittendorf EA, et al
    Breast-Conserving Therapy for Multiple Ipsilateral Breast Cancer After Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2026 Jan 3. doi: 10.1245/s10434-025-18939.
    PubMed     Abstract available


  247. VAN VLISSINGEN EMALCF, van der Ploeg IMC
    ASO Author Reflections: De-Escalating Internal Mammary Sentinel Node Surgery in Breast Cancer.
    Ann Surg Oncol. 2026 Jan 3. doi: 10.1245/s10434-025-18973.
    PubMed    


  248. WANG T, Neish D, Thomas S, Botty van den Bruele A, et al
    ASO Visual Abstract: Radiation Deescalation in Older Women with Early Stage ER+/HER2- Invasive Breast Cancer.
    Ann Surg Oncol. 2026 Jan 3. doi: 10.1245/s10434-025-19009.
    PubMed    


  249. MELANSON A, Mashal S, Apostolova C, Ferroum A, et al
    Uptake of Risk Reducing Mastectomy in Older BRCA1/2 and PALB2 Carriers Undergoing Genetic Testing after 60 Years of Age.
    Ann Surg Oncol. 2026;33:108-117.
    PubMed     Abstract available


  250. WANG J, Shammas RL, Graziano FD, Boe LA, et al
    One or Two Drains? A Propensity Score-Matched Analysis of Postoperative Complications After Tissue Expander Placement.
    Ann Surg Oncol. 2026;33:668-675.
    PubMed     Abstract available


  251. BROWN S, Shen Y, Klimitz FJ, Nair M, et al
    Immediate Lymphatic Reconstruction (ILR) for the Prevention of Lymphedema: A Meta-analysis of Prospective Clinical Trials.
    Ann Surg Oncol. 2026;33:60-76.
    PubMed     Abstract available


  252. OZAWA N, Takeyama E, Sakai H, Katayama A, et al
    Molecular and Biological Features of Invasive Lobular Carcinoma: Toward New Treatment Strategies.
    Ann Surg Oncol. 2026;33:146-158.
    PubMed     Abstract available


  253. NAASEH A, Bewley AF, Nickel KB, Myckatyn TM, et al
    Impact of Sociodemographic and Clinical Factors on Postoperative Outcomes Following Immediate Postmastectomy Autologous Breast Reconstruction.
    Ann Surg Oncol. 2026;33:658-667.
    PubMed     Abstract available


  254. CHANDLER JM, Kim M, Sevilimedu V, Le TV, et al
    Trends in Patient-Reported Outcomes After Breast-Conserving Surgery and Partial-Breast Versus Whole-Breast Irradiation.
    Ann Surg Oncol. 2026;33:50-59.
    PubMed     Abstract available


  255. ZAVERI S, Sun SX, Bevers TB, Albarracin CT, et al
    Implications of the COMET Trial for the Management of Atypical Ductal Hyperplasia.
    Ann Surg Oncol. 2026;33:43-49.
    PubMed     Abstract available


    December 2025
  256. VETTER C, Day CN, Habermann EB, Boughey JC, et al
    Differences in Breast Cancer Care Between Rural Women Undergoing Treatment at a Referral Center and Those Treated Locally.
    Ann Surg Oncol. 2025 Dec 29. doi: 10.1245/s10434-025-18812.
    PubMed     Abstract available


  257. BARMETTLER G, Kantor O
    ASO Author Reflections: Identifying Differences in Treatment Patterns in Sexual and Gender Minorities with Breast Cancer.
    Ann Surg Oncol. 2025 Dec 27. doi: 10.1245/s10434-025-18964.
    PubMed    


  258. VETTER C, Day CN, Habermann EB, Boughey JC, et al
    ASO Visual Abstract: Differences in Breast Cancer Care Between Rural Women Undergoing Treatment at a Referral Center Compared with Those Treated Locally.
    Ann Surg Oncol. 2025 Dec 24. doi: 10.1245/s10434-025-18920.
    PubMed    


  259. VAN GEMERT D, Beelen LM, Mos J, van Egdom L, et al
    ASO Visual Abstract: Breast Cancer-Related Lymphedema (BCRL): Comprehensive Characterization of Patients Seeking Microsurgical Treatment.
    Ann Surg Oncol. 2025 Dec 17. doi: 10.1245/s10434-025-18861.
    PubMed    


  260. LEE JA, Lee HS, Jeon S, Kim D, et al
    ASO Visual Abstract: Risk Factors and Incidence of Reoperation in Direct-to-Implant Breast Reconstruction Surgery Among Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Dec 17. doi: 10.1245/s10434-025-18845.
    PubMed    


  261. ROSS VMS, Addie M, Roy Pickard M, Josey V, et al
    ASO Author Reflections: Neoadjuvant Chemotherapy and Prediction of Residual Axillary Disease in Breast Cancer Patients.
    Ann Surg Oncol. 2025 Dec 16. doi: 10.1245/s10434-025-18905.
    PubMed    


  262. RAYMAKERS AM, King TA, Mittendorf EA, Dey T, et al
    Impact of Breast Cancer-Related Lymphedema on Cancer Care Costs: Longitudinal and Age-Based Analyses.
    Ann Surg Oncol. 2025 Dec 16. doi: 10.1245/s10434-025-18875.
    PubMed     Abstract available


  263. MA D, Cao H, Wu J, Shang T, et al
    ASO Visual Abstract: Analysis of the Current Status of de Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.
    Ann Surg Oncol. 2025 Dec 16. doi: 10.1245/s10434-025-18868.
    PubMed    


  264. BEERTHUIZEN AWJ, Snellen TIM, Bartels SA, Kuijer A, et al
    The Value of Ultrasound in Patients with T1-T2 Breast Cancer with No Palpable Lymph Nodes Enrolled in the EORTC 10981-22023 AMAROS Trial.
    Ann Surg Oncol. 2025 Dec 14. doi: 10.1245/s10434-025-18833.
    PubMed     Abstract available


  265. HANS M, Tamaskar AS, Recko A, Bychkovsky BL, et al
    ASO Visual Abstract: Evaluating the Implementation and Maintenance of a Breast Cancer Risk Assessment and Prevention Program.
    Ann Surg Oncol. 2025 Dec 13. doi: 10.1245/s10434-025-18844.
    PubMed    


  266. BARMETTLER G, Leonard S, Giannakou A, Park KU, et al
    Breast Cancer Presentation and Treatment Patterns in Sexual and Gender Minorities.
    Ann Surg Oncol. 2025 Dec 11. doi: 10.1245/s10434-025-18853.
    PubMed     Abstract available


  267. COBB AN, Dong X, Makope A, Cohen L, et al
    ASO Visual Abstract: Contemporary Nodal Management and Overall Survival in Older Patients with HR-/HER2+ Breast Cancer.
    Ann Surg Oncol. 2025 Dec 8. doi: 10.1245/s10434-025-18836.
    PubMed    


  268. LEE K, Pallesi A, Valdez BJ, Hanes DA, et al
    Factors Associated With Residual Disease on Re-Excision Specimens After Breast-Conserving Surgery for Breast Cancer.
    Ann Surg Oncol. 2025 Dec 6. doi: 10.1245/s10434-025-18813.
    PubMed     Abstract available


  269. DOUGLAS SR, Thomas SM, Chiba A, DiNome ML, et al
    ASO Visual Abstract: Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
    Ann Surg Oncol. 2025 Dec 4. doi: 10.1245/s10434-025-18393.
    PubMed    


  270. TSUCHIDA J, Wu R, Nagahashi M, Ebos JML, et al
    ASO Author Reflections: DNA Repair and Tumor Immunity in Breast Cancer: A Context-Dependent Role for TRIM37.
    Ann Surg Oncol. 2025 Dec 2. doi: 10.1245/s10434-025-18852.
    PubMed    


  271. ULANER GA, Khan S, Savalia NB, Lopez J, et al
    The Van Nuys DCIS Prognostic Index -->The Silverstein DCIS Prognostic Index.
    Ann Surg Oncol. 2025;32:9475-9477.
    PubMed     Abstract available


  272. JENSEN S, Tvedskov TF, Bechmann T, Tramm T, et al
    Additional Axillary Disease After Neoadjuvant Chemotherapy for Patients with Clinically Node-Negative but Sentinel Node-Positive Disease.
    Ann Surg Oncol. 2025;32:9807-9816.
    PubMed     Abstract available


  273. GWARK S, Hwang YH, Paek SH, Lee YW, et al
    Early Postoperative Outcomes of Tumescent-Free Single-Port Robot-Assisted Nipple-Sparing Mastectomy Compared with Tumescent-Using Technique: A Substudy of Retrospective Multicenter Study (SPROUT, KoREa-BSG 14).
    Ann Surg Oncol. 2025;32:9787-9797.
    PubMed     Abstract available


  274. ROSENBERG SM, Rushing C, Schreiber KL, Crowell KA, et al
    Patient-reported Outcomes After Routine Treatment of In Situ/Atypical Lesions: The PORTAL Study.
    Ann Surg Oncol. 2025;32:9776-9786.
    PubMed     Abstract available


  275. DE OLIVEIRA-JUNIOR I, Gonzaga MI, Amirati CC, Vilela NM, et al
    Primary Breast Implant-Associated Squamous Cell Carcinoma: A Proposal for a Better Surgical Approach and Clinical Staging System Based on Tumour Characteristics.
    Ann Surg Oncol. 2025;32:9857-9867.
    PubMed     Abstract available


  276. PARMAR P, Lin J, Bhimani F, Jao L, et al
    Zip-Code Level Disadvantage as a Predictor of Metastatic Breast Cancer at Diagnosis and Delayed Treatment Initiation.
    Ann Surg Oncol. 2025 Dec 1. doi: 10.1245/s10434-025-18693.
    PubMed     Abstract available


    November 2025
  277. ROSS VMS, Addie M, Roy Pickard M, Josey V, et al
    Axillary Management in Breast Cancer Patients with Positive Lymph Nodes Following Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Nov 26. doi: 10.1245/s10434-025-18783.
    PubMed     Abstract available


  278. COBB AN, Dong X, Makope A, Cohen L, et al
    Correction: Contemporary Nodal Management and Overall Survival of Older Patients with HR-/HER2+ Breast Cancer.
    Ann Surg Oncol. 2025 Nov 25. doi: 10.1245/s10434-025-18811.
    PubMed    


  279. GHOSH M, Hoysal DR, Deshpande A, Badwe RA, et al
    Letter to the Editor "Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial".
    Ann Surg Oncol. 2025 Nov 25. doi: 10.1245/s10434-025-18788.
    PubMed    


  280. SHEN Y, Gadiraju GK, Gao R, Nakhlis Md F, et al
    ASO Author Reflections: Beyond Survival: Restoring Quality of Life in Inflammatory Breast Cancer.
    Ann Surg Oncol. 2025 Nov 24. doi: 10.1245/s10434-025-18700.
    PubMed    


  281. TEKCAN SANLI DE, Sanli AN
    Evaluating Survival and Treatment Patterns Using the National Cancer Database in HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2025 Nov 24. doi: 10.1245/s10434-025-18796.
    PubMed    


  282. WANG T, Neish D, Thomas S, Botty van den Bruele A, et al
    Radiation De-Escalation in Older Women with Early-Stage ER+/HER2- Invasive Breast Cancer.
    Ann Surg Oncol. 2025 Nov 23. doi: 10.1245/s10434-025-18746.
    PubMed     Abstract available


  283. WAGNER BD, Rubin J, Lin IH, Raina J, et al
    ASO Visual Abstract: Clinical Features, Microbial Epidemiology, and Recurrence Risk of Cellulitis in Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2025 Nov 23. doi: 10.1245/s10434-025-18789.
    PubMed    


  284. RANGEL M, Paul S, Gupta D, McPeek C, et al
    ASO Visual Abstract: Evaluating the Gail Model: Racial Disparities in Breast Cancer Risk Assessment.
    Ann Surg Oncol. 2025 Nov 23. doi: 10.1245/s10434-025-18753.
    PubMed    


  285. COBB AN, Cortina CS
    Reply to: Letter to the Editor of Annals of Surgical Oncology Concerning "Evaluating Survival and Treatment Patterns Using the National Cancer Database in HER2-Positive Breast Cancer," by Sanli, Deniz et al.
    Ann Surg Oncol. 2025 Nov 22. doi: 10.1245/s10434-025-18797.
    PubMed    


  286. TSUCHIDA J, Wu R, Nagahashi M, Ebos JML, et al
    TRIM37 Expression is Associated with Immune Suppression Poor Response to Neoadjuvant Chemotherapy and Worse Survival in ER-Positive/HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2025 Nov 21. doi: 10.1245/s10434-025-18764.
    PubMed     Abstract available


  287. MARTELLI G, Barretta F, Muzi C, Listorti C, et al
    Sentinel Node Biopsy Alone Versus Sentinel Node Biopsy Plus Axillary Dissection in cT2 cN0/1 Breast Cancer After Neoadjuvant Chemotherapy: 15-Year Results of a Prospective Interventional Study.
    Ann Surg Oncol. 2025 Nov 18. doi: 10.1245/s10434-025-18673.
    PubMed     Abstract available


  288. VAN GEMERT D, Beelen LM, Mos J, van Egdom L, et al
    Breast Cancer-Related Lymphedema (BCRL): Comprehensive Characterization of Patients Seeking Microsurgical Treatment.
    Ann Surg Oncol. 2025 Nov 18. doi: 10.1245/s10434-025-18694.
    PubMed     Abstract available


  289. MARTELLI G
    ASO Author Reflections: No Further Axillary Treatment is Safe if the Sentinel Nodes are Negative After Neoadjuvant Chemotherapy in cT2 cN1 Breast Cancer.
    Ann Surg Oncol. 2025 Nov 15. doi: 10.1245/s10434-025-18775.
    PubMed    


  290. KOBZEVA-HERZOG AJ, Palaniappan S, Jiangliu Y, Kraus E, et al
    ASO Visual Abstract: A Multidisciplinary Breast Cancer Clinic Improves Time to Treatment at an Urban, Safety Net Hospital.
    Ann Surg Oncol. 2025 Nov 15. doi: 10.1245/s10434-025-18677.
    PubMed    


  291. YOO JW, Byeon J, Park WK, Kim J, et al
    Germline BRCA1/2 Mutation Prevalence in Unselected ER-Low/HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2025 Nov 14. doi: 10.1245/s10434-025-18713.
    PubMed     Abstract available


  292. MA D, Cao H, Wu J, Shang T, et al
    ASO Author Reflections: Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the United States: A Multicenter Real-World Study.
    Ann Surg Oncol. 2025 Nov 6. doi: 10.1245/s10434-025-18643.
    PubMed    


  293. SHEN Y, Gadiraju GK, Gao R, Raymakers AM, et al
    Breast Reconstruction for Inflammatory Breast Cancer: Improving Patient-Reported Outcomes in a High-Risk Population.
    Ann Surg Oncol. 2025 Nov 6. doi: 10.1245/s10434-025-18640.
    PubMed     Abstract available


  294. LEE JA, Lee HS, Jeon S, Kim D, et al
    Risk Factors and Incidence of Reoperation in Direct-to-Implant Breast Reconstruction Surgery Among Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Nov 3. doi: 10.1245/s10434-025-18662.
    PubMed     Abstract available


  295. HANS M, Tamaskar AS, Recko A, Bychkovsky BL, et al
    Evaluating the Implementation and Maintenance of a Breast Cancer Risk-Assessment and Prevention Program.
    Ann Surg Oncol. 2025 Nov 1. doi: 10.1245/s10434-025-18656.
    PubMed     Abstract available


  296. BRABENDER D, Siegel E, Culver JO, Comeaux JG, et al
    Identification of Patients at Elevated Cancer Risk through a Community-Based Genetic Testing Program.
    Ann Surg Oncol. 2025;32:9041-9049.
    PubMed     Abstract available


  297. DE CARDOSO DIAS I, Mora HF, Peleteiro B, Fougo JL, et al
    Breast-Conserving Oncoplastic Surgery Stratification: Morbidity Retrospective Analysis and its Association with Procedure Complexity Level.
    Ann Surg Oncol. 2025;32:8769-8779.
    PubMed     Abstract available


  298. VERTIDO A, McKenzie T, Othieno A, Quirarte A, et al
    Accuracy of Breast MRI for Surgical Planning After Neoadjuvant Therapy for Patients with Invasive Lobular Carcinoma.
    Ann Surg Oncol. 2025;32:8710-8719.
    PubMed     Abstract available


    October 2025
  299. TORTORELLO GN, Shafique N, De Jesus EM, Gimotty P, et al
    Sentinel Lymph Node Biopsy in Low-Risk Breast Cancer in Patients >/= 70 Years: How Wisely are We Choosing?
    Ann Surg Oncol. 2025 Oct 30. doi: 10.1245/s10434-025-18534.
    PubMed     Abstract available


  300. HAMID SA, Moses J, Lynch OF, Washington R, et al
    ASO Visual Abstract: Financial Outlook thRough CAncer STorytelling (FOReCAST): Development of a Novel Video-Based Storytelling Intervention to Mitigate Financial Hardship Among Young Women with Breast Cancer.
    Ann Surg Oncol. 2025 Oct 27. doi: 10.1245/s10434-025-18585.
    PubMed    


  301. COX CE, Schumacher J, Lillie M, Carino J, et al
    Simultaneous Omission of Sentinel Lymph Node Biopsy and Radiation in Older Women with Early ER+ Breast Cancer.
    Ann Surg Oncol. 2025 Oct 27. doi: 10.1245/s10434-025-18631.
    PubMed     Abstract available


  302. RANGEL M, Paul S, Gupta D, McPeek C, et al
    Evaluating the Gail Model: Racial Disparities in Breast Cancer Risk Assessment.
    Ann Surg Oncol. 2025 Oct 25. doi: 10.1245/s10434-025-18593.
    PubMed     Abstract available


  303. TANG A, Wu PS, Farmah P, Schulz-Costello K, et al
    Omission of Axillary Lymph Node Dissection in Patients with pT0-2 ER+/HER2- Breast Cancer with 3-5 Positive Lymph Nodes Undergoing Adjuvant Systemic Therapy and Radiation Does Not Impact Overall Survival: A National Cancer Database Analysis.
    Ann Surg Oncol. 2025 Oct 24. doi: 10.1245/s10434-025-18546.
    PubMed     Abstract available


  304. VETTER CD, Hoskin T, Olson C, Giridhar K, et al
    ASO Visual Abstract: Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of Performance for Cancer-Specific Outcomes.
    Ann Surg Oncol. 2025 Oct 22. doi: 10.1245/s10434-025-18350.
    PubMed    


  305. ARIMA J, Chida K, Wu R, Taniguchi K, et al
    ASO Visual Abstract: ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in ER-Positive HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2025 Oct 22. doi: 10.1245/s10434-025-18480.
    PubMed    


  306. WAGNER BD, Rubin J, Lin IH, Raina J, et al
    Clinical Features, Microbial Epidemiology, and Recurrence Risk of Cellulitis in Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2025 Oct 19. doi: 10.1245/s10434-025-18598.
    PubMed     Abstract available


  307. KOBZEVA-HERZOG AJ, Palaniappan S, Jiangliu Y, Kraus E, et al
    A Multidisciplinary Breast Cancer Clinic Improves Time to Treatment at an Urban, Safety Net Hospital.
    Ann Surg Oncol. 2025 Oct 17. doi: 10.1245/s10434-025-18497.
    PubMed     Abstract available


  308. DOUGLAS SR, Thomas SM, van den Bruele AB, Wang T, et al
    ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic.
    Ann Surg Oncol. 2025 Oct 15. doi: 10.1245/s10434-025-18495.
    PubMed    


  309. HUANG SY, Murray M, Rubio A, Okoro N, et al
    ASO Visual Abstract: Impact of Screening Mammography on Breast Cancer Outcomes in Women Aged 80 Years and Over.
    Ann Surg Oncol. 2025 Oct 10. doi: 10.1245/s10434-025-18488.
    PubMed    


  310. MA D, Cao H, Wu J, Shang T, et al
    Analysis of the Current Status of De Novo Metastatic Breast Cancer Surgery in China and the USA: A Multicenter Real-World Study.
    Ann Surg Oncol. 2025 Oct 10. doi: 10.1245/s10434-025-18490.
    PubMed     Abstract available


  311. COBB AN, Cortina CS
    ASO Author Reflections: Prognostic and Therapeutic Implications of Nodal Burden in HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2025 Oct 10. doi: 10.1245/s10434-025-18525.
    PubMed    


  312. CHAKRABORTY M, Sherwani Z, Narra LR, Yehia ZA, et al
    Reply to: "Preoperative Radiation Boost in Early Stage Breast Cancer: Effect on Re-excision and Complication Rates," by Sanli, Deniz et al.
    Ann Surg Oncol. 2025 Oct 8. doi: 10.1245/s10434-025-18489.
    PubMed    


  313. WAGNER BD, Rubin J, Boe LA, Diwan R, et al
    ASO Visual Abstract: Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy.
    Ann Surg Oncol. 2025 Oct 8. doi: 10.1245/s10434-025-18509.
    PubMed    


  314. BIRGIN E, Rahbari NN
    Robotic Central Hepatectomy.
    Ann Surg Oncol. 2025;32:7252-7253.
    PubMed     Abstract available


  315. PHANG F, Finkelman B, Gooch J, Olzinski-Kunze A, et al
    Real-World Application of Alliance ACOSOG Z11102: How Many Patients Can be Spared Mastectomy?
    Ann Surg Oncol. 2025;32:8271-8279.
    PubMed     Abstract available


  316. CHINN J, Earley M, Dashevsky BZ, Stone K, et al
    Comparison of Two Wireless Localization Technologies for Removal of Non-palpable Breast Lesions: SCOUT((R)) Radar Reflector and Pintuition((R)) Magnetic Seed.
    Ann Surg Oncol. 2025;32:8280-8285.
    PubMed     Abstract available


  317. FERRUCCI M, Milardi F, Passeri D, Miglioranza E, et al
    The Combination of Chest Wall Perforator Flaps and Surgeon-Performed Breast Ultrasound: An Effective Synergy to Expand the Boundaries of Breast-Conserving Surgery.
    Ann Surg Oncol. 2025;32:8538-8551.
    PubMed     Abstract available


  318. PLICHTA JK, Bleicher RJ, Boughey J, Margenthaler JA, et al
    Analysis of the 2024 Breast Surgical Oncology Fellowship Match: Survey of Applicants' and Program Directors' Preferences Regarding In-Person Versus Virtual Interviews.
    Ann Surg Oncol. 2025;32:8514-8522.
    PubMed     Abstract available


  319. SANTORO CN, Hoskin TL, Olson CA, Boughey JC, et al
    Is the Clipped Node Enough? Successful Retrieval and False Negative Rate of the Clipped Node After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025;32:8129-8139.
    PubMed     Abstract available


  320. NAASEH A, Tang SX, Lipsey KL, Politi MC, et al
    Feasibility and Efficacy of Decision Aids to Improve Decision-Making for Contralateral Prophylactic Mastectomy: A Systematic Review.
    Ann Surg Oncol. 2025;32:8325-8337.
    PubMed     Abstract available


  321. DICKERSON F, Wiener AA, Breuer C, Schumacher J, et al
    Breast Surgeons' Perspectives of Telehealth Visits for Breast Clinic.
    Ann Surg Oncol. 2025;32:8463-8471.
    PubMed     Abstract available


  322. HUYNH V, Glencer A, Yi M, Wingate E, et al
    Impact of Pathologic Complete Response on Local-Regional Recurrence and Survival in Patients Undergoing Neoadjuvant Systemic Therapy and Breast-Conserving Surgery.
    Ann Surg Oncol. 2025;32:8160-8167.
    PubMed     Abstract available


  323. MILLARD T, Turkheimer LM, Petroni G, Brighton D, et al
    Ninety Days of Preoperative Endocrine Therapy Informs Patient and Physician Preference for Radiation Therapy: Primary Results from the Preoperative Window of Endocrine Therapy to Inform Radiation Therapy Decisions (POWER) Trial.
    Ann Surg Oncol. 2025;32:8169-8179.
    PubMed     Abstract available


  324. MARTIN G, Kensler KH, An A, Gemson E, et al
    Closing the Gap: Disparities in Breast Reconstruction After Mastectomy.
    Ann Surg Oncol. 2025;32:8313-8322.
    PubMed     Abstract available


  325. AMBURN T, Farahani S, Sevilimedu V, Brogi E, et al
    Nipple Discharge and Pathologic Involvement of the Nipple-Areolar Complex: Reconsidering Guidelines for Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2025;32:8434-8444.
    PubMed     Abstract available


  326. SLOBIN J, Travers G, Perez J, Collins V, et al
    Added Value of Fine-Needle Aspiration (FNA) or Breast Magnetic Resonance Imaging (MRI) as Part of the "Triple Test" to Assess Palpable Abnormalities on a Breast Exam With Negative Imaging Findings.
    Ann Surg Oncol. 2025;32:8378-8385.
    PubMed     Abstract available


  327. CHAN K, Palis BE, Cotler JH, Bleicher RJ, et al
    Association of Surgeon Volume with Adherence to American Society of Breast Surgeons Surgical Quality Measures.
    Ann Surg Oncol. 2025;32:8144-8155.
    PubMed     Abstract available


  328. REAGAN AM, Jones VM, Ibrahim-Zada I, Smith SR, et al
    Characterizing the General Surgery Experience of Future Breast Surgeons: A Multi-institutional Study from the US ROPE Consortium.
    Ann Surg Oncol. 2025;32:8340-8348.
    PubMed     Abstract available


  329. REASON EH, Aiduk MD, Nash AL, McDuff SGR, et al
    Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study.
    Ann Surg Oncol. 2025;32:8299-8308.
    PubMed     Abstract available


  330. KAUR M, Dimitroff K, Boughey JC, Esserman LJ, et al
    Disparities in the Surgical Management of the Axilla by Self-Identified Race in the Multicenter Neoadjuvant I-SPY2 Trial.
    Ann Surg Oncol. 2025;32:8211-8219.
    PubMed     Abstract available


  331. BHEEMIREDDY S, Leslie SE, Durden JA, Burnet G, et al
    The Use of ChatGPT-4.0 to Simplify Breast Pathology Reports: A Study on Readability and Accuracy.
    Ann Surg Oncol. 2025;32:8400-8408.
    PubMed     Abstract available


  332. SUMMERSIDE M, Istl AC, Rogers CC, Cobb AN, et al
    From Podium to PubMed: Successful Manuscript Publication of Oral Breast Surgery Abstract Presentations at National Meetings from 2017 to 2022.
    Ann Surg Oncol. 2025;32:8184-8191.
    PubMed     Abstract available


  333. AIELLO C, Eum JL, Smilen SH, Pandya D, et al
    Is This the Right Link? How TikTok Views Oncoplastic Breast Surgery.
    Ann Surg Oncol. 2025;32:8369-8373.
    PubMed     Abstract available


    September 2025
  334. TASHJIAN NL, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
    ASO Visual Abstract: The Association of Clinical Stage at Presentation with Overall Survival in Patients with HER2-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18358.
    PubMed    


  335. COBB AN, Dong X, Makope A, Cohen L, et al
    Contemporary Nodal Management and Overall Survival of Older Patients with HR-/HER2+ Breast Cancer.
    Ann Surg Oncol. 2025 Sep 29. doi: 10.1245/s10434-025-18417.
    PubMed     Abstract available


  336. HAMID SA, Moses J, Lynch OF, Washington R, et al
    Financial Outlook thRough CAncer STorytelling (FOReCAST): Development of a Novel Video-Based Storytelling Intervention to Mitigate Financial Hardship Among Young Women with Breast Cancer.
    Ann Surg Oncol. 2025 Sep 24. doi: 10.1245/s10434-025-18405.
    PubMed    


  337. DOUGLAS SR, van den Bruele AMB, Chiba A
    ASO Author Reflections: Lessons Learned from Neoadjuvant Endocrine Therapy use for Estrogen Receptor Positive Breast Cancer during the Covid-19 Pandemic.
    Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18380.
    PubMed    


  338. MUNCK F, Tvedskov THF
    Reply to "Comment on TAD Outcomes from the Danish Breast Cancer Group Database".
    Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18419.
    PubMed    


  339. DOUGLAS SR, Thomas SM, Chiba A, DiNome ML, et al
    Contemporary Trends in Axillary Surgery for ER-Positive, HER2-Negative Breast Cancer Stratified by Neoadjuvant Endocrine Therapy, Neoadjuvant Chemotherapy, or Upfront Surgery.
    Ann Surg Oncol. 2025 Sep 23. doi: 10.1245/s10434-025-18225.
    PubMed     Abstract available


  340. DOUGLAS SR, Thomas SM, van den Bruele AB, Wang T, et al
    Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the COVID-19 Pandemic.
    Ann Surg Oncol. 2025 Sep 20. doi: 10.1245/s10434-025-18307.
    PubMed     Abstract available


  341. WAGNER BD, Rubin J, Boe LA, Diwan R, et al
    Are We Underestimating Breast Cancer-Related Lymphedema? The Impact of Diagnostic Thresholds and Compression Therapy.
    Ann Surg Oncol. 2025 Sep 19. doi: 10.1245/s10434-025-18334.
    PubMed     Abstract available


  342. MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
    ASO Visual Abstract: Medicaid Expansion Is Associated With Lower Mortality in Patients With Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2025 Sep 17. doi: 10.1245/s10434-025-18159.
    PubMed    


  343. ARIMA J, Chida K, Wu R, Taniguchi K, et al
    ASO Author Reflections: Predictors of Immune Checkpoint Inhibitor Response in ER+/HER2- Breast Cancer: A New Role for ESR1?
    Ann Surg Oncol. 2025 Sep 17. doi: 10.1245/s10434-025-18377.
    PubMed    


  344. ARIMA J, Chida K, Wu R, Taniguchi K, et al
    ESR1 Expression Negatively Correlates with Immune Cell Infiltration and Response to Immune Checkpoint Inhibitors in Estrogen Receptor-Positive/HER2-Negative Breast Cancer.
    Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18260.
    PubMed     Abstract available


  345. MUNCK F, Jensen MB, Hawaz-Ali R, Tvedskov THF, et al
    ASO Visual Abstract: Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection.
    Ann Surg Oncol. 2025 Sep 16. doi: 10.1245/s10434-025-18256.
    PubMed    


  346. ZATECKY J, Coufal O
    De-escalation of Axillary Surgery in Inflammatory Breast Cancer: The Right Time is Coming.
    Ann Surg Oncol. 2025 Sep 15. doi: 10.1245/s10434-025-18356.
    PubMed    


  347. HUANG SY, Murray M, Rubio A, Okoro N, et al
    Impact of Screening Mammography on Breast Cancer Outcomes in Women Aged 80 Years and Over.
    Ann Surg Oncol. 2025 Sep 13. doi: 10.1245/s10434-025-18288.
    PubMed     Abstract available


  348. JENSEN S, Tvedskov T, Bechmann T, Tramm T, et al
    ASO Author Reflections: Is Axillary Lymph Node Dissection Always Justified for Residual Axillary Disease in Breast Cancer After Neoadjuvant Chemotherapy?
    Ann Surg Oncol. 2025 Sep 12. doi: 10.1245/s10434-025-18302.
    PubMed    


  349. AN SJ, Spanheimer PM
    Reply to Letter to the Editor: "Reassessing Predictors of Nodal Pathologic Complete Response in Breast Cancer: Methodological Strengths and Data Gaps in the National Cancer Database Analysis," by Altundag.
    Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18234.
    PubMed    


  350. TEKCAN SANLI DE, Sanli AN
    Comment on TAD Outcomes from the Danish Breast Cancer Group Database.
    Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-18318.
    PubMed    


  351. SHOJAEIAN F, Vasigh M, Del Calvo H, Chaves LG, et al
    Neoadjuvant Versus Adjuvant Therapy for Metaplastic Breast Cancer: Insights from the National Cancer Database-Is There a Winning Strategy?
    Ann Surg Oncol. 2025 Sep 10. doi: 10.1245/s10434-025-17937.
    PubMed     Abstract available


  352. NELIS M, Chichura A, Al-Hilli Z
    ASO Author Reflections: Reevaluating Treatment Sequence in Metaplastic Breast Cancer.
    Ann Surg Oncol. 2025 Sep 9. doi: 10.1245/s10434-025-18316.
    PubMed    


  353. TEKCAN SANLI DE, Sanli AN
    Preoperative Radiation Boost in Early-Stage Breast Cancer: Effect on Re-excision and Complication Rates.
    Ann Surg Oncol. 2025 Sep 6. doi: 10.1245/s10434-025-18322.
    PubMed    


  354. KYEI I, Bea VJ, Gyan KK, Adjei E, et al
    Oncologic Anthropology and the African Diaspora: Twenty-Year Anniversary Report, International Center for the Study of Breast Cancer Subtypes (ICSBCS).
    Ann Surg Oncol. 2025 Sep 6. doi: 10.1245/s10434-025-17807.
    PubMed     Abstract available


  355. LIN Y, Wang YY, Xu ZB, Dong L, et al
    ASO Visual Abstract: miRNAs Associated with Axillary Lymph Node Metastasis in Breast Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18205.
    PubMed    


  356. MARIN C, Strawderman M, Peterson D, Cheng Z, et al
    ASO Visual Abstract: Biology is Queen-The Oncotype DX 21-Gene Recurrence Score has Stronger Prognostic Ability than Lymph Node Burden for Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Sep 5. doi: 10.1245/s10434-025-18244.
    PubMed    


  357. OROZCO JIJ, Valdez BJ, Trasatti ES, Brown SM, et al
    Do Patients with DCIS or Invasive Breast Cancer Carry the Same Risk for Genetic Mutation?
    Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18284.
    PubMed    


  358. AN SJ, Thai CHNC, Agala CB, Abdou YG, et al
    ASO Visual Abstract: Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18238.
    PubMed    


  359. FUJINO S, Yamashita K, Okamoto R, Shibaki S, et al
    ASO Visual Abstract: Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential.
    Ann Surg Oncol. 2025 Sep 4. doi: 10.1245/s10434-025-18105.
    PubMed    


  360. DE JESUS EM, Elmore LC, Fayanju OM
    Annals of Surgical Oncology Landmark Series Disparities in Surgical Oncology: Breast Cancer.
    Ann Surg Oncol. 2025 Sep 3. doi: 10.1245/s10434-025-18157.
    PubMed     Abstract available


  361. THOMPSON D, Fefferman M, Simovic S, Kuchta K, et al
    ASO Visual Abstract: Impact of Quality Improvement Interventions on Biopsy to Treatment Time in Breast Cancer-Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers.
    Ann Surg Oncol. 2025 Sep 3. doi: 10.1245/s10434-025-18179.
    PubMed    


  362. CHAKRABORTY MA, Haffty BG
    ASO Author Reflections: Preoperative Radiation Boost Reduces Re-Excision Rate and Locoregional Treatment Time in Early-Stage Breast Cancer Patients.
    Ann Surg Oncol. 2025 Sep 2. doi: 10.1245/s10434-025-18271.
    PubMed    


  363. YUEN S, McCool K, Bharucha M, Narloch K, et al
    ASO Visual Abstract: Evaluating Trends in Fertility Counseling Among Reproductive-Age Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Sep 2. doi: 10.1245/s10434-025-18129.
    PubMed    


  364. LEVY J, Wagner BD, Roberts A, Shammas RL, et al
    The Impact of Travel Distance on Patient Outcomes after Breast Reconstruction.
    Ann Surg Oncol. 2025;32:6629-6639.
    PubMed     Abstract available


  365. OU X, Liu Z, Liu C, Wang K, et al
    Surgical and Oncologic Outcomes of Tumescence and Sharp Dissection Versus Electrocautery Dissection in Minimal-Access Nipple-Sparing Mastectomy with Immediate Prosthesis Breast Reconstruction: A Real-World Retrospective Cohort Study.
    Ann Surg Oncol. 2025;32:6660-6670.
    PubMed     Abstract available


  366. CHAKRABORTY MA, Sherwani ZK, Narra LR, Abou Yehia Z, et al
    ASO Visual Abstract: Preoperative Radiation Boosts Results in Low Rates of Re-Excision and Reduced Locoregional Treatment Time for Breast Cancer Patients.
    Ann Surg Oncol. 2025 Sep 1. doi: 10.1245/s10434-025-18245.
    PubMed    


    August 2025
  367. VAN HASSEL J, Dimitroff K, Yau C, Mukhtar R, et al
    ASO Visual Abstract: Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
    Ann Surg Oncol. 2025 Aug 29. doi: 10.1245/s10434-025-18131.
    PubMed    


  368. CHU C, Goldman J, Joung H, Go S, et al
    Breast Cancer Incidence Among Patients Undergoing Chest Masculinization Surgery: A Scoping Review.
    Ann Surg Oncol. 2025 Aug 28. doi: 10.1245/s10434-025-18156.
    PubMed     Abstract available


  369. VARMAN PM, Conner A, Bennett WC, Taft D, et al
    ASO Visual Abstract: Impact of Second Opinions on Time to Treatment of Breast Cancer.
    Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18180.
    PubMed    


  370. YI M, Chavez-MacGregor M, Smith BD, Mitchell MP, et al
    ASO Visual Abstract: Comparing Survival Differences Between Patients Undergoing Breast-Conserving Therapy Versus Total Mastectomy as a First Treatment for Early Stage Breast Cancer.
    Ann Surg Oncol. 2025 Aug 27. doi: 10.1245/s10434-025-18217.
    PubMed    


  371. REASON EH, Thomas SM, Chanenchuk T, Botty van den Bruele A, et al
    ASO Visual Abstract: Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.
    Ann Surg Oncol. 2025 Aug 26. doi: 10.1245/s10434-025-18181.
    PubMed    


  372. AMBURN T, Downs-Canner S
    ASO Author Reflections: Nipple-Sparing Mastectomy for Breast Cancer Patients with Nipple Discharge.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18078.
    PubMed    


  373. LYONS W, Fish EM, Bleicher RJ, Chang C, et al
    Management and Outcomes in Patients with Breast Cancer with 1-of-1 and 2-of-2 Positive Sentinel Nodes.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18097.
    PubMed     Abstract available


  374. NAASEH A, Tang SX, Maytin-Hevia AR, Wu N, et al
    ASO Visual Abstract: Are Broadened Guidelines Improving Our Detection of Pathologic Genetic Mutations in Breast Cancer Patients? A 5-Year Comparative Analysis of American Society of Breast Surgeons and National Comprehensive Cancer Network Guidelines.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18182.
    PubMed    


  375. SERRES SK, Saxon-Filipe S, Schwartz T
    Complementary and Alternative Medicine in Breast Cancer: Considerations for the Breast Surgical Oncologist.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-17850.
    PubMed     Abstract available


  376. VAN HASSEL J, Dimitroff K, Yau C, Mukhtar R, et al
    Impact of Time to Surgery Post Neoadjuvant Chemotherapy on Breast Cancer Outcomes: A Retrospective Study of Patients Enrolled in the I-SPY 2 Clinical Trial.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-17933.
    PubMed     Abstract available


  377. MUKHTAR RA, Dimitroff K, Yau C, Chien AJ, et al
    ASO Visual Abstract: Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18104.
    PubMed    


  378. VETTER CD, C Boughey J
    ASO Author Reflections: Refining Prognostic Staging in De Novo Metastatic Breast Cancer: Validation, Limitations, and Future Directions.
    Ann Surg Oncol. 2025 Aug 23. doi: 10.1245/s10434-025-18113.
    PubMed    


  379. MOHAN SC, Chen JH, Tidwell RSS, Kai M, et al
    ASO Visual Abstract: Investigating the Prognostic Impact of Postpartum Diagnosis in Women with De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2025 Aug 21. doi: 10.1245/s10434-025-18098.
    PubMed    


  380. CHAKRABORTY MA, Sherwani ZK, Narra LR, Abou Yehia Z, et al
    Preoperative Radiation Boost Results in Low Rates of Re-excision and Reduced Locoregional Treatment Time in Breast Cancer Patients.
    Ann Surg Oncol. 2025 Aug 20:10.1245/s10434-025-18089.
    PubMed     Abstract available


  381. TASHJIAN NL, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
    ASO Author Reflections: Survival of Patients with HER2-Positive Breast Cancer After Neoadjuvant Chemotherapy Based on Presenting Clinical Stage and Response to Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18188.
    PubMed    


  382. MARIN C, Strawderman M, Peterson D, Cheng Z, et al
    Biology is Queen: The Oncotype DX 21-Gene Recurrence Score Has Stronger Prognostic Ability than Lymph Node Burden for Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18086.
    PubMed     Abstract available


  383. MUNCK F, Jensen MB, Hawaz-Ali R, Tvedskov THF, et al
    Oncologic First Events in Breast Cancer Patients After Targeted Axillary Dissection.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18068.
    PubMed     Abstract available


  384. CHICHURA AM, Chen X, Nelis M, Kopicky L, et al
    Neoadjuvant Chemotherapy is Associated with Worse 5-Year Overall Survival in Patients with Metaplastic Breast Cancer Compared with Primary Surgery: A National Cancer Database Analysis.
    Ann Surg Oncol. 2025 Aug 20. doi: 10.1245/s10434-025-18085.
    PubMed     Abstract available


  385. MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
    ASO Author Reflections: Medicaid's Impact on Breast Cancer.
    Ann Surg Oncol. 2025 Aug 19. doi: 10.1245/s10434-025-18107.
    PubMed    


  386. GHASEMI F, Young J, Asaoka M, Takabe K, et al
    ASO Author Reflections: Refining Breast Cancer Staging to More Accurately Reflect Disease Biology.
    Ann Surg Oncol. 2025 Aug 19. doi: 10.1245/s10434-025-18167.
    PubMed    


  387. TASHJIAN NL, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
    The Association of Clinical Stage at Presentation with Overall Survival of Patients who have HER2-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Aug 14. doi: 10.1245/s10434-025-18050.
    PubMed     Abstract available


  388. LEE EG, Lee DE, Jung SY, Han JH, et al
    ASO Author Reflections: Multimodal Sentinel Lymph Node Mapping in Breast Cancer: Efficacy and Clinical Implications After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Aug 12. doi: 10.1245/s10434-025-18053.
    PubMed    


  389. YI M, Chavez-MacGregor M, Smith BD, Mitchell MP, et al
    Comparing Survival Differences between Patients Undergoing Breast-Conserving Therapy Versus Total Mastectomy as a First Treatment for Early Stage Breast Cancer.
    Ann Surg Oncol. 2025 Aug 11:10.1245/s10434-025-18030.
    PubMed     Abstract available


  390. THOMPSON D, Fefferman M, Simovic S, Kuchta K, et al
    Impact of Quality Improvement Interventions on Biopsy-to-Treatment Time in Breast Cancer: Results from the PROMPT Quality Collaborative of the National Accreditation Program for Breast Centers.
    Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-17935.
    PubMed     Abstract available


  391. KERIVAN L, Wagner J, Nye L, Balanoff C, et al
    ASO Visual Abstract: Surgical Choice Among Women with a First Breast Cancer and Pathogenic Variants in Breast Cancer Genes.
    Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-18071.
    PubMed    


  392. LIN Y, Wang YY, Xu ZB, Dong L, et al
    miRNAs Associated with Axillary Lymph Node Metastasis in Breast Cancer: A Systematic Review and Meta-Analysis.
    Ann Surg Oncol. 2025 Aug 9. doi: 10.1245/s10434-025-17983.
    PubMed     Abstract available


  393. STARI OL, Torok C, Gorog PO, Markus B, et al
    ASO Author Reflections: The Completion May Lead to Conservation: Partial and Complete Intraoperative Ultrasound Enhanced Breast-Conserving Surgery for Invasive Breast Cancer.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18009.
    PubMed    


  394. LIN Y, Wang YY, Xu ZB, Dong L, et al
    ASO Author Reflections: MicroRNAs as Predictive Biomarkers for Axillary Lymph Node Metastasis in Breast Cancer.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18075.
    PubMed    


  395. KERIVAN LT, Larson KE
    ASO Author Reflections: Unilateral Cancer, Bilateral Decisions: Contralateral Risk-Reducing Mastectomy Performance in Patients with a First Breast Cancer and Positive Genetic Testing.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18016.
    PubMed    


  396. NAASEH A, Margenthaler JA
    ASO Author Reflections: Moving Beyond Risk-Based Genetic Testing Criteria: Supporting Universal Genetic Testing in Breast Cancer Patients.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18074.
    PubMed    


  397. CHEN SL, Shah C, Boyages J, Koelmeyer L, et al
    ASO Visual Abstract: The Importance of a Pretreatment Baseline When Screening Patients for Breast-Cancer-Related Lymphedema.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18062.
    PubMed    


  398. BLEICHER RJ
    ASO Author Reflections: The Worried Waiting-Breast Cancer Upstaging and In Vivo Growth During Preoperative Delays.
    Ann Surg Oncol. 2025 Aug 8. doi: 10.1245/s10434-025-18008.
    PubMed    


  399. EDWARDS M, Elder K, Rose A, Tan E, et al
    ASO Visual Abstract: Survival Benefits and Less Intensive Treatment for Women Diagnosed with Early-Stage Breast Cancer While Participating in Population-Based Screening.
    Ann Surg Oncol. 2025 Aug 7. doi: 10.1245/s10434-025-18069.
    PubMed    


  400. MANN GB
    ASBrS Keynote Address: Reimagining Stage 1 Breast Cancer-Evolution of Breast Cancer Management over the Last 120 Years.
    Ann Surg Oncol. 2025 Aug 7. doi: 10.1245/s10434-025-17849.
    PubMed    


  401. CHEN JH, Warneke CL, Middleton L, Singh P, et al
    ASO Visual Abstract: Complication Rates Are Low After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy.
    Ann Surg Oncol. 2025 Aug 7. doi: 10.1245/s10434-025-18064.
    PubMed    


  402. BRENNAN MA, Plichta JK, Rozenblit M, Flanagan MR, et al
    Surgeon Attitudes on the Management of de novo Oligometastatic Breast Cancer.
    Ann Surg Oncol. 2025 Aug 6. doi: 10.1245/s10434-025-17912.
    PubMed    


  403. FUJINO S, Yamashita K, Okamoto R, Shibaki S, et al
    Exploring the Role of CDO1 in Breast Cancer: Insights into Tumor Biology and Therapeutic Potential.
    Ann Surg Oncol. 2025 Aug 5. doi: 10.1245/s10434-025-17944.
    PubMed     Abstract available


  404. LUBARSKY M, Hernandez AE, Borowsky PA, Thompson C, et al
    A Comprehensive Analysis of Unmet Social Needs in Breast Cancer Patients Treated at an Academic Cancer Center and Sister Safety-Net Hospital.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17609.
    PubMed     Abstract available


  405. ALTUNDAG K
    Reassessing Predictors of Nodal Pathologic Complete Response in Breast Cancer: Methodological Strengths and Data Gaps in the National Cancer Database.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-18055.
    PubMed    


  406. CHEN JC, Handley D, Elsaid MI, Carson WE, et al
    Omitting Sentinel Lymph Node Biopsy in Small Hormone Receptor-Positive Breast Cancer: Does Race Matter?
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-18038.
    PubMed    


  407. LEE EG, Lee DE, Jung SY, Han JH, et al
    ASO Visual Abstract: Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Final Analysis.
    Ann Surg Oncol. 2025 Aug 4. doi: 10.1245/s10434-025-17961.
    PubMed    


  408. LUBARSKY M, Hernandez AE, Borowsky PA, Thompson C, et al
    ASO Visual Abstract: A Comprehensive Analysis of Unmet Social Needs in Patients with Breast Cancer Treated at an Academic Cancer Center and Sister Safety-Net Hospital.
    Ann Surg Oncol. 2025 Aug 3. doi: 10.1245/s10434-025-17720.
    PubMed    


  409. VARMAN PM, Conner A, Bennett WC, Taft D, et al
    Impact of Second Opinions on Time to Treatment of Breast Cancer.
    Ann Surg Oncol. 2025 Aug 2. doi: 10.1245/s10434-025-17934.
    PubMed     Abstract available


  410. SHAHEEN MS, Necker FN, Momeni A
    National Trends and Impact of Preoperative CT-Angiography on Autologous Breast Reconstruction.
    Ann Surg Oncol. 2025;32:5838-5844.
    PubMed     Abstract available


  411. SCHUMACHER JR, Hanlon BM, Zahrieh D, Rathouz PJ, et al
    Impact of a Web-Based Decision Aid on Socioeconomically Disadvantaged Patients' Engagement in Breast Surgery Decision-Making: Stepped-Wedge Clinical Trial (Alliance-A231701CD).
    Ann Surg Oncol. 2025;32:5540-5550.
    PubMed     Abstract available


  412. GOOCH JC, McClelland QY, Paschalis K, Dobbins J, et al
    Same Day Discharges Among Elderly Mastectomy Patients: A Single Institution Prospective Study.
    Ann Surg Oncol. 2025;32:5521-5527.
    PubMed     Abstract available


  413. MUELLER C, Rangan R, Kruse M, Al-Hilli Z, et al
    Trends in the Management of Small HER2-Positive Breast Cancers.
    Ann Surg Oncol. 2025;32:5510-5520.
    PubMed     Abstract available


  414. CAVALCANTE FP, de Oliveira VM, Ziegelmann PK, Brenelli FP, et al
    National Survey on Attitudes of Brazilian Breast Surgeons Regarding Oncoplastic Surgery: Success of a Training Model.
    Ann Surg Oncol. 2025;32:5489-5499.
    PubMed     Abstract available


  415. HUYNH VD, Mouabbi J, Kuerer HM, Wanis KN, et al
    Characterization of the Germline Pathogenic Mutational Landscape and Oncologic Outcomes Among 877 Patients with Invasive Lobular Carcinoma.
    Ann Surg Oncol. 2025;32:5477-5488.
    PubMed     Abstract available


  416. NAPIERALA MJ, Olszewski W, Rosinska M, Okarska-Napierala M, et al
    Residual Breast Tissue After Four Types of Mastectomy: A Prospective, Comparative Study.
    Ann Surg Oncol. 2025;32:5467-5476.
    PubMed     Abstract available


  417. SOROUDI D, Parmeshwar N, Gozali A, Piper M, et al
    Post-Mastectomy Flat Closure: A Mixed-Methods Analysis of Patient Outcomes and Perspectives.
    Ann Surg Oncol. 2025;32:5827-5837.
    PubMed     Abstract available


  418. HASSAN AM, Hajj JP, Lewis JP, Ahmed S, et al
    Long-Term Outcomes of Lymphedema After Immediate Lymphatic Reconstruction Following Axillary Lymph Node Dissection.
    Ann Surg Oncol. 2025;32:5817-5826.
    PubMed     Abstract available


    July 2025
  419. MARTIN G, Kensler KH, Tamimi RM, Bea VJ, et al
    ASO Author Reflections: Reconstructing Equity: Policy's Role in Post-Mastectomy Breast Cancer Care.
    Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17941.
    PubMed    


  420. YAO J
    ASO Author Reflections: Prospective Validation of Lymphatic Contrast-Enhanced Ultrasound for Non-invasive Sentinel Lymph Node Assessment in Breast Cancer.
    Ann Surg Oncol. 2025 Jul 31. doi: 10.1245/s10434-025-17761.
    PubMed    


  421. MALHOTRA S, Choi DX, Sevilimedu V, Greenup RA, et al
    Medicaid Expansion Is Associated with Lower Mortality in Patients with Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2025 Jul 30. doi: 10.1245/s10434-025-17865.
    PubMed     Abstract available


  422. PRATT CG, McClelland PH, Long SA, Moore AN, et al
    The Metaplastic Conundrum: A National Cancer Database Analysis of Metaplastic versus Triple-Negative Ductal Breast Cancer.
    Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17932.
    PubMed     Abstract available


  423. VETTER CD, Hoskin T, Olson C, Giridhar K, et al
    Validation of the Performance of the Novel Prognostic Staging System for Overall Survival in De Novo Metastatic Breast Cancer and Demonstration of Performance for Cancer-Specific Outcomes.
    Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17863.
    PubMed     Abstract available


  424. REASON EH, Thomas SM, Chanenchuk T, Botty van den Bruele AM, et al
    Neoadjuvant Chemotherapy is Not Associated with Improved Overall Survival in Metaplastic Breast Cancer Regardless of Tumor Subtype.
    Ann Surg Oncol. 2025 Jul 29. doi: 10.1245/s10434-025-17938.
    PubMed     Abstract available


  425. CHAN K, Yao K
    ASO Author Reflections: Leveraging Cancer Accreditation Standards to Improve the Delivery of Breast Cancer Care.
    Ann Surg Oncol. 2025 Jul 28. doi: 10.1245/s10434-025-17956.
    PubMed    


  426. KERIVAN L, Wagner J, Nye L, Balanoff C, et al
    Surgical Choice among Women with a First Breast Cancer and Pathogenic Variants in Breast Cancer Genes.
    Ann Surg Oncol. 2025 Jul 27. doi: 10.1245/s10434-025-17859.
    PubMed     Abstract available


  427. EDWARDS M, Elder K, Rose A, Tan E, et al
    Survival Benefits and Less Intensive Treatment for Women with Early-Stage Breast Cancer Diagnosed While Participating in Population-Based Screening.
    Ann Surg Oncol. 2025 Jul 25. doi: 10.1245/s10434-025-17845.
    PubMed     Abstract available


  428. MOHAN SC, Johnson HM
    ASO Author Reflections: Postpartum Diagnosis of Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2025 Jul 25. doi: 10.1245/s10434-025-17958.
    PubMed    


  429. STARI OL, Torok C, Gorog PO, Kovacs B, et al
    May the Completion Lead to Conservation: Impact of Partial and Complete Intraoperative Ultrasound Application on Resection Margin Management During Breast-Conserving Surgery for Invasive Breast Cancer: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17822.
    PubMed     Abstract available


  430. YUEN S, McCool K, Bharucha M, Narloch K, et al
    Evaluating Trends in Fertility Counseling among Reproductive-Age Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17857.
    PubMed     Abstract available


  431. MUKHTAR RA, Dimitroff K, Yau C, Chien AJ, et al
    Impact of Neoadjuvant Chemotherapy on Surgical Outcomes and Conversion to Node-Negativity in Invasive Lobular Breast Cancer: Analysis of Molecularly High-Risk Tumors by Histologic Subtype on the I-SPY2 Clinical Trial.
    Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17862.
    PubMed     Abstract available


  432. MOHAN SC, Chen JH, Tidwell RSS, Kai M, et al
    Investigating the Prognostic Impact of Postpartum Diagnosis in Women with De Novo Stage IV Inflammatory Breast Cancer.
    Ann Surg Oncol. 2025 Jul 24. doi: 10.1245/s10434-025-17855.
    PubMed     Abstract available


  433. BLEICHER RJ, Ruth KJ, Williams AD, Ross EA, et al
    Breast Cancer Upstaging Risk and In Vivo Tumor Growth Rates Associated with Preoperative Delays.
    Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17867.
    PubMed     Abstract available


  434. CHEN SL, Shah C, Boyages J, Koelmeyer L, et al
    The Importance of a Pre-treatment Baseline When Screening Patients for Breast-Cancer-Related Lymphedema.
    Ann Surg Oncol. 2025 Jul 23. doi: 10.1245/s10434-025-17854.
    PubMed     Abstract available


  435. NAASEH A, Tang SX, Maytin-Hevia AR, Wu N, et al
    Are Broadened Guidelines Improving our Detection of Pathologic Genetic Mutations in Breast Cancer Patients? A 5-Year Comparative Analysis of American Society of Breast Surgeons and National Comprehensive Cancer Network Guidelines.
    Ann Surg Oncol. 2025 Jul 22. doi: 10.1245/s10434-025-17939.
    PubMed     Abstract available


  436. OSHI M, Ghasemi F, Yamada A, Zhang J, et al
    ASO Author Reflections: Reframing Hippo Pathway Activation as a Prognostic and Predictive Biomarker in HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2025 Jul 22. doi: 10.1245/s10434-025-17875.
    PubMed    


  437. JONES M, Alsafwani ZW, Orozco JIJ, Lele SM, et al
    Pre-Treatment Tumor Collagen is Associated with Triple-Negative Breast Cancer Pathological Response to Chemo-Immunotherapy.
    Ann Surg Oncol. 2025 Jul 21. doi: 10.1245/s10434-025-17904.
    PubMed    


  438. AN SJ, Thai CHNC, Agala CB, Abdou YG, et al
    Predictors of Nodal Pathologic Complete Response After Neoadjuvant Chemotherapy in Breast Cancer.
    Ann Surg Oncol. 2025 Jul 19. doi: 10.1245/s10434-025-17906.
    PubMed     Abstract available


  439. CHEN JH, Warneke CL, Middleton L, Singh P, et al
    Complication Rates are Low After Invasive Procedures on the Lactating Breast in Patients Treated for Breast Cancer During Pregnancy.
    Ann Surg Oncol. 2025 Jul 17. doi: 10.1245/s10434-025-17856.
    PubMed     Abstract available


  440. TAPIAVALA S, Liu Y, Roy S, Hensing W, et al
    Impact of National Society Guidelines and National Comprehensive Cancer Network (NCCN) Guidelines on Genetic Testing Use Among Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17448.
    PubMed     Abstract available


  441. JOHNSON HM, Mitchell KB
    ASO Author Reflections: Oncolactation Guidelines for Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17793.
    PubMed    


  442. VICINI FA
    Intraoperative Radiation Therapy for Early-Stage Breast Cancer: Promise or Peril?
    Ann Surg Oncol. 2025 Jul 14. doi: 10.1245/s10434-025-17785.
    PubMed    


  443. JOHNSON HM, Miller ME, Mitchell KB
    Oncolactation for Patients with Breast Cancer: Executive Summary from the American Society of Breast Surgeons.
    Ann Surg Oncol. 2025 Jul 8. doi: 10.1245/s10434-025-17742.
    PubMed     Abstract available


  444. KNOEDLER S, Jiang J, Moog P, Wirtz JM, et al
    ASO Visual Abstract: Predicting Outcomes of Breast-Conserving Surgery in Breast Cancer Patients Using the Modified 5-Item Frailty Index-A Retrospective Cohort Study.
    Ann Surg Oncol. 2025 Jul 5. doi: 10.1245/s10434-025-17625.
    PubMed    


  445. KEEGAN G, Ravenell J, Crown A, DiMaggio C, et al
    Impact of Unmet Social Needs on Access to Breast Cancer Screening and Treatment: An Analysis of Barriers Faced by Patients in a Breast Cancer Navigation Program.
    Ann Surg Oncol. 2025 Jul 2. doi: 10.1245/s10434-025-17608.
    PubMed     Abstract available


  446. CHIARELLA LS, Huelsboemer L, Diatta F, Klimitz FJ, et al
    The Five-Item Modified Frailty Index Predicts Adverse Surgical Outcomes in Patients Undergoing Mastectomy.
    Ann Surg Oncol. 2025;32:4829-4837.
    PubMed     Abstract available


  447. SWITALLA KM, Falade IO, Quirarte A, Baxter M, et al
    Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery.
    Ann Surg Oncol. 2025;32:4899-4909.
    PubMed     Abstract available


  448. TAYLOR CD, Wang T, Sinco BR, Pilewskie M, et al
    National Variation in Implementation of Sentinel Lymph Node Biopsy for Clinically Node-Positive Patients Undergoing Neoadjuvant Therapy.
    Ann Surg Oncol. 2025;32:4874-4882.
    PubMed     Abstract available


  449. KEEGAN G, Ravenell J, Crown A, DiMaggio C, et al
    ASO Visual Abstract: Impact of Unmet Social Needs on Access to Breast Cancer Screening and Treatment: An Analysis of Barriers Faced by Patients in a Breast Cancer Navigation Program.
    Ann Surg Oncol. 2025 Jul 1. doi: 10.1245/s10434-025-17716.
    PubMed    


    June 2025
  450. LEE EG, Lee DE, Jung SY, Han JH, et al
    Clinical Application of Multimodal Sentinel Lymph Node-Mapping Method for Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: A Final Analysis.
    Ann Surg Oncol. 2025 Jun 30. doi: 10.1245/s10434-025-17740.
    PubMed     Abstract available


  451. HOSANG KM, Bleicher RJ, Yao KA, Dietz JR, et al
    ASO Visual Abstract: Low Socioeconomic Status at the Patient and Institutional Level Impact Achievement of Breast Cancer Quality Standards.
    Ann Surg Oncol. 2025 Jun 29. doi: 10.1245/s10434-025-17690.
    PubMed    


  452. SILVERSTEIN MJ, Kim B, Lin K, Lloyd S, et al
    ASO Visual Abstract: Intraoperative Radiation Therapy (IORT) for Breast Cancer: The Final Analysis of a Prospective Cohort of 1828 Cases.
    Ann Surg Oncol. 2025 Jun 24. doi: 10.1245/s10434-025-17698.
    PubMed    


  453. NGUYEN CL, Poels D, Teoh B, Rastogi P, et al
    Indocyanine Green Fluorescence-Guided Axillary Reverse Mapping for Axillary Lymph Node Dissection in Breast Cancer: The FARM Trial.
    Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17703.
    PubMed     Abstract available


  454. NIERENBERG TC, Plichta JK
    ASO Author Reflections: Adjuvant Therapy Options for Older Women with Early Stage Breast Cancer.
    Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17732.
    PubMed    


  455. HSIEH YC, Huang CS, Chan YH
    A Dose-Image Optimization Trial for Voluven(R)-Assisted Indocyanine Green Fluorescence-Guided Breast Cancer Sentinel Lymph Node Surgery.
    Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17696.
    PubMed     Abstract available


  456. YAO J, Li H, Wang H, Liu B, et al
    Lymphatic Contrast-enhanced Ultrasound as a Noninvasive Predictor of Sentinel Lymph Node Metastasis in Breast Cancer: A Prospective Diagnostic Study.
    Ann Surg Oncol. 2025 Jun 23. doi: 10.1245/s10434-025-17705.
    PubMed     Abstract available


  457. OSHI M, Ghasemi F, Yamada A, Yan L, et al
    Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2025 Jun 21. doi: 10.1245/s10434-025-17657.
    PubMed     Abstract available


  458. JANSEN BAM, Kelder JC, Borchert T, van Uden DJP, et al
    Trends in Surgical Treatment for cT4 Breast Cancer After Neoadjuvant Systemic Therapy: A Nationwide Study in The Netherlands.
    Ann Surg Oncol. 2025 Jun 18. doi: 10.1245/s10434-025-17585.
    PubMed     Abstract available


  459. KNOEDLER S, Jiang J, Moog P, Wirtz JM, et al
    ASO Author Reflections: Frailty as a Predictor in Breast Cancer Surgery: Yesterday's Lessons, Today's Evidence, Tomorrow's Potential.
    Ann Surg Oncol. 2025 Jun 17. doi: 10.1245/s10434-025-17604.
    PubMed    


  460. HOLT LR, Shern TP, Ozmen T
    ASO Author Reflections: Personalizing Tumor Size Assessment in Breast Cancer-A Framework for Dynamic, Patient-Centered Estimation.
    Ann Surg Oncol. 2025 Jun 17. doi: 10.1245/s10434-025-17701.
    PubMed    


  461. KOHLI K, Wang S, Thaploo A, Ho FDV, et al
    ASO Author Reflections: Breast Cancer Among Asian American, Native Hawaiian, and Pacific Islander Patients.
    Ann Surg Oncol. 2025 Jun 16. doi: 10.1245/s10434-025-17510.
    PubMed    


  462. JUNG JJ, Kim HC, Kang E, Kim HK, et al
    Refining Criteria for Axillary Surgery Omission After Neoadjuvant Systemic Therapy in Breast Cancer.
    Ann Surg Oncol. 2025 Jun 12. doi: 10.1245/s10434-025-17618.
    PubMed    


  463. YOON IC, Perez-Rojas S, Ancha B, Elmore LC, et al
    ASO Visual Abstract: Association of Neighborhood Deprivation with Stage at Diagnosis and Treatment Delay for Breast Cancer in Philadelphia.
    Ann Surg Oncol. 2025 Jun 11. doi: 10.1245/s10434-025-17524.
    PubMed    


  464. AHMED S, Manghelli J, Fisher CS, Imeokparia FO, et al
    Effect of Delayed Axillary Lymph Node Dissection on Success Rates of Immediate Lymphatic Reconstruction in Breast Cancer.
    Ann Surg Oncol. 2025 Jun 10. doi: 10.1245/s10434-025-17641.
    PubMed    


  465. THILL M, Ghilli M, Roncella M, Kelling K, et al
    ASO Visual Abstract: Multi-Institutional Study to Evaluate the Effectiveness and Safety of a Supine MRI-Based Guidance System, the Breast Cancer Locator(TM), for Breast-Conserving Surgery in Patients with Nonpalpable Breast Cancer.
    Ann Surg Oncol. 2025 Jun 9. doi: 10.1245/s10434-025-17622.
    PubMed    


  466. EAGLEHOUSE YL, Darmon S, Nealeigh M, Koehlmoos T, et al
    ASO Visual Abstract: Short-Term Outcomes of Breast Cancer Surgery by Race-Ethnicity in the Military Health System.
    Ann Surg Oncol. 2025 Jun 7. doi: 10.1245/s10434-025-17628.
    PubMed    


  467. NIERENBERG TC, Crowell KA, Wang T, Rosenberger LH, et al
    ASO Visual Abstract: Adjuvant Radiation Versus Endocrine Therapy After Lumpectomy for Early Stage Breast Cancer in Older Women-Analysis of Real-World Survival Outcomes.
    Ann Surg Oncol. 2025 Jun 7. doi: 10.1245/s10434-025-17624.
    PubMed    


  468. THILL M, Ghilli M, Roncella M, Kelling K, et al
    A Multi-institutional Study to Evaluate the Effectiveness and Safety of a Supine MRI-Based Guidance System, the Breast Cancer Locator(TM), for Breast Conserving Surgery in Patients with Nonpalpable Breast Cancer.
    Ann Surg Oncol. 2025 Jun 6. doi: 10.1245/s10434-025-17513.
    PubMed     Abstract available


  469. NIERENBERG TC, Crowell KA, Wang T, Rosenberger LH, et al
    Adjuvant Radiation vs Endocrine Therapy After Lumpectomy for Early-Stage Breast Cancer in Older Women: Analysis of Real-World Survival Outcomes.
    Ann Surg Oncol. 2025 Jun 6. doi: 10.1245/s10434-025-17532.
    PubMed     Abstract available


  470. FLANAGAN MR, van den Bruele AMB, Downs-Canner SM, Thomas SM, et al
    ASO Visual Abstract: A Multi-institutional Analysis of Contralateral Axillary Metastases-Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.
    Ann Surg Oncol. 2025 Jun 3. doi: 10.1245/s10434-025-17563.
    PubMed    


  471. HOSANG KM, Bleicher RJ, Yao KA, Dietz JR, et al
    Low Socioeconomic Status at the Patient and Institutional Level Impact Achievement of Breast Cancer Quality Standards.
    Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17529.
    PubMed     Abstract available


  472. VAN DEN BRUELE AB, Rosenberger LH, Downs-Canner S, Flanagan MR, et al
    ASO Author Reflections: Contralateral Axillary Lymph Node Metastasis of Breast Cancer: Time to Re-evaluate Conventional Thinking.
    Ann Surg Oncol. 2025 Jun 2. doi: 10.1245/s10434-025-17535.
    PubMed    


  473. LAVA CX, Harish V, Kapp K, Li KR, et al
    Utility of Surgical Axillary Staging in Microinvasive Ductal Carcinoma In Situ: A National Cancer Database Analysis.
    Ann Surg Oncol. 2025;32:4023-4033.
    PubMed     Abstract available


  474. BHADOURIYA R, Mantena RV, Selvakumar JP, Yadav P, et al
    Disparities in Refusal of Adjuvant Radiation for Breast-Conserving Therapy in the USA.
    Ann Surg Oncol. 2025;32:4034-4040.
    PubMed     Abstract available


  475. WEISS A, Rosito MS, Braun D, Barton B, et al
    Impact of the American Society of Breast Surgeons' Guidelines on Genetic Testing and Contralateral Prophylactic Mastectomy Rates.
    Ann Surg Oncol. 2025;32:3965-3974.
    PubMed     Abstract available


  476. KIM E, Dossett LA, Hughes TM, Jeruss JS, et al
    The Effectiveness of Superparamagnetic Iron Oxide Nanoparticles in Reducing Unnecessary Sentinel Lymph Node Biopsies.
    Ann Surg Oncol. 2025;32:4017-4022.
    PubMed     Abstract available


  477. SPAULDING S, Orzechowski K, Patek K
    Integration of a Genetic Counselor into a Breast Health Center Improves Identification of Patients Needing Genetic Testing.
    Ann Surg Oncol. 2025;32:4002-4007.
    PubMed     Abstract available


  478. NGUYEN AT, Duckworth E, Kandi L, Li RA, et al
    Disparities in Postmastectomy Breast Reconstruction Among American Indian and Alaska Native Women: A Systematic Literature Review and Meta-analysis.
    Ann Surg Oncol. 2025;32:4041-4052.
    PubMed     Abstract available


    May 2025
  479. SAH R, Mathur A, Veldi VDK
    Letter to the Editor Regarding "Differential Effects of Endocrine Therapy Type on Quality of Life in Older (>/= 70 Years) Women with Early-Stage Breast Cancer".
    Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17593.
    PubMed    


  480. SILVERSTEIN MJ, Kim B, Lin K, Lloyd S, et al
    Intraoperative Radiation Therapy (IORT) for Breast Cancer: The Final Analysis of a Prospective Cohort of 1828 Cases.
    Ann Surg Oncol. 2025 May 31. doi: 10.1245/s10434-025-17546.
    PubMed     Abstract available


  481. ORSI C, Davis T, Swindall R, Wadle C, et al
    ASO Visual Abstract: Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting; Rural Breast Cancer Treatment Disparities.
    Ann Surg Oncol. 2025 May 30. doi: 10.1245/s10434-025-17476.
    PubMed    


  482. WEISS A, Agnese DM, Al-Hilli Z, Cabioglu N, et al
    Correction: An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients: From the Society of Surgical Oncology and the American Society of Breast Surgeons.
    Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-025-17580.
    PubMed    


  483. EAGLEHOUSE YL, Darmon S, Nealeigh M, Koehlmoos T, et al
    Short-Term Outcomes of Breast Cancer Surgery by Race-Ethnicity in the Military Health System.
    Ann Surg Oncol. 2025 May 21. doi: 10.1245/s10434-025-17449.
    PubMed     Abstract available


  484. FLANAGAN MR, van den Bruele AMB, Downs-Canner SM, Thomas SM, et al
    A Multi-Institutional Analysis of Contralateral Axillary Metastases: Advanced Local-Regional Disease Divergent from Stage IV Breast Cancer.
    Ann Surg Oncol. 2025 May 20. doi: 10.1245/s10434-025-17406.
    PubMed     Abstract available


  485. WU C, Zhao H, Di H, Cheng K, et al
    ASO Author Reflections: Global Research Status of Breast Cancer Stem Cells.
    Ann Surg Oncol. 2025 May 17. doi: 10.1245/s10434-025-17457.
    PubMed    


  486. ZOU Y, Bian L, Zhang H, Tang H, et al
    ASO Author Reflections: Limited Survival Benefit from Neoadjuvant Chemotherapy in ER+/HER2- Breast Cancer.
    Ann Surg Oncol. 2025 May 17. doi: 10.1245/s10434-025-17408.
    PubMed    


  487. KNOEDLER S, Jiang J, Moog P, Wirtz JM, et al
    Predicting Outcomes of Breast-Conserving Surgery in Patients with Breast Cancer Using the Modified 5-Item Frailty Index: A Retrospective Cohort Study.
    Ann Surg Oncol. 2025 May 16. doi: 10.1245/s10434-025-17438.
    PubMed     Abstract available


  488. WEISS A, Agnese DM, Al-Hilli Z, Cabioglu N, et al
    An Overview of the Importance of Neoadjuvant Systemic Therapy for Breast Cancer Patients.
    Ann Surg Oncol. 2025 May 12. doi: 10.1245/s10434-025-17405.
    PubMed    


  489. YOON IC, Perez-Rojas S, Ancha B, Elmore LC, et al
    Association of Neighborhood Deprivation with Stage at Diagnosis and Treatment Delay for Breast Cancer in Philadelphia.
    Ann Surg Oncol. 2025 May 12. doi: 10.1245/s10434-025-17367.
    PubMed     Abstract available


  490. KOUZMINA E, Castelo M, Look Hong NJ, Hallet J, et al
    ASO Visual Abstract: Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer-Population-Based Trends over Time.
    Ann Surg Oncol. 2025 May 10. doi: 10.1245/s10434-025-17423.
    PubMed    


  491. DENNIS S, Tsukioki T, Kocherginsky M, Qi AK, et al
    ASO Visual Abstract: Neoadjuvant Chemotherapy Response and Genetic Susceptibility in Recently Parous Women with Breast Cancer: A Retrospective Analysis.
    Ann Surg Oncol. 2025 May 8. doi: 10.1245/s10434-025-17370.
    PubMed    


  492. CHO MJ, Chratian S, Hansotia K, Skoracki R, et al
    Reply to: "Prophylactic Lymphovenous Bypass for Breast Cancer-Related Lymphedema: Research Challenges, Statistical Pitfalls, and Solutions".
    Ann Surg Oncol. 2025 May 2. doi: 10.1245/s10434-025-17377.
    PubMed    


  493. ROBERTS A, Campbell AC, Pollack BL, Montagna G, et al
    Racial and Ethnic Differences in Breast Inflammation and Its Association with Lymphedema Risk After Axillary Lymph Node Dissection.
    Ann Surg Oncol. 2025;32:3309-3316.
    PubMed     Abstract available


  494. WARREN YE JR, Stead TS, Tomlinson-Hansen S, Stuckey AR, et al
    Outcomes in Women Undergoing Combined Breast, Plastic, and Gynecologic Surgery.
    Ann Surg Oncol. 2025;32:3302-3308.
    PubMed     Abstract available


  495. ZAVERI S, Sun SX, Zaghloul T, Bevers TB, et al
    Trends in Atypical Ductal Hyperplasia Diagnosis and Upgrade: A 20-Year Experience and Impact of MRI Use on Upgrade Rates.
    Ann Surg Oncol. 2025;32:3244-3251.
    PubMed     Abstract available


  496. JAVID SH, Kazerouni AS, Hippe DS, Hirano M, et al
    Preoperative MRI to Predict Upstaging of DCIS to Invasive Cancer at Surgery.
    Ann Surg Oncol. 2025;32:3234-3243.
    PubMed     Abstract available


  497. TAKAYESU JSK, Baglien B, Edwards D, Marsh R, et al
    Effect of Prepectoral Versus Subpectoral Implant-Based Reconstruction on Post-Mastectomy Radiation Dosimetry.
    Ann Surg Oncol. 2025;32:3705-3712.
    PubMed     Abstract available


  498. ROCHLIN DH, Wang Y, Amakiri UO, Levy J, et al
    Lower Commercial Rates for Breast Surgical Procedures are Associated with Socioeconomic Disadvantage: A Transparency in Coverage Analysis.
    Ann Surg Oncol. 2025;32:3695-3704.
    PubMed     Abstract available


    April 2025
  499. LI K, Moshier E, Shao T, Rosenstein BS, et al
    Differential Effects of Endocrine Therapy Type on Quality of Life in Older (>/=70 Years) Women with Early-Stage Breast Cancer.
    Ann Surg Oncol. 2025 Apr 26. doi: 10.1245/s10434-024-16482.
    PubMed     Abstract available


  500. SATO T, Hagerty BL, Wu R, Ishikawa T, et al
    ASO Author Reflections: Is Mesothelin a Promising Option for Molecular Targeted Therapies in Triple Negative Breast Cancer?
    Ann Surg Oncol. 2025 Apr 24. doi: 10.1245/s10434-025-17314.
    PubMed    


  501. CHENG K, Di H, Wu C, Zhao H, et al
    Mapping Knowledge Landscapes and Themes Trends of Breast Cancer Stem Cells: A Comprehensive Data-Mining-Based Study.
    Ann Surg Oncol. 2025 Apr 23. doi: 10.1245/s10434-025-17336.
    PubMed     Abstract available


  502. WANG J, Yang B, Bian L, Zhang H, et al
    Long-term Outcomes for Neoadjuvant Versus Adjuvant Chemotherapy in ER+/HER2- Locally Advanced Breast Cancer.
    Ann Surg Oncol. 2025 Apr 22. doi: 10.1245/s10434-025-17297.
    PubMed     Abstract available


  503. DOUGLAS SR, Margenthaler JA, McGuire KP, Hwang ES, et al
    Great Debate: Does Breast-Conserving Surgery with Radiotherapy Offer Better Survival than Mastectomy in Early-Stage Breast Cancer?
    Ann Surg Oncol. 2025 Apr 21. doi: 10.1245/s10434-025-17333.
    PubMed    


  504. HAGERTY BL, Sato T, Wu R, Ishikawa T, et al
    ASO Visual Abstract: Mesothelin (MSLN) is Highly Expressed in Triple-Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Pro-inflammatory Tumor Microenvironment.
    Ann Surg Oncol. 2025 Apr 21. doi: 10.1245/s10434-025-17253.
    PubMed    


  505. BOYLE MK, Giuliano AE
    ASO Author Reflections: Advances in Axillary Management for Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Apr 20. doi: 10.1245/s10434-025-17340.
    PubMed    


  506. ORSI C, Davis T, Swindall R, Wadle C, et al
    Disparities in Timeliness of Breast Cancer Treatment in a Rural Setting: Breast Cancer Treatment Disparities.
    Ann Surg Oncol. 2025 Apr 17. doi: 10.1245/s10434-025-17291.
    PubMed     Abstract available


  507. DENNIS S, Tsukioki T, Kocherginsky M, Qi AK, et al
    Neoadjuvant Chemotherapy Response and Genetic Susceptibility in Recently Parous Women with Breast Cancer: A Retrospective Analysis.
    Ann Surg Oncol. 2025 Apr 9. doi: 10.1245/s10434-025-17204.
    PubMed     Abstract available


  508. KOUZMINA E, Castelo M, Look Hong NJ, Hallet J, et al
    Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Population-Based Trends Over Time.
    Ann Surg Oncol. 2025 Apr 4. doi: 10.1245/s10434-025-17236.
    PubMed     Abstract available


  509. CHIARELLA LS, Huelsboemer L, Diatta F, Klimitz FJ, et al
    ASO Author Reflections: The Five-Item Modified Frailty Index in Breast Cancer Surgery: Past Insights, Present Evidence, and Future Directions.
    Ann Surg Oncol. 2025 Apr 4. doi: 10.1245/s10434-025-17273.
    PubMed    


  510. PERRY LM, Sevilimedu V, Polidorio N, Abuhadra N, et al
    ASO Visual Abstract: Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2025 Apr 2. doi: 10.1245/s10434-025-17248.
    PubMed    


  511. PASCHALIS K, Marin C, Miller K, Regis C, et al
    Patients with DCIS Seen at a Specialized High-Risk Breast Clinic Run by Surgical Advanced Practice Providers Have High Rates of Preventive Medication Uptake.
    Ann Surg Oncol. 2025;32:2526-2533.
    PubMed     Abstract available


  512. SWAFFORD EP, Anantha S, Davis J, Heath R, et al
    Lumpectomy Patients are at Highest Risk for Opioid Overprescription: A Comparison Between Practice Patterns and OPEN National Guidelines.
    Ann Surg Oncol. 2025;32:2585-2593.
    PubMed     Abstract available


  513. NAKHLIS F, Baker GM, Li T, McAuliffe PF, et al
    Incidence of Adjacent Synchronous Ipsilateral Infiltrating Carcinoma and/or Ductal Carcinoma In Situ in Patients Diagnosed with Flat Epithelial Atypia by Core Needle Biopsy (TBCRC 034).
    Ann Surg Oncol. 2025;32:2578-2584.
    PubMed     Abstract available


  514. VERDIAL FC, Anderman KJ, Daly AE, Ozmen T, et al
    The Age-Old Question in Nipple-Sparing Mastectomy: Is Older Age a Contraindication?
    Ann Surg Oncol. 2025;32:2569-2577.
    PubMed     Abstract available


  515. MEURS CJC, Kerkhoven C, Siesling S, Menke-Pluijmers MBE, et al
    Surgery for Classic, Pleomorphic and Non-classic Lobular Carcinoma In Situ: Surgery Rate, Risk of Upstaging and Short-Term Follow-Up.
    Ann Surg Oncol. 2025;32:2545-2553.
    PubMed     Abstract available


  516. CHEN Z, Zhang J, Chen W, Chen X, et al
    ASO Author Reflections: Serum Enzymes as Predictive Biomarkers for Pathologic Complete Response in HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2025 Apr 1. doi: 10.1245/s10434-025-17259.
    PubMed    


    March 2025
  517. BOYLE MK, Amersi F, Chung A, Tseng J, et al
    Comparison of Targeted Axillary Dissection with Sentinel Node Biopsy Alone on Nodal Recurrence for Patients who have Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Mar 25. doi: 10.1245/s10434-025-17197.
    PubMed     Abstract available


  518. THAPLOO A, Kohli K, Wang S, Ho FDV, et al
    ASO Visual Abstract: Disparities in Stage at Presentation for Disaggregated Asian American, Native Hawaiian, and Pacific Islander Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Mar 24. doi: 10.1245/s10434-025-17133.
    PubMed    


  519. CHEN Z, Zhang J, Chen W, Chen X, et al
    ASO Visual Abstract: Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients.
    Ann Surg Oncol. 2025 Mar 24. doi: 10.1245/s10434-025-17243.
    PubMed    


  520. LORENTZEN EH, Nguyen K, Chen YJ, King TA, et al
    Downstream Effects of Omission of Axillary Surgery in Older Adults with Early-Stage HR+/HER2- Breast Cancer.
    Ann Surg Oncol. 2025 Mar 21. doi: 10.1245/s10434-025-17196.
    PubMed     Abstract available


  521. PITSINIS V, Benson J
    Reply to: Letter to the Editor in Relation to 'Results of a Prospective Randomized Multicentre Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer:
    Ann Surg Oncol. 2025 Mar 21. doi: 10.1245/s10434-025-17158.
    PubMed    


  522. KARAMITROS G, Grant MP, Lamaris GA
    Prophylactic Lymphovenous Bypass for Breast Cancer-Related Lymphedema: Research Challenges, Statistical Pitfalls, and Solutions.
    Ann Surg Oncol. 2025 Mar 18. doi: 10.1245/s10434-025-17200.
    PubMed    


  523. HAGERTY BL, Sato T, Wu R, Ishikawa T, et al
    Mesothelin (MSLN) is Highly Expressed in Triple Negative Breast Cancer and is Associated with Enhanced Cell Proliferation and Proinflammatory Tumor Microenvironment.
    Ann Surg Oncol. 2025 Mar 13. doi: 10.1245/s10434-025-17117.
    PubMed     Abstract available


  524. OZCAN BB, Arjmandi FK, Polat DS, Xi Y, et al
    ASO Visual Abstract: Factors Associated with Nodal Positivity Following Neoadjuvant Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI.
    Ann Surg Oncol. 2025 Mar 13. doi: 10.1245/s10434-025-17137.
    PubMed    


  525. CHEN Z, Zhang J, Chen W, Chen X, et al
    Serum Enzymes and Pathologic Complete Response to the Addition of Targeted Therapy in Neoadjuvant Chemotherapy for HER2-Positive Breast Cancer Patients.
    Ann Surg Oncol. 2025 Mar 11. doi: 10.1245/s10434-025-17110.
    PubMed     Abstract available


  526. FLESHNER K, Quan ML
    ASO Author Reflections: Uptake of Completion Axillary Lymph Node Dissection in Post-Neoadjuvant Chemotherapy Breast Cancer Patients.
    Ann Surg Oncol. 2025 Mar 8. doi: 10.1245/s10434-025-17129.
    PubMed    


  527. DOGAN B
    ASO Author Reflections: Sentinel Lymph Node Biopsy in Node-Negative Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Considerations and Emerging Evidence.
    Ann Surg Oncol. 2025 Mar 7. doi: 10.1245/s10434-025-17126.
    PubMed    


  528. YOUNG J, Asaoka M, Ghasemi F, Chida K, et al
    ASO Visual Abstract: The American Joint Committee on Cancer (AJCC) Breast Cancer Staging 8th Edition is More Reflective of Cancer Biology Than the 7th Edition.
    Ann Surg Oncol. 2025 Mar 6. doi: 10.1245/s10434-025-17065.
    PubMed    


  529. PERRY LM, Sevilimedu V, Polidorio N, Abuhadra N, et al
    Predictors of Pathologic Complete Response with Neoadjuvant Chemo-Immunotherapy in Early-Stage Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2025 Mar 2. doi: 10.1245/s10434-025-17081.
    PubMed     Abstract available


  530. GAU RY, Chou HH, Tsai HP, Shen SC, et al
    Long-Term Follow-Up of Surgical Outcomes and Oncological Results of Nipple-Sparing Mastectomy with Immediate Reconstruction Through a Single Axillary Incision with Different Approach Methods.
    Ann Surg Oncol. 2025;32:2092-2102.
    PubMed     Abstract available


  531. HEELING E, Kramer GM, Volders JH, van Bommel ACM, et al
    Increasing Rates but Persistent Variability of Immediate Breast Reconstruction: Real-Time Data from a Population-Based Study (2012-2022).
    Ann Surg Oncol. 2025;32:1997-2006.
    PubMed     Abstract available


  532. THAPLOO A, Kohli K, Wang S, Ho FDV, et al
    Disparities in Stage at Presentation for Disaggregated Asian American, Native Hawaiian, and Pacific Islander Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Mar 1. doi: 10.1245/s10434-025-16974.
    PubMed     Abstract available


    February 2025
  533. BOROWSKY PA, Hernandez AE, Kesmodel SB, Goel N, et al
    Genetic Ancestry and 21-Gene Oncotype DX Breast Cancer Recurrence Scores.
    Ann Surg Oncol. 2025 Feb 27. doi: 10.1245/s10434-025-17012.
    PubMed     Abstract available


  534. FLESHNER K, Xu Y, Isherwood S, Yang F, et al
    Real-World Assessment of Locoregional Management of the Axilla in Node-Positive Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2025 Feb 19. doi: 10.1245/s10434-025-17041.
    PubMed     Abstract available


  535. CABIOGLU N, Karanlik H, Igci A, Muslumanoglu M, et al
    ASO Visual Abstract: Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in the NEOSENTITURK-trials MF18-02/18-03.
    Ann Surg Oncol. 2025 Feb 18. doi: 10.1245/s10434-024-16746.
    PubMed    


  536. KITAI T, Yamanaka K
    Letter to the Editor in Relation to "Results of a Prospective Randomized Multicenter Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer: The INFLU
    Ann Surg Oncol. 2025 Feb 14. doi: 10.1245/s10434-025-17016.
    PubMed    


  537. OZCAN BB, Arjmandi FK, Polat DS, Xi Y, et al
    Factors Associated with Nodal Positivity Following Neoadjuvant Systemic Therapy in Breast Cancer Patients Who are Initially Node-Negative on MRI.
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16985.
    PubMed     Abstract available


  538. BOUGHEY JC, Yu H, Switalla K, Velle L, et al
    Oncologic Outcomes with De-Escalation of Axillary Surgery After Neoadjuvant Chemotherapy for Breast Cancer: Results from > 1500 Patients on the I-SPY2 Clinical Trial.
    Ann Surg Oncol. 2025 Feb 13. doi: 10.1245/s10434-025-16973.
    PubMed     Abstract available


  539. REDDY KP, Fayanju OM
    ASO Author Reflections: The Financial Impact of Delayed and Forgone Care Among Patients with Breast Cancer.
    Ann Surg Oncol. 2025 Feb 11. doi: 10.1245/s10434-025-16969.
    PubMed    


  540. YOUNG J, Asaoka M, Ghasemi F, Chida K, et al
    The American Joint Committee on Cancer (AJCC) Breast Cancer Staging, Eighth Edition, is more Reflective of Cancer Biology than the Seventh Edition.
    Ann Surg Oncol. 2025 Feb 7. doi: 10.1245/s10434-025-16889.
    PubMed     Abstract available


  541. ZHANG M, Yuan L, Cui M, Chen J, et al
    ASO Author Reflections: Personal Insights and Reflections on the Burden of Breast Cancer Among Adolescents and Young Adults.
    Ann Surg Oncol. 2025 Feb 6. doi: 10.1245/s10434-024-16858.
    PubMed    


  542. LAWS A, Leonard S, Vincuilla J, Parker T, et al
    ASO Visual Abstract: Risk of Surgical Overtreatment in cN1 Breast Cancer Patients Who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
    Ann Surg Oncol. 2025 Feb 3. doi: 10.1245/s10434-025-16952.
    PubMed    


  543. COLEMAN-BELIN JC, Rubin J, Boe LA, Diwan R, et al
    Protective Factors Associated with Normal Lymphatic Function After Axillary Lymph Node Dissection for Breast Cancer Treatment.
    Ann Surg Oncol. 2025 Feb 3. doi: 10.1245/s10434-025-16918.
    PubMed     Abstract available


  544. SINGH P, Agnese DM, Amin M, Barrio AV, et al
    Society of Surgical Oncology Breast Disease Site Working Group Statement on Bilateral Risk-Reducing Mastectomy: Indications, Outcomes, and Risks.
    Ann Surg Oncol. 2025;32:899-911.
    PubMed     Abstract available


  545. KHAN MMM, Khalil M, Stecko H, Pawlik TM, et al
    Disparities in Next-Generation Genetic Sequencing Among Individuals with Cancer.
    Ann Surg Oncol. 2025;32:650-652.
    PubMed     Abstract available


  546. WINER L, Ruth KJ, Bleicher RJ, Nagarathinam R, et al
    Immunohistochemical Status Predicts Pathologic Complete Response to Neoadjuvant Therapy in HER2-Overexpressing Breast Cancers.
    Ann Surg Oncol. 2025;32:931-943.
    PubMed     Abstract available


  547. LIU LL, Lin YK, Xiang ZL
    The Value of Primary Tumor Resection in Patients with Liver Metastases: A 10-Year Outcome.
    Ann Surg Oncol. 2025;32:1083-1092.
    PubMed     Abstract available


  548. ESPARHAM A, Shoar S, Whittington J, Shafaee Z, et al
    National Trends and In-Hospital Outcomes for Immediate Implant-Based Versus Autologous-Based Breast Reconstruction: A Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2025;32:985-992.
    PubMed     Abstract available


    January 2025
  549. SCHUMACHER JR, Tucholka JL, Breuer CR, McKinney GH, et al
    Ongoing Symptoms and Concerns Experienced by Low-Risk Breast Cancer Survivors Following Active Treatment.
    Ann Surg Oncol. 2025 Jan 29. doi: 10.1245/s10434-025-16959.
    PubMed     Abstract available


  550. NTOWE KW, Lee MS, Yi VN, Kaplan SJ, et al
    ASO Visual Abstract: Short-Term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at High Risk for Breast Cancer: A Systematic Review.
    Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-025-16902.
    PubMed    


  551. REDDY KP, Jarrell K, Berkowitz C, Hulse S, et al
    ASO Visual Abstract: Association Between Delayed/Forgone Medical Care and Resource Utilization Among Women with Breast Cancer in the United States.
    Ann Surg Oncol. 2025 Jan 23. doi: 10.1245/s10434-024-16776.
    PubMed    


  552. CHRISTENHUSZ A, Mirzaei N, Karakatsanis A, Eriksson S, et al
    ASO Visual Abstract: Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-Analysis of Tracer Uptake.
    Ann Surg Oncol. 2025 Jan 22. doi: 10.1245/s10434-024-16780.
    PubMed    


  553. YI JP, Yoon CI, Lim SH, Choi H, et al
    ASO Visual Abstract: Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study.
    Ann Surg Oncol. 2025 Jan 16. doi: 10.1245/s10434-025-16870.
    PubMed    


  554. VAN DEN BRUELE AB, Williams A, Weiss A
    Commentary and Updates on the Management of Male Breast Cancer.
    Ann Surg Oncol. 2025 Jan 13. doi: 10.1245/s10434-024-16756.
    PubMed    


  555. CHO MJ, Chratian S, Skoracki R
    ASO Author Reflections: Breast Cancer-Related Lymphedema Prevention: The Impact of Prophylactic Lymphovenous Bypass.
    Ann Surg Oncol. 2025 Jan 12. doi: 10.1245/s10434-024-16824.
    PubMed    


  556. FEFFERMAN ML, Thompson DM, Wilke LG, Hwang S, et al
    ASO Visual Abstract: Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data.
    Ann Surg Oncol. 2025 Jan 9. doi: 10.1245/s10434-024-16777.
    PubMed    


  557. DARIYA S, Agarwal G
    Letter to the Editor: Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.
    Ann Surg Oncol. 2025 Jan 7. doi: 10.1245/s10434-024-16839.
    PubMed    


  558. NTOWE KW, Lee MS, Yi VN, Kaplan SJ, et al
    Short-term Patient-Reported Outcomes Following Bilateral Risk-Reducing Mastectomy for Patients at a High Risk for Breast Cancer: A Systematic Review.
    Ann Surg Oncol. 2025 Jan 4. doi: 10.1245/s10434-024-16805.
    PubMed     Abstract available


  559. CHO MJ, Senger JL, Park KU, Hansotia K, et al
    ASO Visual Abstract: Preventing Breast Cancer-Related Lymphedema-A Comprehensive Analysis of a 9-Year Single-Center Experience of Prophylactic Lymphovenous Bypass.
    Ann Surg Oncol. 2025 Jan 4. doi: 10.1245/s10434-024-16784.
    PubMed    


  560. GIANNAKOU A, Kantor O, Park KU, Waks AG, et al
    ASO Visual Abstract: Real-World Implications of the SOUND Trial.
    Ann Surg Oncol. 2025;32:121-122.
    PubMed     Abstract available


  561. KIM M, Amakiri UO, Wong F, Barnett J, et al
    Race and Ethnicity Impacts Patient-Reported Outcomes in Implant-Based Breast Reconstruction.
    Ann Surg Oncol. 2025;32:551-561.
    PubMed     Abstract available


  562. KHUBCHANDANI JA, Suttiratana SC, Washington R, White-Bracey D, et al
    Living Flat: Stories from Women of Color After Mastectomy.
    Ann Surg Oncol. 2025;32:104-114.
    PubMed     Abstract available


  563. WANG X, Jackson J, Weed C, Boyle MK, et al
    Staged Nipple Delay Procedure Expands Candidacy for Nipple-Sparing Mastectomy.
    Ann Surg Oncol. 2025;32:98-103.
    PubMed     Abstract available


  564. MATAR-UJVARY R, Sevilimedu V, Morrow M
    Are Clinically Node-Negative Patients with a Positive Preoperative Axillary Lymph Node Biopsy Appropriate Candidates for Sentinel Lymph Node Biopsy?
    Ann Surg Oncol. 2025;32:92-97.
    PubMed     Abstract available


    December 2024
  565. YANG Z, Wu T, Chen P, Li L, et al
    Recurrence Patterns and Long-Term Results After Curative Surgery for Patients With Breast Cancer.
    Ann Surg Oncol. 2024 Dec 30. doi: 10.1245/s10434-024-16726.
    PubMed     Abstract available


  566. SELFRIDGE JM, Schrank Z, Agala CB, Ollila DW, et al
    ASO Visual Abstract: Outcomes and Trends in Axillary Management of Patients with Stage cN3b Breast Cancer.
    Ann Surg Oncol. 2024 Dec 29. doi: 10.1245/s10434-024-16783.
    PubMed    


  567. CHO MJ, Senger JL, Park KU, Hansotia K, et al
    Preventing Breast Cancer-Related Lymphedema: A Comprehensive Analysis of a 9-Year Single-Center Experience of Prophylactic Lymphovenous Bypass.
    Ann Surg Oncol. 2024 Dec 23. doi: 10.1245/s10434-024-16640.
    PubMed     Abstract available


  568. CHRISTENHUSZ A, Mirzaei N, Warnberg F, Alic L, et al
    ASO Author Reflections: Redefining Precision-Insights into Magnetic Sentinel Lymph Node Biopsy for Early Breast Cancer.
    Ann Surg Oncol. 2024 Dec 21. doi: 10.1245/s10434-024-16725.
    PubMed    


  569. KANG YJ, Yi JP, Yoon CI
    ASO Author Reflections: Hidden Impact of COVID-19 on Breast Cancer Outcomes: Lessons From South Korea.
    Ann Surg Oncol. 2024 Dec 21. doi: 10.1245/s10434-024-16721.
    PubMed    


  570. REDDY KP, Jarrell K, Berkowitz C, Hulse S, et al
    Association Between Delayed/Forgone Medical Care and Resource Utilization Among Women with Breast Cancer in the United States.
    Ann Surg Oncol. 2024 Dec 18. doi: 10.1245/s10434-024-16586.
    PubMed     Abstract available


  571. SCHRANK Z, Selfridge JM
    ASO Author Reflections: Can Axillary Lymph Node Dissection be Safely Avoided for Some Stage cN3b Breast Cancer Patients?
    Ann Surg Oncol. 2024 Dec 18. doi: 10.1245/s10434-024-16724.
    PubMed    


  572. TAHTASAKAL R, Hamurcu Z, Oz AB, Balli M, et al
    miR-484 as an "OncomiR" in Breast Cancer Promotes Tumorigenesis by Suppressing Apoptosis Genes.
    Ann Surg Oncol. 2024 Dec 18. doi: 10.1245/s10434-024-16656.
    PubMed     Abstract available


  573. CHRISTENHUSZ A, Mirzaei N, Karakatsanis A, Eriksson S, et al
    Magnetic Sentinel Lymph Node Biopsy in Early Breast Cancer Patients: An Individual Patient Data Meta-analysis of Tracer Uptake.
    Ann Surg Oncol. 2024 Dec 17. doi: 10.1245/s10434-024-16626.
    PubMed     Abstract available


  574. SELFRIDGE JM, Schrank Z, Agala CB, Ollila DW, et al
    Outcomes and Trends in Axillary Management of Stage cN3b Breast Cancer Patients.
    Ann Surg Oncol. 2024 Dec 14. doi: 10.1245/s10434-024-16630.
    PubMed     Abstract available


  575. ZHANG M, Yuan L, Cui M, Chen J, et al
    Analysis the Burden of Breast Cancer Among Adolescents and Young Adults Using the Global Burden of Disease 2021.
    Ann Surg Oncol. 2024 Dec 12. doi: 10.1245/s10434-024-16648.
    PubMed     Abstract available


  576. FEFFERMAN ML, Thompson DM, Wilke LG, Hwang S, et al
    Commission on Cancer Center Performance with the New Breast Cancer Quality Measures: A Review of Historical Data.
    Ann Surg Oncol. 2024 Dec 10. doi: 10.1245/s10434-024-16594.
    PubMed     Abstract available


  577. PANG J, Ding N, Liu X, He X, et al
    ASO Author Reflections: Reflections on the Role of the Systemic Immune-Inflammation Index in Prognostic Assessment in HER2-Positive Metastatic Breast Cancer.
    Ann Surg Oncol. 2024 Dec 10. doi: 10.1245/s10434-024-16664.
    PubMed    


  578. REH N, Caston NE, Williams CP, Dwarampudi SR, et al
    Therapeutic Clinical Trial Eligibility and Enrollment among Women with Breast Cancer: Implications for Understanding Trial Disparities.
    Ann Surg Oncol. 2024 Dec 9. doi: 10.1245/s10434-024-16607.
    PubMed     Abstract available


  579. CABIOGLU N, Karanlik H, Igci A, Muslumanoglu M, et al
    ASO Author Reflections: Nodal Recurrence Is Rare in Patients with cN+/ycN0 Breast Cancer after Neoadjuvant Chemotherapy Regardless of the Extent of Axillary Surgery or Nodal Pathology in the NEOSENTITURK-Trials MF18-02/18-03 Provided Regional Nodal Ir
    Ann Surg Oncol. 2024 Dec 9. doi: 10.1245/s10434-024-16651.
    PubMed     Abstract available


  580. SHIM V, Karlea A, Brenman LM, Gul J, et al
    ASO Visual Abstract: Impact of Mainstream Germline Genetic Testing with Expanded Eligibility for Early Stage Breast Cancer Patients in a Large Integrated Health System.
    Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16559.
    PubMed    


  581. YI JP, Yoon CI, Lim SH, Choi H, et al
    Prognosis of Patients with Breast Cancer Following Delayed Diagnosis During the COVID-19 Pandemic: A Real-World Cohort Study.
    Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16645.
    PubMed     Abstract available


  582. LAWS A, Leonard S, Vincuilla J, Parker T, et al
    Risk of Surgical Overtreatment in cN1 Breast Cancer Patients who Become ypN0 After Neoadjuvant Chemotherapy: SLNB Versus TAD.
    Ann Surg Oncol. 2024 Dec 4. doi: 10.1245/s10434-024-16625.
    PubMed     Abstract available


  583. WINER LK, Williams AD
    ASO Author Reflections: Beyond the Binary: Using IHC Status to Predict Response to Neoadjuvant Therapy in HER2+ Early-Stage Breast Cancer.
    Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16606.
    PubMed    


  584. CABIOGLU N, Karanlik H, Igci A, Muslumanoglu M, et al
    Breast Cancer Recurrence in Initially Clinically Node-Positive Patients Undergoing Sentinel Lymph Node Biopsy After Neoadjuvant Chemotherapy in the NEOSENTITURK-Trials MF18-02/18-03.
    Ann Surg Oncol. 2024 Dec 2. doi: 10.1245/s10434-024-16472.
    PubMed     Abstract available


  585. GIANNAKOU A, Kantor O, Park KU, Waks AG, et al
    Real-World Implications of the SOUND Trial.
    Ann Surg Oncol. 2024;31:8776-8785.
    PubMed     Abstract available


  586. WOESTE MR, Jacob K, Shindorf M, Gaskins JT, et al
    Identifying Factors Predicting Margin Status After Mastectomy.
    Ann Surg Oncol. 2024;31:8882-8890.
    PubMed     Abstract available


  587. ECKERT KM, Hoskin TL, Olson CA, Goetz MP, et al
    In-Breast Tumor Progression During Neoadjuvant Chemotherapy: Impact on and Factors Influencing Distant Recurrence-Free Survival.
    Ann Surg Oncol. 2024;31:8856-8865.
    PubMed     Abstract available


  588. DISKIN B, Sevilimedu V, Morrow M, Van Zee K, et al
    Management of Ipsilateral Breast Tumor Recurrence Following Breast Conservation Surgery for Ductal Carcinoma In Situ: A Data-Poor Zone.
    Ann Surg Oncol. 2024;31:8843-8847.
    PubMed     Abstract available


  589. DEY P, Kc M, Proussaloglou EM, Khubchandani JA, et al
    Incidence of Pathologic Nodal Disease in Clinically Node-Negative, Microinvasive or T1a Breast Cancers.
    Ann Surg Oncol. 2024;31:8821-8828.
    PubMed     Abstract available


  590. LIMBERG JN, Jones T, Thomas SM, Ntowe KW, et al
    Omission of Axillary Lymph Node Dissection in Patients with Residual Nodal Disease After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024;31:8813-8820.
    PubMed     Abstract available


    November 2024
  591. SAMPLE JW, Hoskin TL, Johnson JE, Mrdutt MM, et al
    ASO Visual Abstract: Early Compliance with Commission on Cancer Operative Standards for Breast Cancer Surgery.
    Ann Surg Oncol. 2024 Nov 26. doi: 10.1245/s10434-024-16583.
    PubMed    


  592. HUSTON-PATERSON HH, Mora V, Karlan BY, Teshome M, et al
    Medicaid Coverage of NCCN- and ASCO/SSO-Guideline-Concordant BRCA Germline Testing for Patients with Breast Cancer: Opportunity to Embrace Rapid Advancements in Precision Medicine.
    Ann Surg Oncol. 2024 Nov 23. doi: 10.1245/s10434-024-16306.
    PubMed     Abstract available


  593. PANG J, Ding N, Liu X, He X, et al
    Prognostic Value of the Baseline Systemic Immune-Inflammation Index in HER2-Positive Metastatic Breast Cancer: Exploratory Analysis of Two Prospective Trials.
    Ann Surg Oncol. 2024 Nov 20. doi: 10.1245/s10434-024-16454.
    PubMed     Abstract available


  594. SO A, Yi M, Simons JM, Kuerer HM, et al
    ASO Visual Abstract: Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16506.
    PubMed    


  595. MUPPIDI N, Adesoye T, Yi M, Sun SX, et al
    ASO Visual Abstract: Clinical Outcomes for Early-Stage Node-Negative HER2-Positive Breast Cancer Patients Receiving Upfront Surgery or Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2024 Nov 19. doi: 10.1245/s10434-024-16213.
    PubMed    


  596. HU J, Deng X, Li L, Liu H, et al
    ASO Visual Abstract: The Predictive Factors of Combined Implant Application for Breast Cancer Patients Receiving Immediate Breast Reconstruction with a Pedicled Omental Flap.
    Ann Surg Oncol. 2024 Nov 16. doi: 10.1245/s10434-024-16500.
    PubMed    


  597. SO A, Hunt KK
    ASO Author Reflections: De-escalating Axillary Surgery in Patients with Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Nov 13. doi: 10.1245/s10434-024-16461.
    PubMed    


  598. SAMPLE JW, Hoskin TL, Johnson JE, Mrdutt MM, et al
    Early Compliance with Commission on Cancer Operative Standards for Breast Cancer Surgery.
    Ann Surg Oncol. 2024 Nov 10. doi: 10.1245/s10434-024-16477.
    PubMed     Abstract available


  599. VASIGH M, Mohamed A, Jacobs L, Lange J, et al
    ASO Visual Abstract: The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer.
    Ann Surg Oncol. 2024 Nov 5. doi: 10.1245/s10434-024-16404.
    PubMed    


  600. MCCAFFREY RL, James AJ, Torres-Guzman RA, Addae JK, et al
    Incidence of High Risk and Malignant Pathological Findings in Transgender and Gender Diverse Individuals Undergoing Gender-Affirming Mastectomy.
    Ann Surg Oncol. 2024;31:8086-8092.
    PubMed     Abstract available


  601. GOTTIPATI S, Goldbach M, Tchou J
    ASO Author Reflections: Rationale to Routinely Retest ER, PR and HER-2/neu Receptor Status in Residual Disease After Neoadjvuant Chemotherapy.
    Ann Surg Oncol. 2024;31:8108-8109.
    PubMed    


  602. HO IW, Chichura A, Pederson HJ, Xavier BA, et al
    Current State of Evidence-Based Long-Term Monitoring Protocols for Breast Plastic Surgery Patients.
    Ann Surg Oncol. 2024;31:8372-8382.
    PubMed     Abstract available


  603. HANEY V, Lee SM, Goldman J, Akiska YM, et al
    Evaluating the Effect of MarginProbe((R)) Use on Re-excisions After Partial Mastectomy: A Single-Institution Analysis.
    Ann Surg Oncol. 2024;31:8068-8075.
    PubMed     Abstract available


  604. DEL CALVO H, Wu Y, Lin HY, Nassif EF, et al
    Margin Width and Local Recurrence in Patients with Phyllodes Tumors of the Breast.
    Ann Surg Oncol. 2024;31:8048-8056.
    PubMed     Abstract available


  605. KIM M, Tadros AB, Boe LA, Vingan P, et al
    Breast-Conserving Therapy Versus Postmastectomy Breast Reconstruction: Propensity Score-Matched Analysis.
    Ann Surg Oncol. 2024;31:8030-8039.
    PubMed     Abstract available


  606. AMAKIRI UO, Tadros AB, Kim M, Boe LA, et al
    ASO Author Reflections: Propensity Score-Matched Patient-Reported Outcomes After Breast-Conserving Therapy and Postmastectomy Breast Reconstruction.
    Ann Surg Oncol. 2024;31:8104-8105.
    PubMed    


    October 2024
  607. MOORE AM, Caudle AS, Sun SX, Yi M, et al
    ASO Visual Abstract: Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer.
    Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16397.
    PubMed    


  608. SO A, Yi M, Simons JM, Kuerer HM, et al
    Significance of Residual Nodal Disease in Clinically Node-Negative Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16382.
    PubMed     Abstract available


  609. BAYLEY EM, Liu HY, Bonetti MA, Egro FM, et al
    ChatGPT as Valuable Patient Education Resource in Breast Cancer Care.
    Ann Surg Oncol. 2024 Oct 23. doi: 10.1245/s10434-024-16369.
    PubMed    


  610. CONNORS C, Valente SA, ElSherif A, Escobar P, et al
    Real-World Outcomes with the KEYNOTE-522 Regimen in Early-Stage Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2024 Oct 22. doi: 10.1245/s10434-024-16390.
    PubMed     Abstract available


  611. MOORE AM, Caudle AS, Sun SX, Yi M, et al
    Impact of Clipped Node as a Sentinel Lymph Node on Axillary Staging Following Neoadjuvant Chemotherapy in Clinically Node-Positive Breast Cancer.
    Ann Surg Oncol. 2024 Oct 17. doi: 10.1245/s10434-024-16341.
    PubMed     Abstract available


  612. ESPARHAM A, Shoar S, Whittington J, Shafaee Z, et al
    ASO Author Reflections: Immediate Implant-Based Versus Autologous-Based Breast Reconstruction After Mastectomy in Patients with Breast Cancer.
    Ann Surg Oncol. 2024 Oct 12. doi: 10.1245/s10434-024-16374.
    PubMed    


  613. KIM LS, Moore MS, Schneider E, Canner J, et al
    ASO Visual Abstract: National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer.
    Ann Surg Oncol. 2024 Oct 2. doi: 10.1245/s10434-024-16259.
    PubMed    


  614. KIM M, Matros E, Boe LA, Stern CS, et al
    Predicting Postoperative Satisfaction with Breasts: How Important is the Preoperative BREAST-Q Score?
    Ann Surg Oncol. 2024;31:6602-6610.
    PubMed     Abstract available


  615. LORENTZEN EH, Chen YJ, Jin G, King TA, et al
    Potential Overtreatment of DCIS in Patients with Limited Life Expectancy.
    Ann Surg Oncol. 2024;31:6812-6819.
    PubMed     Abstract available


  616. JONES VM, Nelson JA, Sevilimedu V, Le T, et al
    Impact of Mastectomy Flap Necrosis on Patient-Reported Quality-of-Life Measures After Nipple-Sparing Mastectomy: A Preliminary Analysis.
    Ann Surg Oncol. 2024;31:6795-6803.
    PubMed     Abstract available


  617. DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
    Correction: Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
    Ann Surg Oncol. 2024 Oct 1. doi: 10.1245/s10434-024-16315.
    PubMed    


  618. GASS J, Teshome M, Blair SL
    25nd Annual Meeting of the American Society of Breast Surgeons: Our Silver Jubilee.
    Ann Surg Oncol. 2024;31:7245-7246.
    PubMed    


  619. JACKSON KM, Grumley JG
    ASO Author Reflections: Employment of Oncoplastic Breast Surgery for Management of Large, Multifocal, or Multicentric Breast Cancers: Another Tool in the Toolbox.
    Ann Surg Oncol. 2024;31:7594-7595.
    PubMed    


  620. MILLEN JC, Grumley JG
    ASO Author Reflections: Cost Comparison of Extreme Oncoplastic Breast-Conserving Surgery and Mastectomy with Reconstruction.
    Ann Surg Oncol. 2024;31:7471.
    PubMed    


  621. ELMORE LR, Bayley EM, Clark BZ, McAuliffe PF, et al
    Is the Number or Proximity of Margins Less than 2 mm Associated with an Increased Mastectomy Rate in Patients Attempting Breast Conservation Therapy for Ductal Carcinoma In Situ?
    Ann Surg Oncol. 2024;31:7609-7618.
    PubMed     Abstract available


  622. HUA T, Wright GP, Thompson JL
    ASO Author Reflections: The Utility of Clinical Breast Examinations in a High-Risk Patient Population.
    Ann Surg Oncol. 2024;31:7532-7533.
    PubMed    


  623. JACKSON KM, Millen JC, Handy N, Orozco JIJ, et al
    Breast Conservation Project: Clinical Outcomes of Extreme Oncoplastic Breast-Conserving Therapy Versus Mastectomy for Large and Multiple Lesions.
    Ann Surg Oncol. 2024;31:7582-7593.
    PubMed     Abstract available


  624. AUBREY JM, Levine A, Movassaghi A, Liefeld HR, et al
    2021 CMS Evaluation and Management Guideline Changes Reduce Note Length in Outpatient Breast Surgery Documentation.
    Ann Surg Oncol. 2024;31:7535-7537.
    PubMed    


  625. WEISS A, Mitchell M, O'Sullivan CC, Boughey JC, et al
    ASO Author Reflections: Extreme Early Adoption-The Omission of Axillary Lymph Node Dissection is Being Adopted into Practice Before Clinical Trial Data are Available: Where Might this Lead?
    Ann Surg Oncol. 2024;31:7372-7374.
    PubMed    


  626. CLELLAND EN, Mukhtar RA
    ASO Author Reflections: Detecting Local Recurrence After Primary Treatment for Invasive Lobular Carcinoma of the Breast.
    Ann Surg Oncol. 2024;31:7323-7324.
    PubMed    


  627. GAO TP, HoSang KM, Bleicher RJ, Kuo LE, et al
    Evolving Economics: The Erosion of Medicare Reimbursement in Breast Surgery (2003-2023).
    Ann Surg Oncol. 2024;31:7303-7311.
    PubMed     Abstract available


  628. VEMURU S, Helmkamp L, Adams M, Colborn K, et al
    Longitudinal Trends in Patient-Reported Outcomes in the First Year After Lumpectomy Versus Mastectomy.
    Ann Surg Oncol. 2024;31:7597-7606.
    PubMed     Abstract available


  629. DALTON EC, Williams AD
    ASO Author Reflections: Put the Scalpel Down-Axillary Surgery is not Indicated for Patients >/= 70 Years Undergoing Mastectomy for DCIS.
    Ann Surg Oncol. 2024;31:7508-7509.
    PubMed    


  630. CARDARELLI CL, Dalton EC, Chang C, Williams AD, et al
    Should Palpable Nodes Be Exclusionary in Patients Who Are Otherwise Candidates for ACOSOG Z0011-Type Trials?
    Ann Surg Oncol. 2024;31:7445-7458.
    PubMed     Abstract available


  631. HOSSINO D, Silverstein MJ, Savalia N, Jayich M, et al
    Extreme Oncoplasty: Oncologically Safe When Compared with Mastectomy.
    Ann Surg Oncol. 2024;31:7284-7288.
    PubMed     Abstract available


  632. MILLEN JC, Sibia U, Jackson K, Stern SL, et al
    Comparing Costs: Does Extreme Oncoplastic Breast-Conserving Surgery Confer a Cost Benefit When Compared with Mastectomy and Reconstruction?
    Ann Surg Oncol. 2024;31:7463-7470.
    PubMed     Abstract available


  633. PILTIN MA, Norwood P, Ladores V, Mukhtar RA, et al
    Internal Mammary Lymphadenopathy Does Not Impact Oncologic Outcomes in Patients Treated with Neoadjuvant Chemotherapy: Results from the I-SPY2 Clinical Trial.
    Ann Surg Oncol. 2024;31:7420-7428.
    PubMed     Abstract available


  634. DALTON EC, Chang C, Cardarelli C, Bleicher RJ, et al
    Nodal Surgery for Patients >/= 70 Undergoing Mastectomy for DCIS? Choose Wisely.
    Ann Surg Oncol. 2024;31:7498-7507.
    PubMed     Abstract available


  635. WEISS A, Colugnati F, Mitchell M, Li Y, et al
    Contemporary Axillary Surgical Management in Patients with Pathologically Node Positive Disease After Neoadjuvant Chemotherapy: A Survey of Members of the American Society of Breast Surgeons.
    Ann Surg Oncol. 2024;31:7362-7371.
    PubMed     Abstract available


  636. JAKUB JW, Boughey JC, Hieken TJ, Piltin M, et al
    Lymphedema Rates Following Axillary Lymph Node Dissection With and Without Immediate Lymphatic Reconstruction: A Prospective Trial.
    Ann Surg Oncol. 2024;31:7349-7359.
    PubMed     Abstract available


  637. CLELLAND EN, Quirarte A, Rothschild HT, Kaur M, et al
    Surveillance Strategies After Primary Treatment for Patients with Invasive Lobular Carcinoma of the Breast: Method of Local Recurrence Detection After Breast-Conserving Surgery.
    Ann Surg Oncol. 2024;31:7315-7322.
    PubMed     Abstract available


  638. FALADE I, Mukhtar RA
    ASO Author Reflections: The Oncologic Safety of Immediate Oncoplastic Approaches in Invasive Lobular Carcinoma.
    Ann Surg Oncol. 2024;31:7418-7419.
    PubMed    


  639. FALADE I, Switalla K, Quirarte A, Baxter M, et al
    Oncologic Safety of Immediate Oncoplastic Surgery Compared with Standard Breast-Conserving Surgery for Patients with Invasive Lobular Carcinoma.
    Ann Surg Oncol. 2024;31:7409-7417.
    PubMed     Abstract available


    September 2024
  640. SHIM V, Karlea A, Habel L
    ASO Author Reflections: Mainstream Genetic Testing Makes It Feasible for a Large Integrated System to Expand the Testing Eligibility in Breast Cancer.
    Ann Surg Oncol. 2024 Sep 28. doi: 10.1245/s10434-024-16311.
    PubMed    


  641. VASIGH M, Mohamed A, Jacobs L, Lange J, et al
    The Association Between Breast Cancer Predisposing Genetic Variants and Multifocal, Multicentric Breast Cancer.
    Ann Surg Oncol. 2024 Sep 27. doi: 10.1245/s10434-024-16243.
    PubMed     Abstract available


  642. KIM LS, Moore MS, Schneider E, Canner J, et al
    National Patterns of Hospital Admission Versus Home Recovery Following Mastectomy for Breast Cancer.
    Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16107.
    PubMed     Abstract available


  643. DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
    ASO Visual Abstract: Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
    Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16070.
    PubMed    


  644. MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
    ASO Visual Abstract: Financial Toxicity Among Women with Breast Cancer Varies by Age and Race.
    Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16091.
    PubMed    


  645. SAUCKE MC, Jacobson N, McKinney G, Neuman HB, et al
    Role of the Surgeon in De-Escalating Emotion During a Breast Cancer Surgery Consultation: A Qualitative Study of Patients' Experiences in Alliance A231701CD.
    Ann Surg Oncol. 2024 Sep 25. doi: 10.1245/s10434-024-16156.
    PubMed     Abstract available


  646. PITSINIS V, Kanitkar R, Vinci A, Choong WL, et al
    ASO Author Reflections: ICG Fluorescent-Guided Surgery for Sentinel Lymph Node Biopsy Used as a Single Tracer Shown Sensitivity, Safety, and Efficacy in Early Breast Cancer Surgery.
    Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16266.
    PubMed    


  647. FREEMAN JQ, Huo D, Howard FM
    ASO Author Reflections: Breast-Conserving Surgery After Neoadjuvant Systemic Therapy for Early-Stage Breast Cancer: Quantitative Biomarkers and Disparities in the Precision-Medicine Era.
    Ann Surg Oncol. 2024 Sep 23. doi: 10.1245/s10434-024-16265.
    PubMed     Abstract available


  648. RECORD SM, Thomas SM, Dalton J, van den Bruele AB, et al
    ASO Visual Abstract: Triple-Negative Breast Cancer in Older Patients: Does SLNB Guide Therapy?
    Ann Surg Oncol. 2024 Sep 21. doi: 10.1245/s10434-024-16249.
    PubMed    


  649. FU MR, Liu B, Qiu JM, Sun Y, et al
    ASO Visual Abstract: The Effects of Daily-Living Risks on Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2024 Sep 19. doi: 10.1245/s10434-024-16231.
    PubMed    


  650. SHIM V, Karlea A, Brenman LM, Gul J, et al
    Mainstream Germline Genetic Testing with Expanded Eligibility for Early Breast Cancer Patients in a Large Integrated Health System.
    Ann Surg Oncol. 2024 Sep 18. doi: 10.1245/s10434-024-16223.
    PubMed     Abstract available


  651. PARRISH KM, Thomas SM, Cartwright SB, van den Bruele AB, et al
    ASO Visual Abstract: Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer-A National Cancer Database Study.
    Ann Surg Oncol. 2024 Sep 18. doi: 10.1245/s10434-024-16206.
    PubMed    


  652. AN SJ, Thai CHNC, Ismail S, Agala CB, et al
    ASO Visual Abstract: Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution.
    Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16210.
    PubMed    


  653. FINE RE, Gilmore RC, Tomkovich KR, Dietz JR, et al
    Cryoablation Without Excision for Early-Stage Breast Cancer: ICE3 Trial 5-Year Follow-Up on Ipsilateral Breast Tumor Recurrence.
    Ann Surg Oncol. 2024 Sep 16. doi: 10.1245/s10434-024-16181.
    PubMed     Abstract available


  654. PITSINIS V, Kanitkar R, Vinci A, Choong WL, et al
    Results of a Prospective Randomized Multicenter Study Comparing Indocyanine Green (ICG) Fluorescence Combined with a Standard Tracer Versus ICG Alone for Sentinel Lymph Node Biopsy in Early Breast Cancer: The INFLUENCE Trial.
    Ann Surg Oncol. 2024 Sep 12. doi: 10.1245/s10434-024-16176.
    PubMed     Abstract available


  655. DALTON JC, Record SM, Plichta JK
    ASO Author Reflections: Investigating the Role of Sentinel Lymph Node Biopsy in Older Patients with Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2024 Sep 12. doi: 10.1245/s10434-024-16236.
    PubMed    


  656. FREEMAN JQ, Shubeck SP, Chen N, Yarlagadda SR, et al
    Quantitative Biomarkers, Genomic Assays, and Demographics Associated with Breast-Conserving Surgery Following Neoadjuvant Therapy in Early-Stage, Hormone Receptor-Positive, HER-Negative Breast Cancer.
    Ann Surg Oncol. 2024 Sep 9. doi: 10.1245/s10434-024-16160.
    PubMed     Abstract available


  657. MUPPIDI N, Adesoye T, Hunt KK, Teshome M, et al
    ASO Author Reflections: Evolving Multidisciplinary Decision Making for Early-Stage, HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2024 Sep 9. doi: 10.1245/s10434-024-16190.
    PubMed    


  658. PARRISH K, Chiba A
    ASO Author Reflections: Not All pCRs are Created Equal, the Challenge of Inflammatory Breast Cancer.
    Ann Surg Oncol. 2024 Sep 7. doi: 10.1245/s10434-024-16129.
    PubMed    


  659. SHAH C, Whitworth P, Vicini FA, Narod S, et al
    ASO Visual Abstract: The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT((R)) PREDICT Study.
    Ann Surg Oncol. 2024;31:5959-5960.
    PubMed    


  660. SHAH C, Whitworth P, Vicini FA, Narod S, et al
    The Clinical Utility of a 7-Gene Biosignature on Radiation Therapy Decision Making in Patients with Ductal Carcinoma In Situ Following Breast-Conserving Surgery: An Updated Analysis of the DCISionRT((R)) PREDICT Study.
    Ann Surg Oncol. 2024;31:5919-5928.
    PubMed     Abstract available


  661. RAHURKAR S, Jonnalagadda P, Stover D, Andersen B, et al
    Identifying and Treating Those at Risk: Disparities in Rapid Relapse Among TNBC Patients in the National Cancer Database.
    Ann Surg Oncol. 2024;31:5896-5910.
    PubMed     Abstract available


  662. PARK KU, Padamsee TJ, Birken SA, Lee S, et al
    Factors Influencing Implementation of the Commission on Cancer's Breast Synoptic Operative Report (Alliance A20_Pilot9).
    Ann Surg Oncol. 2024;31:5888-5895.
    PubMed     Abstract available


  663. SETO Y, Ishitobi M, Shien T, Oshiro C, et al
    ASO Visual Abstract: Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.
    Ann Surg Oncol. 2024;31:5957-5958.
    PubMed    


    August 2024
  664. CORTINA CS, Purdy A, Brazauskas R, Stachowiak SM, et al
    ASO Visual Abstract: The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals-A Pilot Single-Arm Educational Intervention Trial.
    Ann Surg Oncol. 2024 Aug 30. doi: 10.1245/s10434-024-15905.
    PubMed    


  665. FERRUCCI M, Passeri D, Milardi F, Francavilla A, et al
    ASO Visual Abstract: Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged >/= 90 Years: A Large Retrospective Cohort Study.
    Ann Surg Oncol. 2024 Aug 29. doi: 10.1245/s10434-024-16086.
    PubMed    


  666. RECORD SM, Thomas SM, Dalton J, van den Bruele AB, et al
    Triple-Negative Breast Cancer in Older Patients: Does SLNB Guide Therapy?
    Ann Surg Oncol. 2024 Aug 28. doi: 10.1245/s10434-024-16106.
    PubMed     Abstract available


  667. MUPPIDI N, Adesoye T, Yi M, Sun SX, et al
    Clinical Outcomes in Patients with Early Stage Node-Negative HER2-Positive Breast Cancer Receiving Upfront Surgery or Neoadjuvant Systemic Therapy.
    Ann Surg Oncol. 2024 Aug 27. doi: 10.1245/s10434-024-16087.
    PubMed     Abstract available


  668. FU MR, Liu B, Qiu JM, Sun Y, et al
    ASO Author Reflections: Infection and Skin Trauma Incrementally Increase the Risk of Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2024 Aug 25. doi: 10.1245/s10434-024-16078.
    PubMed    


  669. MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
    ASO Author Reflections: Young Adults and Racial Minorities May Be at High Risk for Financial Toxicity After Breast Cancer Treatment.
    Ann Surg Oncol. 2024 Aug 22. doi: 10.1245/s10434-024-16050.
    PubMed    


  670. LIMBERG JN, Thomas SM, Dalton JC, Ntowe KW, et al
    ASO Visual Abstract: Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia.
    Ann Surg Oncol. 2024 Aug 19. doi: 10.1245/s10434-024-15963.
    PubMed    


  671. TCHOU J, Gottipati S, Goldbach M, Baxter M, et al
    ASO Visual Abstract: Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and is Common in Patients with HER2+ Breast Cancer.
    Ann Surg Oncol. 2024 Aug 19. doi: 10.1245/s10434-024-16090.
    PubMed    


  672. PARRISH KM, Thomas SM, Cartwright SB, van den Bruele AB, et al
    Rates of Pathologic Complete Response and Overall Survival in Patients with Inflammatory Breast Cancer: A National Cancer Database Study.
    Ann Surg Oncol. 2024 Aug 19. doi: 10.1245/s10434-024-16026.
    PubMed     Abstract available


  673. AN SJ, Thai CHNC, Ismail S, Agala CB, et al
    Nodal Response and Survival After Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive Breast Cancer: 20-Year Experience from a Single Institution.
    Ann Surg Oncol. 2024 Aug 17. doi: 10.1245/s10434-024-16059.
    PubMed     Abstract available


  674. MACCALLUM C, Elder K, Nickson C, Ruecker K, et al
    ASO Visual Abstract: Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer.
    Ann Surg Oncol. 2024 Aug 17. doi: 10.1245/s10434-024-15996.
    PubMed    


  675. HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
    ASO Visual Abstract: Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
    Ann Surg Oncol. 2024 Aug 16. doi: 10.1245/s10434-024-15990.
    PubMed    


  676. SWITALLA KM, Boughey JC, Dimitroff K, Yau C, et al
    ASO Visual Abstract: Clipping the Positive Lymph Node in Patients with Clinically Node-Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
    Ann Surg Oncol. 2024 Aug 13. doi: 10.1245/s10434-024-15965.
    PubMed    


  677. CHENG O, Fiser C, Paysour J, Aluwalia R, et al
    Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
    Ann Surg Oncol. 2024 Aug 13. doi: 10.1245/s10434-024-15789.
    PubMed     Abstract available


  678. KHORFAN R, Vora HP, Namm JP, Solomon NL, et al
    Expanded Indications for Neoadjuvant Endocrine Therapy in Early-Stage Breast Cancer During the COVID-19 Pandemic.
    Ann Surg Oncol. 2024 Aug 12. doi: 10.1245/s10434-024-15787.
    PubMed     Abstract available


  679. GLENCER AC, Wanis KN, Brown S, Lucci A, et al
    ASO Visual Abstract: Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership-Consensus and Opportunities.
    Ann Surg Oncol. 2024 Aug 10. doi: 10.1245/s10434-024-15910.
    PubMed    


  680. LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
    Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Inflammatory Breast Cancer Patients after Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Aug 9. doi: 10.1245/s10434-024-15796.
    PubMed     Abstract available


  681. TCHOU J, Gottipati S, Goldbach M, Baxter M, et al
    Change in Biomarker Profile After Neoadjuvant Chemotherapy is Prognostic and Common Among Patients with HER2+ Breast Cancer.
    Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15889.
    PubMed     Abstract available


  682. DI LENA E, Iny E, Wong SM, Bassel M, et al
    ASO Visual Abstract: Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.
    Ann Surg Oncol. 2024 Aug 8. doi: 10.1245/s10434-024-15961.
    PubMed    


  683. MATTAR A, Antonini M, Amorim A, Mateus EF, et al
    ASO Visual Abstract: PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer.
    Ann Surg Oncol. 2024 Aug 6. doi: 10.1245/s10434-024-15971.
    PubMed    


  684. WANIS KN, Goetz L, So A, Glencer AC, et al
    ASO Visual Abstract: The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast
    Ann Surg Oncol. 2024 Aug 6. doi: 10.1245/s10434-024-15913.
    PubMed    


  685. HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
    Correction: Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
    Ann Surg Oncol. 2024 Aug 5. doi: 10.1245/s10434-024-16009.
    PubMed    


  686. FERRUCCI M, Passeri D, Milardi F, Francavilla A, et al
    Surgery Plays a Leading Role in Breast Cancer Treatment for Patients Aged >/=90 Years: A Large Retrospective Cohort Study.
    Ann Surg Oncol. 2024 Aug 4. doi: 10.1245/s10434-024-15790.
    PubMed     Abstract available


  687. KHORFAN R, Vora HP, Namm JP, Solomon NL, et al
    ASO Visual Abstract: Expanded Indications for Neoadjuvant Endocrine Therapy in Early Stage Breast Cancer During the COVID-19 Pandemic.
    Ann Surg Oncol. 2024 Aug 4. doi: 10.1245/s10434-024-15921.
    PubMed    


  688. DALTON JC, Crowell KA, Ntowe KW, van den Bruele AB, et al
    ASO Visual Abstract: Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2024 Aug 2. doi: 10.1245/s10434-024-15972.
    PubMed    


  689. FALADE I, Switalla K, Quirarte A, Baxter M, et al
    ASO Visual Abstract: Oncologic Safety of Immediate Oncoplastic Surgery Compared to Standard Breast Conserving Surgery for Patients with Invasive Lobular Carcinoma.
    Ann Surg Oncol. 2024;31:5004-5005.
    PubMed    


  690. DALY AE, Anderman KJ, Smith BL
    ASO Author Reflections: Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.
    Ann Surg Oncol. 2024;31:5211-5212.
    PubMed    


  691. SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
    ASO Visual Abstract: Positive Nipple Margins in Nipple Sparing Mastectomy-Management of Nipples Containing Cancer or Atypia.
    Ann Surg Oncol. 2024;31:5230.
    PubMed    


  692. HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
    ASO Visual Abstract: "Peace of Mind" After Mastectomy: A Scoping Review.
    Ann Surg Oncol. 2024;31:5213-5214.
    PubMed    


  693. WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
    ASO Visual Abstract: Simultaneous Co-surgeon Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstructions-Feasibility and Clinical Outcomes.
    Ann Surg Oncol. 2024;31:5419-5420.
    PubMed    


  694. BEST CS, Kung TA
    ASO Author Reflections: Improving Patient Access to Autologous Breast Reconstruction.
    Ann Surg Oncol. 2024;31:5417-5418.
    PubMed    


  695. HAMID SA, Bakkila B, Schultz KS, Grimshaw AA, et al
    "Peace of Mind" After Mastectomy: A Scoping Review.
    Ann Surg Oncol. 2024;31:5168-5179.
    PubMed     Abstract available


  696. SHANNO JN, Daly AE, Anderman KJ, Santa Cruz HS, et al
    Positive Nipple Margins in Nipple-Sparing Mastectomy: Management of Nipples Containing Cancer or Atypia.
    Ann Surg Oncol. 2024;31:5148-5156.
    PubMed     Abstract available


  697. WANG CS, Al-Nowaylati AR, Matusko N, Momoh AO, et al
    Simultaneous Co-surgeon Deep Inferior Epigastric Perforator (DIEP) Flap Breast Reconstructions: Feasibility and Clinical Outcomes.
    Ann Surg Oncol. 2024;31:5409-5416.
    PubMed     Abstract available


  698. FU MR, Liu B, Qiu JM, Sun Y, et al
    The Effects of Daily-Living Risks on Breast Cancer-Related Lymphedema.
    Ann Surg Oncol. 2024 Aug 1. doi: 10.1245/s10434-024-15946.
    PubMed     Abstract available


  699. NTOWE KW, Thomas SM, Dalton JC, Olunuga E, et al
    ASO Visual Abstract: Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.
    Ann Surg Oncol. 2024 Aug 1. doi: 10.1245/s10434-024-15922.
    PubMed    


  700. MOORE AM, Caudle AS, Sun SX, Yi M, et al
    ASO Visual Abstract: Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes on Targeted Axillary Dissection.
    Ann Surg Oncol. 2024 Aug 1. doi: 10.1245/s10434-024-15966.
    PubMed    


    July 2024
  701. MACCALLUM C, Elder K, Nickson C, Ruecker K, et al
    ASO Author Reflections: Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer.
    Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15953.
    PubMed    


  702. GAO T, HoSang K, Bleicher R, Kuo L, et al
    ASO Author Reflections: The Looming Challenge of Declining Reimbursements in Breast Cancer Care.
    Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15838.
    PubMed    


  703. DALTON JC, Plichta JK
    ASO Author Reflections: Personalized Surgical Considerations in Older Women with HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15930.
    PubMed    


  704. SHAH C, Boyages J, Koelmeyer L, Chen SL, et al
    ASO Visual Abstract: Timing of Breast Cancer-Related Lymphedema Development Over 3 Years: Observations from a Large, Prospective Randomized Screening Trial Comparing Bioimpedance Spectroscopy (BIS) Versus Tape Measure.
    Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15906.
    PubMed    


  705. PRATT CG, Whitrock JN, Carter MM, Long SA, et al
    ASO Visual Abstract: Implementation of Choosing Wisely(c) Recommendations for Lymph Node Surgery in Male Breast Cancer.
    Ann Surg Oncol. 2024 Jul 31. doi: 10.1245/s10434-024-15924.
    PubMed    


  706. MYERS SP, Aviki E, Sevilimedu V, Thom B, et al
    Financial Toxicity Among Women with Breast Cancer Varies by Age and Race.
    Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15895.
    PubMed     Abstract available


  707. HU J, Lu L
    ASO Author Reflections: Significance of Predicting Omental Insufficiency in Breast Cancer Patients Receiving Immediate Breast Reconstruction with Pedicled Omental Flap After Mastectomy.
    Ann Surg Oncol. 2024 Jul 29. doi: 10.1245/s10434-024-15958.
    PubMed    


  708. LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
    ASO Visual Abstract: Clipped Axillary Node as a Potential Surrogate for Overall Axillary Nodal Status in Patients with Inflammatory Breast Cancer After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15919.
    PubMed    


  709. BELLINI A, Keegan THM, Li Q, Maguire FB, et al
    ASO Visual Abstract: Disparities in the Occurrence of Long-Term Effects of Bone Marrow Suppression after Treatment in Adolescent Young Adult Breast Cancer Survivors.
    Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15912.
    PubMed    


  710. MATTAR A, Antonini M, Amorim A, Mateus EF, et al
    PROMRIINE (PRe-operatory Magnetic Resonance Imaging is INEffective) Study: A Systematic Review and Meta-analysis of the Impact of Magnetic Resonance Imaging on Surgical Decisions and Clinical Outcomes in Women with Breast Cancer.
    Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15833.
    PubMed     Abstract available


  711. CHENG O, Postlewait LM
    ASO Author Reflections: Defining the Need for Services for Patients at High Risk of Breast Cancer at a Safety-Net Hospital: An Approach to Narrowing the Disparities Gap.
    Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15940.
    PubMed    


  712. HUA T, Mendoza S, McCririe-Balcom M, Kelley J, et al
    ASO Visual Abstract: Routine Clinical Breast Examination is a Low-Yield Practice Among Women at High Risk of Breast Cancer.
    Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15914.
    PubMed    


  713. MATTAR A
    ASO Author Reflection: Reevaluating the Role of Preoperative MRI in Breast Cancer Surgery: Lessons Learned and Future Directions.
    Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15925.
    PubMed    


  714. LOHANI KR, Hoskin TL, Yasir S, Olson CA, et al
    ASO Author Reflections: Time to Explore Minimally Invasive Axillary Nodal Staging After Neo-Adjuvant Chemotherapy in Inflammatory Breast Cancer.
    Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15856.
    PubMed     Abstract available


  715. DOLL A, Lipsyc-Sharf M, Sim MS, Baker JL, et al
    ASO Visual Abstract: Outcome of Patients with Pregnancy-Associated Breast Cancer Who Have Subsequent Pregnancies.
    Ann Surg Oncol. 2024 Jul 27. doi: 10.1245/s10434-024-15918.
    PubMed    


  716. HERNANDEZ AE, Borowsky PA, Lubarsky M, Carroll C, et al
    Associations Between Perceived Discrimination, Screening Mammography, and Breast Cancer Stage at Diagnosis: A Prospective Cohort Analysis.
    Ann Surg Oncol. 2024 Jul 26. doi: 10.1245/s10434-024-15757.
    PubMed     Abstract available


  717. CORTINA CS
    ASO Author Reflections: A Breast Cancer Risk Assessment and the Decision for Gender-Affirming Chest Masculinization Surgery or Oncologic Risk-Reducing Mastectomies in Transgender and Gender-Diverse Individuals.
    Ann Surg Oncol. 2024 Jul 26. doi: 10.1245/s10434-024-15801.
    PubMed    


  718. FERRUCCI M, Passeri D, Milardi F, Montagna G, et al
    ASO Author Reflections: Breast Cancer in Patients Aged >/= 90 Years: Surgery or No Surgery-This Is the Question.
    Ann Surg Oncol. 2024 Jul 26. doi: 10.1245/s10434-024-15885.
    PubMed    


  719. WANIS KN, Goetz L, So A, Glencer AC, et al
    The Prevalence of Sentinel Lymph Node Positivity and Implications for the Utility of Frozen Section Diagnosis Following Neoadjuvant Systemic Therapy in Patients with Clinically Node-Negative HER2-Positive or Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15712.
    PubMed     Abstract available


  720. MACCALLUM C, Elder K, Nickson C, Ruecker K, et al
    Contrast-Enhanced Mammography in Local Staging of Screen-Detected Breast Cancer.
    Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15848.
    PubMed     Abstract available


  721. DOMINICI LS, Laws A, Lagendijk M, Grossmith S, et al
    Patient-Reported Outcomes 10 Years After Breast-Conserving Surgery for Early-Stage Breast Cancer.
    Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15876.
    PubMed     Abstract available


  722. SWITALLA KM, Boughey JC, Mukhtar RA
    ASO Author Reflections: Evolving Paradigms in Axillary Management for Breast Cancer: Insights from the ISPY-2 Neoadjuvant Chemotherapy Trial.
    Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15873.
    PubMed    


  723. HU J, Deng X, Li L, Liu H, et al
    The Predictive Factors of Combined Implant Application for Breast Cancer Patients Receiving Immediate Breast Reconstruction with a Pedicled Omental Flap.
    Ann Surg Oncol. 2024 Jul 24. doi: 10.1245/s10434-024-15882.
    PubMed     Abstract available


  724. MOORE AM, Caudle AS, Sun SX, Yi M, et al
    Residual Nodal Burden After Neoadjuvant Chemotherapy in cN1 Breast Cancer Patients with Positive Nodes at Targeted Axillary Dissection.
    Ann Surg Oncol. 2024 Jul 23. doi: 10.1245/s10434-024-15797.
    PubMed     Abstract available


  725. LEE EG, Lee DE, Jung SY, Han JH, et al
    Correction: ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Jul 23. doi: 10.1245/s10434-024-15901.
    PubMed    


  726. DOLL A, Kapoor NS
    ASO Author Reflections: First Descriptions of Patients with Pregnancy Associated Breast Cancer and Subsequent Pregnancy.
    Ann Surg Oncol. 2024 Jul 23. doi: 10.1245/s10434-024-15854.
    PubMed    


  727. STRIJBOS BTM, Janssen L, Voogd AC, Zwaans WAR, et al
    ASO Author Reflections: Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors.
    Ann Surg Oncol. 2024 Jul 21. doi: 10.1245/s10434-024-15855.
    PubMed    


  728. LIMBERG JN, Thomas SM, Dalton JC, Ntowe KW, et al
    Trajectory of Subsequent Breast Cancer Diagnoses in a Diverse Patient Cohort with Breast Atypia.
    Ann Surg Oncol. 2024 Jul 21. doi: 10.1245/s10434-024-15788.
    PubMed     Abstract available


  729. GLENCER AC, Wanis KN, Brown S, Lucci A, et al
    Self-Reported Management of Inflammatory Breast Cancer Among the American Society of Breast Surgeons Membership: Consensus and Opportunities.
    Ann Surg Oncol. 2024 Jul 21. doi: 10.1245/s10434-024-15713.
    PubMed     Abstract available


  730. PRATT CG, Whitrock JN, Carter MM, Long SA, et al
    Implementation of Choosing Wisely((R)) Recommendations for Lymph Node Surgery in Male Breast Cancer.
    Ann Surg Oncol. 2024 Jul 20. doi: 10.1245/s10434-024-15811.
    PubMed     Abstract available


  731. STRIJBOS BTM, Janssen L, Voogd AC, Zwaans WAR, et al
    ASO Visual Abstract: Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors.
    Ann Surg Oncol. 2024 Jul 18. doi: 10.1245/s10434-024-15850.
    PubMed    


  732. GLENCER AC, Hunt KK, Teshome M
    ASO Author Reflections: Management of Inflammatory Breast Cancer: No Role for Surgical De-escalation Yet.
    Ann Surg Oncol. 2024 Jul 17. doi: 10.1245/s10434-024-15806.
    PubMed    


  733. LIMBERG JN, Hwang ES
    ASO Author Reflections: Trajectory of Subsequent Breast Cancer After Breast Atypia Diagnosis Suggests Need for Vigilant Follow-up.
    Ann Surg Oncol. 2024 Jul 17. doi: 10.1245/s10434-024-15869.
    PubMed    


  734. KRECKO LK, Neuman HB, Greenberg CC, Wilke LG, et al
    ASO Visual Abstract: Validation of the AJCC Eighth-Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01).
    Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15620.
    PubMed    


  735. DALTON JC, Crowell KA, Ntowe KW, van den Bruele AB, et al
    Utility of Axillary Staging in Older Patients with HER2-Positive Breast Cancer.
    Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15812.
    PubMed     Abstract available


  736. BELLINI A, Keegan THM, Li Q, Maguire FB, et al
    Disparities in the Occurrence of Long-Term Effects of Bone Marrow Suppression after Treatment in Adolescent Young Adult Breast Cancer Survivors.
    Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15707.
    PubMed     Abstract available


  737. MUNCK F, Jensen MB, Vejborg I, Gerlach MK, et al
    ASO Visual Abstract: Residual Axillary Metastases in Node-Positive Breast Cancer Patients After Neoadjuvant Treatment-A Register-Based Study.
    Ann Surg Oncol. 2024 Jul 16. doi: 10.1245/s10434-024-15752.
    PubMed    


  738. IWAI Y, Perez-Rojas S, Thomas SM, Tadros AB, et al
    ASO Visual Abstract: Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.
    Ann Surg Oncol. 2024 Jul 15. doi: 10.1245/s10434-024-15691.
    PubMed    


  739. BHIMANI F, Feldman S, Cavalli A, Chen Y, et al
    ASO Visual Abstract: Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.
    Ann Surg Oncol. 2024 Jul 15. doi: 10.1245/s10434-024-15832.
    PubMed    


  740. TORTORELLO GN, Shafique N, Keele L, Susman CG, et al
    Longitudinal Increases in Time to Surgery for Patients with Breast Cancer: A National Cohort Study.
    Ann Surg Oncol. 2024 Jul 13. doi: 10.1245/s10434-024-15723.
    PubMed     Abstract available


  741. PARK KU, Showalter SL, Dirbas FM
    Surgical Perspectives on the Updated ASTRO Guideline on Partial Breast Irradiation for Breast Cancer.
    Ann Surg Oncol. 2024 Jul 13. doi: 10.1245/s10434-024-15639.
    PubMed     Abstract available


  742. SWITALLA KM, Boughey JC, Dimitroff K, Yau C, et al
    Clipping the Positive Lymph Node in Patients with Clinically Node Positive Breast Cancer Treated with Neoadjuvant Chemotherapy: Impact on Axillary Surgery in the ISPY-2 Clinical Trial.
    Ann Surg Oncol. 2024 Jul 12. doi: 10.1245/s10434-024-15792.
    PubMed     Abstract available


  743. BELLINI A, Sauder CAM
    ASO Author Reflections: Disparities Exist for Adolescent Young Adult Breast Cancer Survivors.
    Ann Surg Oncol. 2024 Jul 11. doi: 10.1245/s10434-024-15803.
    PubMed    


  744. CARROLL JF, Hoskin TL, Hieken TJ
    Correlation of PET-CT Nodal Imaging and Pathologic Response to Neoadjuvant Immunotherapy for Node-Positive Breast Cancer.
    Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15826.
    PubMed    


  745. DOLL A, Lipsyc-Sharf M, Sim MS, Baker JL, et al
    Outcome of Patients with Pregnancy-Associated Breast Cancer Who Have Subsequent Pregnancies.
    Ann Surg Oncol. 2024 Jul 10. doi: 10.1245/s10434-024-15798.
    PubMed     Abstract available


  746. NTOWE KW, Thomas SM, Dalton JC, Olunuga E, et al
    Demographics and Clinical Decision Making in Patients with Germline Moderate Penetrance Non-BRCA Mutations in Breast Cancer Related Genes.
    Ann Surg Oncol. 2024 Jul 8. doi: 10.1245/s10434-024-15793.
    PubMed     Abstract available


  747. BOTTY VAN DEN BRUELE A, Weiss A
    Updated Guidelines on When to Consider Germline Testing for Patients with Breast Cancer.
    Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15638.
    PubMed    


  748. CHEUN JH, Chung S, Han JH, Lee YW, et al
    Surveillance for Distant Metastasis in Breast Cancer Patients Who Underwent Contemporary Management: A Report from the Korean Breast Cancer Society Survivor Research Group.
    Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15665.
    PubMed     Abstract available


  749. DI LENA E, Iny E, Wong SM, Bassel M, et al
    Impact of Margin Status on Local Recurrence in Patients with Breast Cancer Undergoing Breast-Conserving Surgery After Neoadjuvant Chemotherapy: A Retrospective Multi-Institutional Cohort Study.
    Ann Surg Oncol. 2024 Jul 5. doi: 10.1245/s10434-024-15716.
    PubMed     Abstract available


  750. SHAH C, Boyages J, Koelmeyer L, Chen SL, et al
    Timing of Breast Cancer Related Lymphedema Development Over 3 Years: Observations from a Large, Prospective Randomized Screening Trial Comparing Bioimpedance Spectroscopy (BIS) Versus Tape Measure.
    Ann Surg Oncol. 2024 Jul 4. doi: 10.1245/s10434-024-15706.
    PubMed     Abstract available


  751. BHIMANI F, Feldman S, McEvoy M
    ASO Author Reflections: Evaluating the Effectiveness of Axillary Reverse Mapping in Reducing Breast Cancer-Related Lymphedema Among Ethnically Diverse Patients.
    Ann Surg Oncol. 2024 Jul 4. doi: 10.1245/s10434-024-15663.
    PubMed    


  752. BEAULIEU-JONES BR, Ha EJ, Fefferman A, Wang J, et al
    ASO Visual Abstract: Association of Race, Ethnicity, Language and Insurance and Time to Treatment Initiation Among Women with Breast Cancer at an Urban, Academic, Safety-Net Hospital.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15647.
    PubMed    


  753. HUA T, Mendoza S, McCririe-Balcom M, Kelley J, et al
    Routine Clinical Breast Examination Is a Low-Yield Practice Among Women at High Risk of Breast Cancer.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15702.
    PubMed     Abstract available


  754. MCINTOSH SA, Mactier M, Fairhurst K, Gath J, et al
    ASO Visual Abstract: Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15683.
    PubMed    


  755. MISHRA A, Deo SVS, Kumar N, Bansal B, et al
    ASO Visual Abstract: A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low-Middle Income Country.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15696.
    PubMed    


  756. SHEN A, Qiang W, Zhao H, Han G, et al
    Contemporaneous Symptom Networks of Breast Cancer-Related Upper Limb Lymphedema: A Network Analysis.
    Ann Surg Oncol. 2024 Jul 3. doi: 10.1245/s10434-024-15676.
    PubMed     Abstract available


  757. KING TA, Mittendorf EA
    Breast Articles From 2023: Informing Practice Across the Continuum of Care.
    Ann Surg Oncol. 2024;31:4470-4476.
    PubMed     Abstract available


  758. SETO Y, Ishitobi M, Nakayama T
    ASO Author Reflections: Do Patients with Ipsilateral Breast Tumor Recurrence Prefer Repeat Breast-Conserving Surgery or Mastectomy?
    Ann Surg Oncol. 2024;31:4540.
    PubMed    


  759. SETO Y, Ishitobi M, Shien T, Oshiro C, et al
    Patient Preference for Surgical Methods for Ipsilateral Breast Tumor Recurrence.
    Ann Surg Oncol. 2024;31:4512-4517.
    PubMed     Abstract available


  760. KIM M, Gilliland JL, Parnes MF, Bruce C, et al
    BREAST-Q REACT: Qualitative Assessment of the Design, Functionality, and Clinical Utility of a New Score Interpretation Tool.
    Ann Surg Oncol. 2024;31:4498-4511.
    PubMed     Abstract available


  761. CHU JJ, Tadros AB, Vingan PS, Assel MJ, et al
    ASO Visual Abstract: Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early Symptoms Predict 30-Day Surgical Complications.
    Ann Surg Oncol. 2024;31:4547-4548.
    PubMed    


    June 2024
  762. JONNALAGADDA P, Rahurkar S
    ASO Author Reflections: Disparities in Triple-Negative Breast Cancer Care: Are Some Patients Being Overlooked?
    Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15640.
    PubMed    


  763. PILEWSKIE M, Eroglu I, Sevilimedu V, Le T, et al
    Participation in a High-Risk Program Is Associated with a Diagnosis of Earlier-Stage Disease Among Women at Increased Risk for Breast Cancer Development.
    Ann Surg Oncol. 2024 Jun 29. doi: 10.1245/s10434-024-15633.
    PubMed     Abstract available


  764. STRIJBOS BTM, Janssen L, Voogd AC, Zwaans WAR, et al
    Persistent Pain After Breast Cancer Treatment, an Underreported Burden for Breast Cancer Survivors.
    Ann Surg Oncol. 2024 Jun 28. doi: 10.1245/s10434-024-15682.
    PubMed     Abstract available


  765. CORTINA CS, Purdy A, Brazauskas R, Stachowiak SM, et al
    The Impact of a Breast Cancer Risk Assessment on the Decision for Gender-Affirming Chest Masculinization Surgery in Transgender and Gender-Diverse Individuals: A Pilot Single-Arm Educational Intervention Trial.
    Ann Surg Oncol. 2024 Jun 28. doi: 10.1245/s10434-024-15701.
    PubMed     Abstract available


  766. LEE EG, Lee DE, Jung SY, Han JH, et al
    ASO Author Reflections: Assessing the Efficacy of Multimodal Sentinel Lymph Node Mapping in Breast Cancer Patients After Neoadjuvant Chemotherapy.
    Ann Surg Oncol. 2024 Jun 24. doi: 10.1245/s10434-024-15580.
    PubMed    


  767. JUNG JJ, Moon HG
    ASO Author Reflections: Contralateral Axillary Metastasis in Breast Cancer: Prognostic Variability and Benefits of Surgical Treatment.
    Ann Surg Oncol. 2024 Jun 20. doi: 10.1245/s10434-024-15440.
    PubMed    


  768. IWAI Y, Perez-Rojas S, Thomas SM, Tadros AB, et al
    Guideline-Concordant Surgical Care for Lobular Versus Ductal Inflammatory Breast Cancer.
    Ann Surg Oncol. 2024 Jun 17. doi: 10.1245/s10434-024-15540.
    PubMed     Abstract available


  769. CARROLL JF, Hoskin TL, Leon-Ferre RA, Boughey JC, et al
    Impact of Presenting Stage on Overall Survival in Patients Treated with Neoadjuvant Chemotherapy for Triple Negative Breast Cancer.
    Ann Surg Oncol. 2024 Jun 13. doi: 10.1245/s10434-024-15583.
    PubMed     Abstract available


  770. LEE EG, Lee DE, Jung SY, Han JH, et al
    ASO Visual Abstract: Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
    Ann Surg Oncol. 2024 Jun 12. doi: 10.1245/s10434-024-15482.
    PubMed    


  771. MISHRA A, Deo SVS, Kumar N, Bansal B, et al
    A Prospective Questionnaire-Based Study Evaluating Genetic Literacy and Impact of Brief Educational Intervention Among Breast Cancer Patients in a Low- to Middle-Income Country.
    Ann Surg Oncol. 2024 Jun 11. doi: 10.1245/s10434-024-15527.
    PubMed     Abstract available


  772. BHIMANI F, Feldman S, Cavalli A, Chen Y, et al
    Axillary Reverse Mapping Aids in Reducing the Rates of Breast Cancer-Related Lymphedema in Underserved Ethnically Diverse Population.
    Ann Surg Oncol. 2024 Jun 6. doi: 10.1245/s10434-024-15577.
    PubMed     Abstract available


  773. JUNG JJ, Cheun JH, Kang E, Shin I, et al
    ASO Visual Abstract: Survival After the Contralateral Axillary Metastasis in Breast Cancer.
    Ann Surg Oncol. 2024 Jun 6. doi: 10.1245/s10434-024-15546.
    PubMed    


  774. GILMORE RC, Fine RE
    Reply to: Comment on: Cryoablation Without Excision for Low-Risk Early-Stage Breast Cancer: 3-Year Interim Analysis of Ipsilateral Breast Tumor Recurrence in the ICE3 Trial.
    Ann Surg Oncol. 2024 Jun 5. doi: 10.1245/s10434-024-15502.
    PubMed    


  775. MYERS SP, Sevilimedu V, Jones VM, Abuhadra N, et al
    ASO Visual Abstract: Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2024 Jun 4. doi: 10.1245/s10434-024-15491.
    PubMed    


  776. KRECKO LK, Neuman HB, Greenberg CC, Wilke LG, et al
    Validation of the AJCC 8th Edition Breast Cancer Prognostic Staging System in Legacy Alliance Trials (AFT-01).
    Ann Surg Oncol. 2024 Jun 2. doi: 10.1245/s10434-024-15477.
    PubMed     Abstract available


  777. CHAUHAN H, Ashrafian H, Takats Z, Leff DR, et al
    ASO Author Reflections: The Impact of DCIS on Positive Margin Rates.
    Ann Surg Oncol. 2024;31:3948-3949.
    PubMed    


  778. CHAUHAN H, Jiwa N, Nagarajan VR, Thiruchelvam P, et al
    Clinicopathological Predictors of Positive Resection Margins in Breast-Conserving Surgery.
    Ann Surg Oncol. 2024;31:3939-3947.
    PubMed     Abstract available


  779. CARROLL MC, Yen RW, Leech M, Barth RJ Jr, et al
    A Systematic Review and Meta-analysis of the Role of Preoperative MRI in In-breast Tumor Recurrence After Breast-Conserving Surgery.
    Ann Surg Oncol. 2024;31:3926-3938.
    PubMed     Abstract available


  780. VINGAN PS, Serafin J, Boe L, Zhang KK, et al
    Reducing Disparities: Regional Anesthesia Blocks for Mastectomy with Reconstruction Within Standardized Regional Anesthesia Pathways.
    Ann Surg Oncol. 2024;31:3684-3693.
    PubMed     Abstract available


  781. GONZALEZ L, Johnson NC, Jones VC, Taylor L, et al
    An Observational Cohort Study Comparing Positive Margin Rates Using an Electromagnetic Navigational System Versus Wire Localization in Breast Conservation Surgery.
    Ann Surg Oncol. 2024;31:3669-3671.
    PubMed    


  782. KIM Y, Ganduglia-Cazaban C, Tamirisa N, Lucci A, et al
    Contemporary Analysis of Reexcision and Conversion to Mastectomy Rates and Associated Healthcare Costs for Women Undergoing Breast-Conserving Surgery.
    Ann Surg Oncol. 2024;31:3649-3660.
    PubMed     Abstract available



  783. The American Society of Breast Surgeons Official Proceedings, Volume XXV 2024 Annual Meeting Scientific Session Abstracts.
    Ann Surg Oncol. 2024;31.
    PubMed    


    May 2024
  784. SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
    Racial Disparities in Breast Cancer Genetic Testing May be Mitigated by Counseling.
    Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15434.
    PubMed     Abstract available


  785. SIEGEL JB, Bertolino M, Mukherjee R, Meeder K, et al
    ASO Visual Abstract: Racial Disparities in Breast Cancer Genetic Testing may be Mitigated by Counseling.
    Ann Surg Oncol. 2024 May 29. doi: 10.1245/s10434-024-15536.
    PubMed    


  786. NG TP, Loo BYK, Yong N, Chia CLK, et al
    ASO Visual Abstract: Implant-Based Breast Reconstruction After Mastectomy for Breast Cancer: A Meta-analysis of Randomised Controlled Trials and Prospective Studies Comparing Use of Acellular Dermal Matrix (ADM) Versus Without ADM.
    Ann Surg Oncol. 2024 May 23. doi: 10.1245/s10434-024-15446.
    PubMed    


  787. MYERS SP, Downs-Canner SM
    ASO Author Reflections: Immune-Related Adverse Events During Neoadjuvant Chemoimmunotherapy for Triple-Negative Breast Cancer May Influence Time to Adjuvant Radiation.
    Ann Surg Oncol. 2024 May 22. doi: 10.1245/s10434-024-15445.
    PubMed    


  788. MCINTOSH SA, Mactier M, Fairhurst K, Gath J, et al
    Understanding Patient Experiences to Inform Future Studies to Optimize Personalization of Treatment for Early Breast Cancer.
    Ann Surg Oncol. 2024 May 21. doi: 10.1245/s10434-024-15459.
    PubMed     Abstract available


  789. ROACH EA, Weil CR, Cannon G, Grant J, et al
    ASO Visual Abstract: The Role of Axillary Lymph Node Dissection Versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b-N3c Disease Who Receive Adjuvant Radiotherapy.
    Ann Surg Oncol. 2024 May 20. doi: 10.1245/s10434-024-15419.
    PubMed    


  790. MYERS SP, Sevilimedu V, Jones VM, Abuhadra N, et al
    Impact of Neoadjuvant Chemoimmunotherapy on Surgical Outcomes and Time to Radiation in Triple-Negative Breast Cancer.
    Ann Surg Oncol. 2024 May 20. doi: 10.1245/s10434-024-15359.
    PubMed     Abstract available


  791. PARVEZ E, Bogach J, Kirkwood D, Pond G, et al
    ASO Visual Abstract: Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis.
    Ann Surg Oncol. 2024 May 11. doi: 10.1245/s10434-024-15376.
    PubMed    


  792. NGUYEN CL, Cui R, Zhou M, Ali F, et al
    ASO Visual Abstract: Cost-Effectiveness of Radar Localization Versus Wire Localization for Wide Local Excision of Non-palpable Breast Cancer.
    Ann Surg Oncol. 2024 May 9. doi: 10.1245/s10434-024-15383.
    PubMed    


  793. LEE EG, Lee DE, Jung SY, Han JH, et al
    Clinical Application of Multimodal Sentinel Lymph Node Mapping Method in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy: An Interim Analysis.
    Ann Surg Oncol. 2024 May 8. doi: 10.1245/s10434-024-15317.
    PubMed     Abstract available


  794. HAMID SA, Schultz KS, Greenup RA
    ASO Author Reflections: "Peace of Mind" After Surgery for Breast Cancer: Implications for Preference-Sensitive Shared Decision Making.
    Ann Surg Oncol. 2024 May 7. doi: 10.1245/s10434-024-15408.
    PubMed    


  795. PFOB A, Kokh DB, Surovtsova I, Riedel F, et al
    Oncologic Outcomes for Different Axillary Staging Techniques in Patients with Nodal-Positive Breast Cancer Undergoing Neoadjuvant Systematic Treatment: A Cancer Registry Study.
    Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15292.
    PubMed     Abstract available


  796. NIJVELDT JJ, Rajan KK, Boersma K, Noorda EM, et al
    ASO Visual Abstract: Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer-A Retrospective Analysis.
    Ann Surg Oncol. 2024 May 6. doi: 10.1245/s10434-024-15375.
    PubMed    


  797. MUNCK F, Jensen MB, Vejborg I, Gerlach MK, et al
    Residual Axillary Metastases in Node-Positive Breast Cancer Patients After Neoadjuvant Treatment: A Register-Based Study.
    Ann Surg Oncol. 2024 May 4. doi: 10.1245/s10434-024-15354.
    PubMed     Abstract available


  798. JUNG JJ, Cheun JH, Kang E, Shin I, et al
    Survival After Contralateral Axillary Metastasis in Breast Cancer.
    Ann Surg Oncol. 2024 May 2. doi: 10.1245/s10434-024-15370.
    PubMed     Abstract available


  799. GREENE AJE, Davis J, Moon J, Dubin I, et al
    Determination of Factors Associated with Upstage in Atypical Ductal Hyperplasia to Identify Low-Risk Patients Where Active Surveillance May be an Alternative.
    Ann Surg Oncol. 2024;31:3177-3185.
    PubMed     Abstract available


  800. CHU JJ, Tadros AB, Vingan PS, Assel MJ, et al
    Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early Symptoms Predict 30-Day Surgical Complications.
    Ann Surg Oncol. 2024;31:3377-3386.
    PubMed     Abstract available


    April 2024
  801. KAUFMAN C, Sarantou T, Donovan C, Kamali Polat A, et al
    ASO Author Reflections: Increasing Time of Diagnosis to Breast Cancer Surgery.
    Ann Surg Oncol. 2024 Apr 29. doi: 10.1245/s10434-024-15295.
    PubMed    


  802. ROACH EA, Weil CR, Cannon G, Grant J, et al
    The Role of Axillary Lymph Node Dissection versus Sentinel Lymph Node Dissection in Breast Cancer Patients with Clinical N2b-N3c Disease Who Receive Adjuvant Radiotherapy.
    Ann Surg Oncol. 2024 Apr 22. doi: 10.1245/s10434-024-15280.
    PubMed     Abstract available


  803. PARVEZ E, Bogach J, Kirkwood D, Pond G, et al
    Immigration Status and Breast Cancer Surgery Quality of Care Metrics: A Population-Level Analysis.
    Ann Surg Oncol. 2024 Apr 18. doi: 10.1245/s10434-024-15250.
    PubMed     Abstract available


  804. XIONG M, Young AT, Fernandez A, Jones JS, et al
    Understanding Breast Cancer Surgery Through Tiktok: an Analysis of Video Content and Viewer Engagement.
    Ann Surg Oncol. 2024 Apr 9. doi: 10.1245/s10434-024-15268.
    PubMed     Abstract available


  805. QIU M, Liang F, Xie Y, Yang H, et al
    Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction: A Prospective Study of Initial 68 Procedures.
    Ann Surg Oncol. 2024;31:2777-2785.
    PubMed     Abstract available


  806. WESTENEND P, Meurs C, van Bekkum S, van Rosmalen J, et al
    ASO Author Reflections: What Can Prediction Models for Upstaging of DCIS Diagnosed on Biopsy Tell Us About DCIS Surveillance Trials?
    Ann Surg Oncol. 2024;31:2272-2273.
    PubMed    


  807. EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
    ASO Visual Abstract: Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy-Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
    Ann Surg Oncol. 2024;31:2276-2277.
    PubMed    


  808. SINGH P, Agnese D, Amin M, Barrio AV, et al
    Society of Surgical Oncology Breast Disease Site Working Group Statement on Contralateral Mastectomy: Indications, Outcomes, and Risks.
    Ann Surg Oncol. 2024;31:2212-2223.
    PubMed     Abstract available


  809. RUBENSTEIN RN, Kim M, Plotsker EL, Chu JJ, et al
    Early Complications in Prepectoral Tissue Expander-Based Breast Reconstruction.
    Ann Surg Oncol. 2024;31:2766-2776.
    PubMed     Abstract available


  810. QIU M, Liang F, Xie Y, Yang H, et al
    ASO Author Reflections: A Novel Technique of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction.
    Ann Surg Oncol. 2024;31:2791-2792.
    PubMed    


  811. POLIDORIO N, Montagna G, Sevilimedu V, Le T, et al
    Do HER2-Low Tumors Have a Distinct Clinicopathologic Phenotype?
    Ann Surg Oncol. 2024;31:2231-2243.
    PubMed     Abstract available


  812. QIU M, Liang F, Xie Y, Yang H, et al
    ASO Visual Abstract: Clinical Outcomes of Transaxillary Reverse-Sequence Endoscopic Nipple-Sparing Mastectomy and Direct-to-Implant Prepectoral Breast Reconstruction-A Prospective Study of Initial 68 Procedures.
    Ann Surg Oncol. 2024;31:2794-2795.
    PubMed    


  813. EVERIDGE SA, Sun J, Teshome M, Tamirisa N, et al
    Lobular Neoplasia Diagnosed by MRI-Guided Breast Biopsy: Identifying Upgrade Rate to Malignancy and Outcomes of Clinical and Surgical Management.
    Ann Surg Oncol. 2024;31:2224-2230.
    PubMed     Abstract available


  814. WIENER AA, Schumacher JR, Perlman SB, Wilke LG, et al
    A Four-Arm Randomized Clinical Trial of Topical Pain Control for Sentinel Node Radiotracer Injections in Patients with Breast Cancer.
    Ann Surg Oncol. 2024 Apr 1. doi: 10.1245/s10434-024-15235.
    PubMed     Abstract available


    March 2024
  815. SCODARI BT, Schaefer AP, Kapadia NS, Brooks GA, et al
    The Association Between Oncology Outreach and Timely Treatment for Rural Patients with Breast Cancer: A Claims-Based Approach.
    Ann Surg Oncol. 2024 Mar 27. doi: 10.1245/s10434-024-15195.
    PubMed     Abstract available


  816. NIJVELDT JJ, Rajan KK, Boersma K, Noorda EM, et al
    Implementation of the Targeted Axillary Dissection Procedure in Clinically Node-Positive Breast Cancer: A Retrospective Analysis.
    Ann Surg Oncol. 2024 Mar 24. doi: 10.1245/s10434-024-15182.
    PubMed     Abstract available


  817. NGUYEN CL, Cui R, Zhou M, Ali F, et al
    Cost-Effectiveness of Radar Localisation Versus Wire Localisation for Wide Local Excision of Non-palpable Breast Cancer.
    Ann Surg Oncol. 2024 Mar 12. doi: 10.1245/s10434-024-15142.
    PubMed     Abstract available


  818. CHUNG AP, Dang CM, Karlan SR, Amersi FF, et al
    ASO Visual Abstract: A Prospective Study of Sentinel Node Biopsy Omission in Women Age >/= 65 with ER+ Breast Cancer.
    Ann Surg Oncol. 2024 Mar 6. doi: 10.1245/s10434-024-15137.
    PubMed    


  819. COSTARELLI L, Arienzo F, Broglia L, La Pinta M, et al
    Clipping a Positive Lymph Node Improves Accuracy of Nodal Staging After Neoadjuvant Chemotherapy for Breast Cancer Patients, but Does It Drive Management Changes?
    Ann Surg Oncol. 2024 Mar 1. doi: 10.1245/s10434-024-15052.
    PubMed     Abstract available


    February 2024
  820. JAKUB JW, Advani P, Maxwell R, Vallow L, et al
    SOUND (Sentinel Node Versus Observation After Axillary Ultrasound) Trial: Are We Ready to Change the Tune of Our Breast Cancer Practice?
    Ann Surg Oncol. 2024 Feb 28. doi: 10.1245/s10434-024-15111.
    PubMed    


    November 2023
  821. SETO A, Pass A, Babkowski R, Volpicelli ER, et al
    Routine Use of a Standardized Mastectomy Diagram by Surgeons Improves Accuracy and Timeliness of the Final Pathological Report.
    Ann Surg Oncol. 2023;30:7124-7130.
    PubMed     Abstract available


  822. FRANCO I, Alshalalfa M, Hernandez A, Mahal BA, et al
    Genomic Characterization of Aggressive Breast Cancer in Younger Women.
    Ann Surg Oncol. 2023;30:7569-7578.
    PubMed     Abstract available


  823. MEURS CJC, van Bekkum S, van Rosmalen J, Menke-Pluijmers MBE, et al
    Validation and Clinical Utility of a Prediction Model for the Risk of Upstaging to Invasive Breast Cancer After a Biopsy Diagnosis Ductal Carcinoma In Situ.
    Ann Surg Oncol. 2023;30:7069-7080.
    PubMed     Abstract available


  824. ZAVERI S, Everidge S, FitzSullivan E, Hwang R, et al
    Extremely Low Incidence of Local-Regional Recurrences Observed Among T1-2 N1 (1 or 2 Positive SLNs) Breast Cancer Patients Receiving Upfront Mastectomy Without Completion Axillary Node Dissection.
    Ann Surg Oncol. 2023;30:7015-7025.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.

Privacy / Datenschutzerklärung | Imprint / Impressum